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Abstract 
Social dysfunction is a hallmark feature of Autism Spectrum Disorder (ASD).  However 
since the initial description of ASD by Kanner (1943) it has been recognized that the disorder 
may manifest from a more basic neuropsychological deficit in attention and/or arousal, and 
previous studies have found altered autonomic and attentional responses during both baseline 
conditions and in response to socially-relevant stimuli in those with ASD.  Based on this line of 
inquiry, we recently used eye-tracking technology to examine visual scanning and pupillary 
responses and found a larger tonic (baseline) pupil size (Anderson & Colombo, 2009) and altered 
phasic (task-specific) pupillary responses to human faces, with no group-based differences in 
visual scanning (Anderson, Colombo, & Shaddy, 2006) in 2-5 year old children with ASD 
compared to age-matched controls.  To replicate and extend these previous results, children (20 – 
72 months of age) with ASD (n = 12), along with Down syndrome (DS; n = 9), and typically-
developing (TD; n = 11) age-matched controls were presented with a social and a non-social 
dynamic and multimodal video clip.  Each stimulus was presented for 10 minutes on two 
separate testing days; location of gaze and pupil size was recorded, along with salivary measures 
of alpha-amylase and cortisol.  Tonic measures of pupil size, AA and cortisol were also recorded 
during a baseline period.  The ASD group was significantly distinguished in group-based 
analyses from both the DS and TD groups through (a) a larger tonic pupil size, (b) lower tonic 
levels of AA, which were significantly related to tonic pupil size, and (c) increased phasic pupil 
responses to the social stimulus.  These findings provide replication of our previous 
investigations and a unique finding of lower AA levels in the ASD group.  These results may 
provide clues about underlying norepinephrine system pathology in ASD, and the potential of 
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non-invasive measures of pupil size and salivary AA in the early identification and screening of 
the disorder. 
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Alpha-Amylase, Cortisol, and Pupillary Responses to Social and Non-Social Dynamic Scenes in 
Young Children with Autism Spectrum Disorder 
 Social dysfunction is a hallmark feature of Autism Spectrum Disorder (ASD) and is one 
of the three core behavioral deficits used to diagnose the disorder; the core dysfunctions include 
deficits in social interaction, communication, and the presence of repetitive or stereotyped 
behaviors (American Psychiatric Association [APA], 1994).  In addition, there are a number of 
other fundamental impairments and deficits demonstrated in persons with ASD.  Persons with 
ASD have shown deficits in social orienting, human face processing, emotion processing, 
executive function, theory of mind, abstraction, central coherence, joint attention, attentional 
orienting, sustained attention, sensory modulation, arousal, and motor disturbances (see Bailey, 
Phillips, & Rutter, 1996; Joseph, 1999; Klinger, Dawson, & Renner, 2003, for reviews).  
Neurological investigations have generated both neuroanatomical and neurochemical findings in 
persons with ASD.  The neuroanatomical findings suggest impairments in the brainstem, 
cerebellum, ventricles, amygdala, hippocampus, limbic cortex, temporal lobe, parietal lobe, 
frontal lobe, and corpus callosum to be involved in ASD (see Acosta & Pearl, 2004; Bauman & 
Kemper, 1985; Brambilla, Hardan, di Nemi, Perez, Soares, & Barale, 2003; Palmen, van 
Engeland, Hof, & Schmitz, 2004, for reviews).  Neurochemical investigations have found 
alterations in epinephrine, norepinephrine (NE), serotonin (5-HT), acetycholine (ACh), 
glutamate (Glu), and gamma-aminobutryric acid (GABA) systems in those with ASD (see, 
Cook, 1990; Volkmar & Anderson, 1989, for reviews). 
Neuropathologic Models of Autism Spectrum Disorder 
Since the initial description of ASD by Kanner (1943), it has been recognized that the 
symptoms of the disorder may manifest from a more basic neuropsychological deficit in 
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attention and/or arousal (e.g., Ornitz, 1969; Dawson & Lewy, 1989).  Since this time, 
investigations at multiple-levels of analysis have led to a heterogeneous range of behavioral, 
cognitive, and neurological findings in ASD.  However, despite the fact that ASD is generally 
accepted as a neurodevelopmental disorder, the neuropathologic origin of this disorder remains 
elusive and a wide array of theories on the neurological origin of ASD have been posited.  
Contemporary neuropathologic theories, based on results from post-mortem and neuroimaging 
studies, have focused on the limbic system, cerebellum, and brainstem as being the source of 
ASD neuropathology, with attention and arousal continuing to emerge as a consistent theme in 
these contemporary theories.   
Limbic System 
Limbic system.  One of the most consistent neuroanatomical findings from postmortem 
examinations in ASD is a reduced cell size and increased cell density within the hippocampus, 
amygdala, mammillary bodies, anterior cingulate gyrus, and septum, all of which make up a 
major portion of the forebrain limbic system (Bauman & Kemper, 1984, 1985, 1987, 1990), and 
a decreased number of neurons within the amygdala (Schumann & Amaral, 2006).  Bauman and 
Kemper (1998) suggested that the nature of the limbic system impairment in ASD is consistent 
with a curtailed development of these structures, as small, densely packed neurons in the limbic 
system are typically seen during earlier stages of development before they have reached adult 
proportions.  In addition, early acquired lesions to newborn rhesus monkeys within the 
amygdala, hippocampus, and adjacent cortical areas have been found to produce similar motor 
stereotypies, memory (e.g., impaired explicit memory, which is rapid one-trial learning, and 
preserved habitual memory, which is acquired by repeated presentation of the same object), and 
socioemotional (e.g., lack of social initiation, increased irritability in social situations, decreased 
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social interaction, lack of eye contact) deficits as those found in persons with ASD (Bachevalier, 
1994).  Therefore, it has been suggested that prenatal impairment within the limbic system 
causes a cascade of developmental effects that may include further neural impairment of cortical 
structures via corticolimbic connections (Bauman & Kemper, 1998), and additional neural 
compensatory effects that may include a progressive increase in brain weight that could reflect 
increased neurogenesis, decreased apoptosis, and decreased synaptic pruning (Bauman & 
Kemper, 2005).  Bauman and Kemper (1998) suggested that prenatal impairment to the forebrain 
limbic structures could disrupt the acquisition and interpretation of information resulting in the 
cognitive, language, and social interaction deficits found in those with ASD.  In addition they 
suggested that the preservation of habit memory would lead to a need for sameness and 
preoccupied interests, and impaired explicit memory would lead to an inability to acquire social, 
language, and cognitive skills.   
Amygdala.  A more recent limbic system theory of ASD has focused specifically on the 
amygdala (Baron-Cohen et al., 2000) and is based on the role that the amygdala is believed to 
play in social cognition (Brothers, 1990).  Experimental lesions of the amygdala have been found 
to result in social avoidance, lack of eye contact, absence of facial expressions and emotional 
reactions, abnormal movement patterns and stereotypies, increased aggression, loss of fear, and 
examination of objects by mouth and smell in non-human primates, with the greatest social 
effects occurring when lesions were sustained during the neonatal period (see Baron-Cohen et 
al., 2000; Sweeten, Posey, Shekhar, & McDougle, 2002, for reviews).  Studies of human 
amygdala lesions and functional magnetic resonance imaging (fMRI) also support a role for the 
amygdala in social behavior.  Persons with amygdala lesions have been shown to display social 
deficits similar to those found in ASD (see Sweeten et al., 2002, for a review), and increased 
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amygdala activation has been found to be associated with the presentation of facial expressions 
and interpretation of gaze direction (see Pelphrey, Adolphs, & Morris, 2004, for a review).  
Neuroimaging examinations have further implicated the presence of amygdala impairments in 
persons with ASD, although the results of these investigations have been inconsistent.  For 
example, some MRI examinations have found reduced (Aylward et al., 1999; Nacewicz et al., 
2006) and increased (Abell et al., 1999; Howard et al., 2000; Sparks et al., 2002) amygdala 
volumes, while others have found no differences (Haznedar et al., 2000; Saitoh, Courchesne, 
Egaas, Lincoln, & Schreibman, 1995).  Although age has been found to have a significant effect 
on amygdala volume in ASD, with studies of children with ASD showing enlarged amygdala 
volume, adult ASD studies have found no differences (Stanfield et al., 2008).  Thus age 
differences may explain the volumetric discrepancies in amygdala imaging studies in ASD.  In 
addition, fMRI examinations in ASD have revealed increased amygdala activation to human 
faces (Kleinhans et al., 2009) and while fixating within the eye region of human faces (Dalton et 
al., 2005), while other studies have found less amygdala activation to human faces depicting fear 
(Ashwin, Baron-Cohen, Wheelwright, O’Riordan, & Bullmore, 2007), when inferring mental 
states from the eye region of human faces (Baron-Cohen et al., 1999) and when inferring gender 
(Critchley et al., 2000) in persons with ASD.   
A more recent line of inquiry, has suggested that the amygdala may not be the source of 
ASD social deficits (Amaral & Corbett, 2003; Bauman, Lavenex, Mason, Capitanio, & Amaral, 
2004; Dziobek, Fleck, Rogers, Wolf, & Convit, 2006).  Instead, based on non-human primate 
studies of bilateral lesions to the amygdala in adults and neonates, it has been suggested that the 
role of the amygdala may be to evaluate the environment for possible threats, as impaired 
primates have been shown to display decreased fear responses to fear-provoking objects and 
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increased fear responses during novel social interactions, with preserved social behaviors 
(Amaral & Corbett, 2003; Bauman et al., 2004; Prather et al., 2001).  Thus, while the role of the 
amygdala in ASD is unclear, these recent investigations suggest that impairment within this 
structure may be related to abnormal fears and anxiety rather than social deficits.  However, 
further investigations are needed to determine the role of the amygdala in ASD and to determine 
if amygdala impairment might be a core dysfunction or may be a secondary consequence of 
other neural impairments.   
Cerebellum and Brainstem 
Since the initial description of ASD by Kanner (1943), it has been recognized that the 
symptoms of ASD may manifest from a more basic neuropsychological deficit in arousal and 
attention (e.g., Courchesne et al., 1995; Dawson & Lewy, 1989; Ornitz, 1969).  This is because 
appropriate levels of arousal and the allocation of attention are necessary precursors to higher 
cognitive functions (e.g., Colombo, 2001; James, 1890; Lane & Pearson, 1982); therefore, 
attentional and/or arousal deficits could interfere with an individuals’ with ASD ability to attend, 
process, and interact with the environment and result in a failure to acquire normative skills (e.g., 
Bryson, Landry, & Wainwright, 1997; Dawson & Lewy, 1989).  In addition, the neural systems 
that underlie arousal and attention (e.g., the cerebellum, pons and medulla), can alter neuronal 
activity in areas responsible for sensory, motor, and emotional processing (Posner & Raichle, 
1994).  Consequently, structural examinations have revealed consistent abnormalities within the 
cerebellum and brainstem in persons with ASD, and these observations have led to several 
theories on how cerebellum and brainstem impairment may be involved in generating the 
behavioral, cognitive, and neural effects found in ASD.   
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Cerebellum.  The majority of postmortem examinations investigating the cerebellum in 
ASD have revealed a significant reduction in the number of Purkinje cells (Bailey et al., 1998; 
Bauman, Filipek, & Kemper, 1997; Bauman & Kemper, 1985, 1990, 1994, 1998; Fatemi et al., 
2002; Ritvo et al., 1986; Vargas, Nascimbene, Krishnan, Zimmerman, & Pardo, 2004; 
Weidenheim et al., 2001; Williams, Hauser, Purpura, DeLong, & Swisher, 1980), however a 
recent study using an updated stereology method found only half of the ASD brains (three out of 
six) to contain this reduction (Whitney, Kemper, Bauman, Rosene, & Blatt, 2008).  MRI 
examinations have also revealed cerebellum impairment in those with ASD, although the 
direction and results of these investigations have been varied.  Some studies have revealed a 
decreased size of the cerebellar vermis lobules VI-VIII (Courchesne et al., 2001; Courchesne, 
Yeung-Courchesne, Press, Hesselink, & Jernigan, 1988; Kaufmann et al., 2003; Muurakami, 
Courchesne, Press, Yeung-Courchesne, & Hesselink, 1989; Piven et al., 1992; Rojas et al., 2006) 
and lobules VIII – X (Hashimoto, Tayama, Miyazaki, Murakawa, & Kuroda, 1993; Levitt et al., 
1999; Rojas et al., 2006), reduced vermis volume (Scott, Schumann, Goodlin-Jones, & Amaral, 
2009), increased (Hardan, Minshew, Harenski, & Keshavan, 2001) and reduced cerebellar 
volume (Hallahan et al., 2009), and proportionately decreased (Gaffne, Tsai, Kuperman, & 
Minchin, 1987) and increased cerebellum size (Herbert et al., 2003; Sparks et al., 2002) in ASD; 
other studies have found no differences (Garber & Ritvo, 1992; Hashimoto et al., 1993; 
Hashimoto, Murakawa, Miyazaki, Tayama, & Kuroda, 1992; Holttum, Minshew, Sanders, & 
Phillips, 1992; Kleiman, Neff, & Rosman, 1992; Manes, Piven, Vrancic, Nanclares, Plebst, & 
Starstein, 1999).  However, a recent meta-analysis of MRI investigations suggests that the 
heterogeneity of these results may be due to age; Stanfield et al (2008) found that as the mental- 
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and chronological-age of the subjects increased the reduction in vermal lobule VI-VII volumes 
of subjects with ASD became less evident.  
Functionally, the cerebellum is believed to play a role in attentional orienting 
(Akshoomoff & Courchesne, 1992; Allen, Buxton, Wong, & Courchesne, 1997) and further 
evidence for cerebellum involvement in ASD comes from studies revealing that persons with 
ASD have slowed orienting responses to target stimuli that occur at intervals of 500 msec or less, 
but show typical responses to target stimuli that occur after 700 msec (e.g. Casey, Gordon, 
Mannheim, & Rumsey, 1993; Harris, Courchesne, Townsend, Carper, & Lord, 1999; Townsend 
et al., 1999; Townsend, Harris, & Courchesne, 1996; Townsend & Courchesne, 1994).  In 
addition, functional neuroimaging examinations reveal reduced cerebellar activation to target 
stimuli (Allen & Courchesne, 2003), while listening to tones (Muller et al., 1999), and during 
tasks requiring the judgment of emotional expressions (Critchley et al., 2000).   
It has been suggested that the reduction in inhibitory Purkinje cells within the cerebellum 
could lead to frontal and temporal lobe impairments through excessive excitatory output from the 
cerebellum during development (Carper & Courchesne, 2000; Courchesne, 2004).  This could 
lead to altered minicolumns within frontal and temporal regions (Casanova, Buxhoeveden, 
Switala, & Roy, 2002).  Minicolumns have been found to be smaller and more narrow in size, 
but with an increased number in persons with ASD (Buxhoeveden et al., 2006; Casanova et al., 
2002, 2006), which likely contributes to the increased frontal lobe volume found in those with 
the disorder (Buxhoeveden et al., 2006).  In addition, larger frontal cortical volume has been 
shown to be negatively correlated with decreased cerebellar vermis lobules VI and VII volumes 
in children with ASD, but not in controls (Caper & Courchesne, 2000), implicating a 
developmental link between these impairments.  Thus, cerebellum impairment could affect the 
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neural pathology in ASD through common neural pathways between the cerebellum and cortical 
structures (Allen et al., 2005; Middleton & Strick, 2001) and the ability of the cerebellum to 
influence the development of the cortex (e.g., Quartz & Sejnowski, 1997).  Cognitively, 
cerebellum impairment would lead to slowed orienting early in life impairing joint attention 
abilities and subsequently other social, language, and cognitive skills (Courchesne, Chisum, & 
Townsend, 1994).   
 Inferior olive.  The inferior olive of the medulla has also been found to be consistently 
impaired in postmortem examinations of persons with ASD.  In particular, olivary neurons have 
been found to be displaced (Bailey et al., 1998; Bauman & Kemper, 1985, 1994; Rodier, Ingram, 
Tisdale, Nelson, & Romano, 1996) and atypical in size (Bauman & Kemper, 1985, 1994), and to 
contain swollen axon terminals (Weidenheim et al., 2001).  The inferior olive receives diverse 
inputs from the thalamus, areas of the brainstem, cerebellum, and spinal cord, but all of the 
efferent projections are to the cerebellum and are the sole source of climbing fibers, which are 
fibers that climb the Purkinje cells within the cerebellum (DeZeeuw et al., 1998; Holmes & 
Stewart, 1908).  The nature of the inferior olive impairment in ASD suggests that this 
impairment most likely occurred prior to cerebellum impairment because pre- or postnatal injury 
to the cerebellum results in inferior olive cell loss (Greenfield, 1954; Norman, 1940).  Therefore, 
it has been suggested that inferior olive impairment may be the source of ASD neuropathology 
(Bauman & Kemper, 2005; Welsh, Ahn, & Placantonakis, 2005), causing a reduction in the 
number of Purkinje cells and subsequent neural and cognitive effects.   
 Pons.  Postmortem and neuroimaging examinations have also revealed impairment 
within the pontine structure in ASD.  In postmortem studies, the pons has been found to be 
atypical in size (Rodier et al., 1996), have an atypical tract within the pontine tegmentum (Bailey 
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et al., 1998), and to contain swollen axons terminals (Weidenheim et al., 2001).  More 
specifically, the locus coeruleus (LC) of the pons has been found to be widely dispersed with 
loosely grouped LC neurons (Bailey et al., 1998) and swollen axon terminals (Weidenheim et al., 
2001), although a more recent postmortem study found no LC abnormalities in persons with 
ASD (Martchek, Thevarkunnel, Bauman, Blatt, & Kemper, 2006).  In addition, MRI 
examinations have revealed the pontine structure to be smaller in persons with ASD than 
controls (Ciesielski, Harris, Hart, & Pabst, 1997; Craig et al., 2007; Gaffney, Kuperman, Tsai, & 
Minchin, 1988; Hashimoto et al., 1991, 1995; Hashimoto, Tayama, Miyazaki, Murakawa, & 
Kuroda, 1993), while other studies have been unable to replicate this result (Elia et al., 2000; 
Garber & Ritvo, 1992; Hardan et al., 2001; Hashimoto et al., 1992, Hashimoto, Tayama, 
Miyazaki, Murakawa, Shimakawa et al., 1993; Hsu, Yeung-Courchesne, Courchesne, & Press, 
1991; Kleiman et al., 1992; Piven et al., 1992).     
The LC of the pons begins development at 3.5 weeks post-conception (Bayer, Altman, 
Russo, & Zhang, 1993), which is earlier than the amygdala, cerebellum, and inferior olive (see 
Figure 1).  The LC contains the largest group of NE neurons in CNS (Dahlstrom & Fuxe, 1964) 
and sends projections to almost every region of the brain (e.g., Aston-Jones, Foote, & Bloom, 
1984; Foote, Bloom, & Aston-Jones, 1983).  In addition, due to the early development of this 
structure and vast NE innervations, the LC plays a very important role in the regulation of CNS 
development by providing NE innervations to the CNS throughout embryogenesis (e.g., Coyle, 
1977; Schlumpf, Shoemaker, & Bloom, 1980; Sievers, Lolova, Jenner, Klemm, & Sievers, 
1981).  In fact, LC-NE neurons have been found to penetrate telencephalic structures at 
approximately seven weeks postconception and play a role in the neurogenesis, migration, and 
differentiation of cortical structures (Schlumpf et al., 1980).  Functionally, the LC is believed to 
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mediate the processing of information via connections with attentional, memory, sensory, and 
motor systems (e.g., Aston-Jones & Cohen, 2005; Berridge & Waterhouse, 2003), and is 
involved in preparing the CNS to be activated by salient stimuli, sleep-wake cycle regulation, 
nociception, and autonomic responses (e.g., Aston-Jones et al., 1984; Berridge & Waterhouse, 
2003).  Consequently, sleep-wake cycle deficits (e.g., Honomichl, Goodlin-Jones, Burnham, 
Gaylor, & Anders, 2002; Richdale & Prior, 1995; Schreck et al., 2004), decreased pain 
perception (e.g., Baranek & Berkson, 1994; Keintz & Dunn, 1997), and atypical autonomic 
responses to salient stimuli (e.g., Althaus et al., 2004; Anderson, Colombo, & Shaddy, 2006; 
Dawson & Lewy, 1989; Hirstein et al., 2001) have been found in those with ASD.  Given the 
structural and functional findings in ASD and the ability of the LC to influence the development 
of neural structures and cognitive functions found to be impaired in those with the disorder, the 
LC has been proposed as a possible source of ASD neuropathology (Aston-Jones, Rajkowski, & 
Cohen, 2000; Dahlstrom, 1989; Mehler & Purpura, 2009). 
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Figure 1.  Estimated timetable of human neurogenesis of structures implicated to be the source 
of neuropathology in Autism Spectrum Disorders.  Adapted by permission from “Timetables of 
Neurogenesis in the Human Brain Based on Experimentally Determined Patterns in the Rat,” by 
S. A. Bayer, J. Altman, R. J. Russo, and X. Zhang, 1993, NeuroToxicology, 14.  Copyright 1993 
by Intox Press, Inc.   
 
Summary and Conclusions 
 The results of the postmortem, neuroimaging, and cognitive studies presented above 
implicate the involvement of the limbic system, cerebellum, inferior olive, and pontine structures 
in producing ASD symptomology.  While arguments have been made for each of these structures 
to be impaired in ASD, the evidence for the primacy of these structures as the source of ASD 
neuropathology is not compelling; a definitive case has not been established due to (a) 
inconsistent results, (b) an inability to show how the candidate structure can influence the 
development of other affected structures and systems, and (c) limited knowledge about typical 
and atypical neural development of the affected structures.  In addition, although emphasis is 
placed on the structural evidence of the candidate neural regions in ASD, it should be noted, that 
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evidence for involvement and/or primacy of a particular structure may only be evident in the 
functional capacity of the structure due to developmental processes and compensatory effects.   
Therefore, future investigations into each of the structures functions, efferent and afferent 
connections, and pre- and postnatal development in typical and atypical populations will help to 
illuminate the role that each of the affected structures play in producing ASD symptomology.  
 One of the consistent themes that emerge from the current neurological theories presented 
above is that each of the proposed systems are implicated in producing attentional and or/arousal 
responses.  Therefore, it seems prudent to conduct investigations of the neural systems involved 
in producing attentional and arousal responses in ASD at multiple levels of analysis; hopefully 
these will lead to a greater understanding of how the pathology and functional impairments of 
these systems are involved in producing the disorders’ symptomology.  In addition, because 
lower-order attentional and arousal responses are likely to be present very early in life due to the 
early development of their underlying structures, these investigations could also lead to the 
identification of early markers of ASD and further understanding of how these impairments may 
produce higher-order deficits.   
Study Direction and Document Plan 
It is the goal of my previous and future investigations to use multiple levels of analysis to 
examine attentional and arousal responses in ASD to gain a better understanding of their 
presence and involvement in the disorder, their potential as early markers, and the underlying 
neural systems.  Because social dysfunction is a hallmark feature of ASD, one particular line of 
inquiry is the investigation of attentional and arousal responses to social stimuli.  Persons with 
ASD have unique responses that include decreased time and frequency of looks (e.g., Dawson et 
al., 2004; Dawson, Meltzoff, Osterling, Rinaldi, & Brown, 1998; Jones, Carr, & Klin, 2008; 
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Klin, Jones, Schultz, & Cohen, 2002; Maestro et al., 2002; Pelphrey et al., 2002; Riby & 
Hancock, 2009a; Sweetenham et al., 1998) and atypical autonomic reactions to stimuli with 
social relevance (e.g., Anderson et al., 2006; Falck-Ytter, 2008; Hirstein, Iversen, & 
Ramachandran, 2001; Van Hecke et al., 2009).  In addition, attentional responses to social 
stimuli are most commonly reported to differentiate those with ASD during the first year of life 
(e.g., Adrien et al., 1993; Maestro et al., 2002; Osterling & Dawson, 1994; Werner, Dawson, 
Osterling, & Dinno, 2000; Zwaigenbaum et al., 2005).   
Based on this line of inquiry, we recently used eye-tracking technology to examine the 
visual scanning and pupillary responses of two to five year old children with ASD, along with 
mental and chronological age-matched controls, to face (human and animal) and non-face (toy 
and landscape) static stimuli (Anderson et al., 2006).  We were not able to differentiate the 
groups based on the duration of time they spent looking at the face stimuli.  However, we did 
find the ASD group to have a significant decrease in pupil size from baseline levels to human 
faces, particularly within the internal features (eyes, nose, and mouth) of the face, while both 
mental and chronological age-matched controls showed an increase in pupil size and did not 
differ.  In addition, we found the baseline pupil size of the ASD group to be significantly larger 
than both mental and chronological age-matched controls who did not differ (Anderson & 
Colombo, 2009).  It is the goal of the current study to replicate the results of these previous 
investigations, while addressing some of the methodological concerns, and extending the 
findings by investigating neurological systems that may contribute to the atypical pupillary 
responses during baseline conditions and in response to social stimuli in children with ASD. 
The review of literature that follows will focus on the pupillary system and its potential 
role in ASD.  Therefore, a general review of the pupillary system, tonic and phasic influences on 
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this system, along with the neural structures and neurochemical systems responsible for the 
control of pupil size will first be provided.  This is followed by a review of tonic and phasic 
pupillary and non-pupillary autonomic responses in ASD and an examination of ASD 
impairments within neural systems central to the control of pupil size (the NE and hypothalamic 
systems).  Finally, the aim of the current study will be provided along with specific hypotheses 
and predictions that were made based on this review of literature for the results of the current 
study.    
Pupillary System 
 The pupil is an opening in the iris that allows light to enter the eye and strike the retina.  
The size of the pupil is determined by an integrated ratio of inhibitory and excitatory activity 
within the sympathetic and parasympathetic divisions of the autonomic nervous system (ANS). 
This ratio is determined largely by the characteristics and salience of the visual input.  The most 
common external stimulation that invokes activation of the pupillary system is reflexive 
pupillary responses to changes in luminance and accommodation efforts.  The light reflex is a 
change in the size of the pupil, which serves to regulate the amount of light entering the eye; 
thus, the pupil is constricted under conditions of high luminance and dilated under conditions of 
low luminance (e.g., Andreassi, 2000; Barbur, 2004; Loewenfeld, 1999).  The near-reflex or 
accommodation response is a change in the curvature of the lens, used to control the depth of the 
visual field; reduction of the pupil size occurs when an object approaches the eye (e.g., 
Andreassi, 2000; Loewenfeld, 1999).   
In addition, there are small changes in pupil size that are not a consequence of the 
physical properties of the stimulus, but are instead invoked by the psychological content.  These 
small-scale pupillary responses have long been used as an index of the amount of central nervous 
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system processing that is allocated to a task (e.g., Beatty & Lucero-Wagoner, 2000; Loewenfeld, 
1999).  However, the magnitude of these task-specific or phasic pupillary responses are 
modulated by the organisms more characteristic or enduring tonic state of arousal (e.g., Beatty & 
Lucero-Wagoner, 2000), and tonic pupil diameter has been used as an indicator of tonic arousal 
(e.g., Lavie, 1979; Lowenstein & Lowenfeld, 1952; Merritt, Schnyders, Patel, Basner, & O’Neill, 
2004; Wilhelm et al., 2001).  
Finally, it should be noted that pupil size can also be influenced by neurological 
impairments and pharmacological substances that affect either efferent or afferent pathways (see 
Beatty & Lucero-Wagoner, 2000; for a review).   
Neuroanatomy of the Pupillary Response 
 The size of the pupil is controlled by the tone of two opposing smooth muscles, the 
sphincter and dilator pupillae.  The sphincter pupillae is innervated by the parasympathetic 
system, mediated by ACh, and causes the iris to constrict.  In contrast, the dilator pupillae is 
innervated by the sympathetic system, mediated by NE, and causes the iris to dilate.  A balance 
between the central sympathetic and parasympathetic divisions of the ANS modulates the 
diameter of the pupil at any point in time.   
 Parasympathetic control of constriction.  The afferent neurons of the parasympathetic 
system that regulate pupil constriction descend from the retina and send excitatory connections, 
mediated by Glu, to the pretectal olivary nucleus.  The pretectal olivary nucleus then sends 
excitatory connections, again mediated by Glu, bilaterally to synapse on preganglionic cells 
within the Edinger-Westphal (EW) nucleus of the midbrain (Gamlin & Clarke, 1995; Hou, 
Langley, Szabadi, & Bradshaw, 2006; Kourouyan & Horton, 1997).  These ACh mediated 
preganglionic fibers then synapse on the ciliary ganglion (CG).  Postganglionic fibers, also 
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mediated by ACh, then exit the CG and travel via short ciliary fibers to synapse on the sphincter 
pupillae and cause contraction of the iris (Andreassi, 2000; Beatty & Lucero-Wagoner, 2000; 
Hou et al., 2006).   
 Sympathetic control of dilation.  The afferent neurons of the sympathetic system that 
regulate pupil dilation descend from the cortex to the posterior hypothalamus (PH) and lateral 
hypothalamus (LH) (Andreassi, 2000; Beatty & Lucero-Wagoner, 2000; Szabadi & Bradshaw, 
1996).  The hypothalamus then sends excitatory connections, presumably mediated by histamine 
and orexin, to the LC, ventrolateral medulla (A1) and ventrolateral pons (A5) (Hou et al., 2006; 
Stenberg, 2007; Szabadi & Bradshaw, 1996).  The LC and A1/A5 nuclei then send NE 
innervations through the cervico-thoratic spinal cord where they synapse on α1-adrenergic 
receptors of preganglionic neurons within the ciliospinal center of the Budge (Beatty & Lucero-
Wagoner, 2000; Szabadi & Bradshaw, 1996).  Preganglionic cholinergic fibers then synapse on 
cells within the superior cervical ganglion.  Postganglionic NE fibers then extend through the 
carotid plexus and opthalamic branch of the trigeminal nerve to synapse on α1-adrenergic 
receptors of the dilator pupillae (Andreassi, 2000; Beatty & Lucero-Wagoner, 2000; Hou et al., 
2006).   
 Inhibitory influences.  In addition to the central excitatory pathways of the sympathetic 
and parasympathetic divisions, two central inhibitory pathways also serve to regulate pupil size 
by providing inhibitory influences on the EW nucleus.  First, the LC provides a direct tonic 
inhibitory influence by releasing NE onto α2-adrenergic receptors within the EW nucleus (Breen, 
Burde, & Loewy, 1983; Hou et al., 2006; Koss, Gherezghiher, & Nomura, 1984; Szabadi & 
Bradshaw, 1996).  Second, there is a tonic non-noradrenergic inhibitory influence on the EW 
nucleus, possibly mediated through the release of GABA, from the hypothalamus (Koss et al., 
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1984; Koss & Wang, 1972; Li & van den Pol, 2005; Szabadi & Bradshaw, 1996; Wilhelm et al., 
2001).  Two indirect adrenergic connections serve to enhance the tonic inhibitory influence of 
the hypothalamus on the EW nucleus.  The LC provides an indirect influence on the EW nucleus 
through activation of α1-adrenergic receptors within the frontal cortex, causing excitatory 
activation of the hypothalamus to enhance the inhibitory effect on the EW nucleus (Hou et al., 
2006; Koss et al., 1984; Lowenstein & Loewenfeld, 1961; Szabadi & Bradshaw, 1996).  The 
A1/A5 areas also influence inhibition of the EW nucleus through activation of α1-adrenergic 
receptors within the hypothalamus (Guyenet, 1991; Koss et al., 1984; Szabadi & Bradshaw, 
1996).  Thus, atypical tonic or phasic pupillary responses may reflect a disequilibrium between 
the parasympathetic and sympathetic divisions of the pupillary system.  Figure 2 depicts both the 
excitatory and inhibitory process involved in the regulation of pupil size. 
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Figure 2.  Excitatory and inhibitory processes involved in the regulation of pupil size.  PH =  
posterior hypothalamus; LH = lateral hypothalamus; OPN = olivary pretectal nucleus; EW = 
Edinger-Westphal nucleus; LC = locus coeruleus; A1 = ventrolateral medulla; A5 = ventrolateral 
pons; SCG = superior cervical ganglion; CG = ciliary ganglion; NE = norepinephrine; Glu = 
glutamate; GABA = gamma-aminobutyric acid; H = histamine; Ox = orexin; ACh = 
acetycholine.  Solid lines represent excitatory connections.  Dashed lines represent inhibitory 
connections.  Adapted from “Autonomic Pharmacology of α2-adrenoceptors” by E. Szabadi and 
C. M. Bradshaw, 1996, Journal of Psychopharmacology, 3, p. 11.  And “Comparison of 
Diphenhydramine and Modafinil on Arousal and Autonomic Functions in Healthy Volunteers” 
by R. H. Hou, R. W. Langley, E. Szabadi, and C. M. Bradshaw, 2007, Journal of 
Psychopharmacology, 21, p. 574.  Copyright 1996 and 2006 by the British Association for 
Psychopharmacology.   
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Tonic Pupillary Responses  
Tonic pupil size has been measured by examining pupillary responses, independent of 
psychological stimulation, under a range of luminance and distance levels.  These measures have 
been shown to vary across the lifespan and throughout the day in accordance with changes in 
alertness.    
Age-related changes in pupil size.  Tonic pupil size varies across the lifespan, with the 
diameter of the pupil gradually increasing from birth to approximately 20 years of age (Kohnen, 
Zubov, & Kohnen, 2004; Lowenfeld, 1999; MacLachlan & Howland, 2002), and then declining  
linearly throughout the rest of the lifespan (e.g., Bitsios, Prettyman, & Szabadi, 1996; Boev et 
al., 2005; Bourne, Smith, & Smith, 1979; Karatekin, Marcus, & Couperus, 2007; Kumnick, 
1954, 1956; MacLachlan & Howland, 2002; Schmid, Ceurremans, Luedtke, Wilhelm, & 
Wilhelm, 2004).  This change in tonic pupil size has been attributed to the development and 
degeneration of the structure of the eye and the neural structures that control pupil size.   
Therefore, tonic pupillary responses outside of the relative range for a particular age 
group could be indicative of atypical development or degenerative processes affecting the eye 
and/or neural structures controlling pupil size.  For example, it has been found that persons with 
Alzheimer’s disease (AD) have smaller pupil sizes than healthy controls of the same age (e.g., 
Fotiou, Fountoulakis, Tsolaki, Goulas, & Palikaras, 2000; Hou et al., 20006; Prettyman, Bitsios, 
& Szabadi, 1997).  The typical decline in pupil size with age is mirrored by a decline in the 
number of cells within the LC (e.g., Baker, Tork, Hornung, & Halasz, 1989; Chan-Palay & Asan, 
1989; Manaye, McIntire, Mann, & German, 1995).  However, persons with AD have a more 
profound cell loss within the rostral portion of the LC than healthy age-matched controls (Chan-
Palay & Asan, 1989; German et al., 1992; Mareyniuk, Mann, & Yates, 1986).  Therefore, it has 
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been suggested that the cell loss within the LC leads to decreased inhibition of the EW nucleus 
and thus a smaller tonic pupil size in those with AD (Hou et al., 2006; Prettyman et al., 1997).   
Arousal-related changes in pupil size.  Tonic pupil diameter has also been shown to 
vary throughout the day with changes in levels of arousal.  The tonic diameter of the pupil is 
largest during the waking state and decreases with levels of arousal (Lowenstein & Loewenfeld, 
1961, 1964; Wilhelm et al., 2001), with the smallest pupil size occurring during REM sleep 
(Lowenfeld, 1999; Yoss, Moyer, & Hollenhorst, 1970).  In addition to pupil size being smaller 
during periods of low arousal, drowsiness is also accompanied by pupillary oscillations that 
heighten in depth as sleepiness increases (Lowenfeld, 1999; Wilhelm et al., 2001).  This tonic 
change in pupil size with arousal is attributed to alterations in the balance between the 
sympathetic and parasympathetic divisions of the pupillary system.  During periods of high 
arousal sympathetic activation is increased and the parasympathetic system is inhibited, but 
during periods of low arousal sympathetic activation and parasympathetic inhibition is decreased 
(Lowenfeld, 1999).   
There are several interrelated neurological structures and neurochemical systems 
involved in the control of arousal, and alterations in any of these systems could result in changes 
in levels of arousal and consequently changes in tonic pupil size.  The reticular formation 
contains circuits of neurons (comprised of the medulla, pons, and midbrain) that, when activated 
by sensory input, send excitatory connections to the cortex via the dorsal (through the thalamus) 
and ventral (through the hypothalamus, basal ganglia, and basal forebrain) pathways resulting in 
arousal or alertness (Jones, 2005; Moruzzi & Magoun, 1949).  These neuronal systems maintain 
arousal through the use of several neurotransmitters, NE, histamine, orexin, ACh, 5-HT, DA, and 
GABA (see Jones, 2005; Stenberg, 2007, for reviews).  Of particular importance to the current 
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study are the NE (A1/A5 and LC) and hypothalamic (PH and LH) systems, as these systems play 
a major role in the maintenance of arousal, and in the activation of the sympathetic and inhibition 
of the parasympathetic pupillary system.   
The effects of NE on arousal are mediated by A1/A5 nuclei and the LC (e.g., Stenberg, 
2007).  The A1/A5 nuclei mediate arousal through projections to the hypothalamus and forebrain 
(e.g., Espana & Berridge, 2006; Stenberg, 2007); while the LC sends diffuse NE projections to 
the forebrain, brainstem, and spinal cord (e.g., Berridge & Waterhouse, 2003).  Of these NE 
nuclei, the LC is considered the most important for arousal due to its diverse projections and 
because it contains the largest group of NE neurons in the brain (Dahlstrom & Fuxe, 1964).  
There are two action levels of the LC-NE system, tonic and phasic activation.  Tonic activation 
indicates the level of spontaneous firing of LC-NE neurons and is related to changing levels of 
alertness within the sleep-wake cycle; the LC-NE neurons fire most during waking, are reduced 
during slow-wave sleep, and are almost absent during REM sleep (Aston-Jones & Bloom, 1981).  
In addition, during the waking state the tonic levels of the LC-NE system indicate the systems 
readiness to phasically respond; when tonic activity is elevated or low, phasic activation and 
behavioral performance is decreased, but when tonic activity is at intermediate levels phasic 
activation is robust and behavioral performance is excellent (e.g., Aston-Jones & Cohen, 2005).  
Both tonic and phasic pupillary responses have been found to mirror the respective responses of 
the LC-NE system; when tonic pupil diameter is elevated or low, phasic diameters are reduced, 
but when tonic diameters are at intermediate levels, there is phasic dilation (Aston-Jones & 
Cohen, 2005; Rajkowski, Kubiak, Ivanova, & Aston-Jones, 1998; Rajkowski, Kubiak, & Aston-
Jones, 1993).  In addition, tonic pupil diameters have been shown to be highly correlated with 
changes in levels of tonic LC-NE discharge rates (Rajkowski et al., 1993, 1998).  
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The PH and LH mediate the effects of histamine and orexin on arousal, respectively.  
Both of these neurochemical systems are responsible for the maintenance of waking and send 
excitatory connections to cortical and brainstem regions (e.g., Jones, 2005; Stenberg, 2007).  
Similar to the LC-NE system, histaminergic- and orexin-containing neurons fire most during 
waking, are decreased during slow-wave sleep, and are almost absent during REM sleep (Lee, 
Hassani, & Jones, 2005; Takahashi, Lin, & Sakai, 2006).  Orexin and histamine act to maintain 
and preserve optimal states of arousal through enhancing the spontaneous firing of LC-NE 
neurons (Hou et al., 2006; van den Pol et al., 2002) and to a lesser extent through activation of 
A1/A5 noradrenergic neurons (Baldo, Daniel, Berridge, & Kelley, 2003), and through providing 
excitatory feedback between the LH and PH (Hou et al., 2006).  In contrast, NE tonically inhibits 
orexin and histamine release indirectly through activation of the α2-receptors on the ventrolateral 
preoptic nucleus (VLPO), causing a release of GABA onto the PH (Hou et al., 2006; Li & van 
den Pol, 2005; Samuels, Hou, Langley, Szabadi, & Bradshaw, 2006).  In addition, the LH 
provides dynorphin to the VLPO to inhibit release of GABA (Hou et al., 2006).   Thus, the LC 
provides a negative feedback system indirectly to the hypothalamus that helps to maintain the 
optimal intermediate levels of tonic LC-NE discharge rates (Li & van den Pol, 2005; van den 
Pol, 2002) and consequently pupil sizes. 
Phasic Pupillary Responses 
 Phasic pupillary responses have long been used to index the amount of cognitive 
processing or attention that is allocated to a particular task.  These responses have been examined 
in tasks that measure cognitive load, information processing, learning, memory, perception, 
language processing, and emotional processing (see Andreassi, 2000; Beatty & Lucero-Wagoner, 
2000, for reviews).  In general, it has been found that phasic pupil size increases and light reflex 
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amplitude decreases with escalations in task difficulty (e.g., Bradshaw, 1968; Brown et al., 1999; 
Hess & Polt, 1964; Steinhauer, Condray, & Kasparek, 2000; Steinhauer, Siegle, Condray, & 
Pless, 2004).  However, it has been found that if the task becomes too difficult (as indicated by 
poor behavioral performance), phasic pupil size begins to decrease (Aston-Jones & Cohen, 
2005).  In tasks requiring the allocation of short-term memory, phasic pupil size shows a linear 
increase as each item is presented, then shows a linear decline as each item is recalled 
(Kahneman & Beatty, 1967).  In addition, during these memory tasks, pupil size is larger when 
familiar items are being recalled (Beatty & Kahneman, 1966). 
Stimuli that are salient to a subject have also been found to elicit a larger phasic pupil 
size and a decrease in light reflex amplitude.  Specifically, target stimuli elicit larger pupillary 
responses than missed target stimuli and non-target stimuli (pupils may decrease to below 
baseline levels for non-target stimuli; Beatty, 1982), with the amplitude of these dilations 
decreasing with time on the task (Beatty, 1982; Karatekin et al., 2007; Qiuyuan, Richer, 
Wagoner, & Beatty, 1985).  In addition, phasic dilations to conditioned targets are larger when 
the stimulus probability is low (Friedman, Hakerem, Sutton, & Fleiss, 1973; Qiuyuan et al., 
1985), and when incentives are high (Kahneman & Peavler, 1969).  Stimuli that are social in 
nature, such as human faces, also appear to be salient and cause increased cognitive attention as 
evidenced by larger phasic pupillary responses.  For example, human faces have been shown to 
elicit a larger phasic pupil size than shape stimuli in infants one to four months of age 
(Fitzgerald, 1968).  In adults, a larger change in pupil size has been observed to upright human 
faces than to those that are inverted or scrambled, or to macaque monkey faces (Conway, Jones, 
DeBruine, Little, & Sahraie, 2008).  Also, larger pupillary dilations have been found to 
accompany the presentation of a human face with direct gaze in adult female subjects than those 
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with indirect gaze (Porter, Hood, Troscianko, & Macrae, 2006).  Finally, aversive stimuli have 
been shown to elicit a larger phasic dilation than either neutral (Chapman, Oka, Bradshaw, 
Jacobson, & Donaldson, 1999; Sterpenich et al., 2006) or positive stimuli (Libby, Lacey, & 
Lacey, 1973), and to elicit a decrease in the amplitude of the light reflex response (Bitsios, 
Szabadi, & Bradshaw, 1996, 1998, 2004).  Studies on phasic pupillary responses suggest that as 
a task becomes more salient and requires more cognitive resources or attention, phasic pupil 
diameter increases and light reflex amplitude decreases, but when a stimulus is not salient or 
does not require as much attention or cognitive resources pupil size begins to decrease and light 
reflex amplitude is increased. 
Tonic and Phasic Responses in Autism Spectrum Disorder 
Tonic Responses 
Pupillary responses.  To date, three studies have been published examining tonic 
pupillary responses in persons with ASD.  First, Rubin (1961) examined dark-adapted pupillary 
dilations and light-adapted pupillary constrictions in five children with ASD (7 to 12 years of 
age) compared to four typically-developing children (7 to 9 years of age).  The ASD group was 
found to have a significantly slower pupillary constriction rate to light stimulation, along with an 
overall smaller dilation during dark adaptation.  More recently, Fan, Miles, Takahashi, and Yao 
(2009) examined pupillary light reflexes in 24 persons with ASD (7 to 20 years of age) compared 
to 44 typically-developing children (6 to 16 years of age).  Similar to the Rubin (1961) study, 
Fan et al. (2009) found the ASD group to have longer constriction latencies (time to maximum 
constriction), and a smaller maximum constriction amplitude in response to light stimulation 
than controls.  Finally, as reported earlier, Anderson and Colombo (2009) examined the resting 
pupil size in seven children with ASD (2 to 5 years of age) compared to mental (n = 6) and 
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chronological age-matched (n = 9) controls.  Pupil size was averaged across the presentation of 
nine blank grey slides presented for an average of 15 s (presented during the Anderson et al., 
2006 study).  The ASD group was found to have a significantly larger average pupil size, which 
remained stable across time, than both control groups who did not differ from each other. Thus, 
the few examinations of tonic pupil size in ASD implicate atypical tonic responding during both 
resting and reflex conditions in those with the disorder.    
Non-pupillary autonomic responses.  In agreement with the tonic pupillary results 
presented above, the examination of baseline or resting cardiac, respiratory, electrodermal and 
skin temperature responses in individuals with ASD are indicative of atypical tonic activation in 
those with the disorder.  Specifically, persons with ASD have been found to have atypical 
cardiac responses at rest that include an elevated mean HR (Bal et al., 2009; Cohen & Johnson, 
1977; Hirstein et al., 2001; Kootz & Cohen, 1981; Kootz, Marinelli, & Cohen, 1982; Ming, Julu, 
Brimacombe, Connor, & Daniels, 2005), and decreased respiratory sinus arrhythmia (RSA; Bal 
et al., 2009; Van Hecke et al., 2009), a putative measure of cardiac vagal tone which is regulated 
by the parasympathetic system (e.g., Porges, 1995).  Decreased cardiac sensitivity to baroreflex, 
as a measure of parasympathetic output, along with increased diastolic and mean arterial blood 
pressure has also been found in persons with ASD (Ming et al., 2005).  In addition to these 
cardiac responses, increased respiration rates and skin conductance, and lower skin temperature 
have also been found in those with ASD (Palkovitz & Wiesenfeld, 1980; Zahn, Rumsey, & Van 
Kammen, 1987).  Based on the results of these autonomic investigations, individuals with ASD 
appear to have higher tonic sympathetic activity as evidenced by mean HR, blood pressure, 
respiration rates and skin conductance, along with decreases in tonic parasympathetic input as 
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evidenced by decreased RSA and sensitivity to baroreflex, along with decreased skin 
temperature.     
Summary and conclusions.  Examinations of tonic pupillary responses, along with non-
pupillary autonomic responses during baseline conditions, implicate an altered balance of 
inhibitory and excitatory activity within the sympathetic and parasympathetic divisions of the 
autonomic system in ASD.  Specifically, the report of a larger resting pupil size (Anderson & 
Colombo, 2009) along with the slowed light reflex response and less extensive reflex amplitudes 
in ASD (Fan et al., 2009; Rubin, 1961) suggest increased tonic sympathetic activation, along 
with decreased parasympathetic input (e.g., Lowenfeld, 1999).  While there are only a few 
studies on tonic pupil size in ASD, the studies presented above examining baseline/resting levels 
of cardiac, respiratory, skin conductance, and skin temperature responses further implicate this 
altered balance of autonomic responding in ASD.  In addition, the results of these autonomic 
investigations implicate an altered ANS balance that mirrors that of the tonic pupillary findings 
(increased sympathetic and decreased parasympathetic responding in ASD).        
As stated earlier, tonic pupil size can be indicative of the effects of age and/or tonic 
arousal.  From birth to 20 years of age, tonic pupil size gradually increases and the average value 
of the tonic pupil diameter during each year of life is similar across healthy individuals (Kohnen 
et al., 2004; Lowenfeld, 1999; MacLachlan & Howland, 2002), with a similar age-related arc 
occurring in maximum constriction and dilation reflex amplitudes (Lowenfeld, 1999).   In two of 
the tonic pupillary studies, the ASD group was age-matched with controls to account for these 
possible age-related differences (Anderson & Colombo, 2009; Fan et al., 2009); in addition, light 
reflex latency has been found to be independent of age (Fotiou et al., 2007).  Therefore, the 
differences in resting and reflex pupil measures are most likely not attributable to age, but rather 
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these differences may be attributable to altered levels of tonic arousal.  The tonic diameter of the 
pupil has been shown to vary with changes in levels of alertness, with the resting pupil diameter 
increasing and reflex responses becoming more extensive and reliable as the individual becomes 
more alert (Lowenfeld, 1999; Lowenstein & Loewenfeld, 1961, 1964; Wilhelm et al., 2001; Yoss 
et al., 1970).  The larger tonic pupil size, along with less extensive and slowed reflex responses 
in ASD may therefore be indicative of higher levels of arousal.  This could be the result of an 
increased level of arousal due to the testing environment or atypical functioning of the 
neurological systems controlling arousal and pupillary responses.   
Phasic Responses 
Pupillary responses.   Only three studies have examined phasic pupillary responses in 
persons with ASD.  First, van Engeland, Roelofs, Verbaten, and Siangen (1991) examined the 
pupillary responses of children with ASD (mean age was 9.7 years) compared to children who 
were typically-developing and children who had either an externalizing (such as conduct 
disorder) or internalizing disorder (such as avoidant disorder), to a habituation paradigm using 
black and white abstract stimuli.  While all of the children showed a decrease in phasic pupillary 
responses to the stimuli across habituation trials, there were no differences between the ASD and 
control groups.  Second, as presented earlier, Anderson et al. (2006) examined the pupillary 
responses of children with ASD (2 to 5 years of age) compared to mental and chronological age-
matched controls to face and non-face static pictures.  We found the ASD group to have a 
significant decrease in pupil size from baseline values to human faces, particularly to the internal 
features of the face, compared to the control groups that showed an increase in pupil size.  In 
addition, we found these differences to be independent of baseline/tonic pupil size (Anderson & 
Colombo, 2009).  Finally, Falck-Ytter (2008) examined the pupillary responses (normalized 
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according to baseline values) of children with ASD (mean age was 5 years and 2 months) 
compared to typically-developing controls in response to upright and inverted human faces.  The 
ASD group was found to have a larger pupil size to inverted faces than controls.  In addition, the 
difference in pupil size between the inverted and upright faces was significantly larger for the 
ASD group than controls, with the ASD group showing a larger pupil size to the presentation of 
inverted faces than to those that were presented upright.  Based on the data from these studies, 
children with ASD appear to have atypical phasic pupillary responses, which may be unique to 
human faces and indicative of atypical processing of these stimuli.    
Non-pupillary autonomic responses.  In addition to the pupillary responses presented 
above, persons with ASD have also been found to have atypical phasic reactions that manifest in 
non-pupillary autonomic responses such as cardiac, respiratory, and electrodermal responses.  In 
ASD, these atypical autonomic responses have been found during a variety of tasks that include 
habituation, target detection, and in response to environmental stressors and socially-relevant 
stimuli.  When a stimulus is presented repeatedly, behavioral and autonomic responses to the 
stimulus typically decrease over repeated presentations (e.g., Colombo, 1995; Richards, 1997).  
Persons with ASD have failed to show this expected decline in respiratory, cardiac, and skin 
conductance responses during a habituation paradigm to shapes (Barry & James, 1988; James & 
Barry, 1980; 1984); although, as reported above, differences were not found when examining 
pupil size (van Engeland et al., 1991).  The lack of cardiac, respiratory and electrodermal 
habituation has been suggested as an indication of inadequate stimulus processing in ASD (e.g., 
Barry & James, 1988; James & Barry, 1980; 1984), and studies on cardiac and electrodermal 
responses to stimuli that are typically salient to a subject provide further support of an autonomic 
deficit during stimulus intake in individuals with the disorder.   
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In general during task performance, a decline in cardiac vagal tone, through 
measurements such as RSA, is typically associated with increased attentional engagement (e.g., 
Richards & Casey, 1991; Richards & Cronise, 2000; Richards & Turner, 2001), and is generally 
seen with corresponding increases in autonomic measures of sympathetic activity such as mean 
HR, blood pressure and electrodermal responses (e.g., Bernston, Cacioppo, & Quigley, 1991; 
Recordati, 2003).  However, increases in sympathetic levels can also indicate aversive or stress-
based responses (e.g., Bosch et al., 2009; Eisenberg et al., 1990; Uchino, Cacioppo, Malarkey & 
Glaser, 1995), with large increases in sympathetic activation leading to less-than-optimal 
stimulus processing (e.g., Aston-Jones & Cohen, 2005).  In persons with ASD, increases in mean 
HR (Kootz & Cohen, 1981) and estimates of central cardiac vagal tone (Althaus et al., 2004) 
during non-social target detection tasks have been found.  When presented with environmental 
stressors persons with ASD have been found to have atypical mean HR responses, with one 
study finding a lower mean HR when presented with stressors such as increases in luminance, 
noise, and interactions in a classroom environment (Graveling & Brooke, 1978), while a more 
recent study found a higher mean HR to stressors such as a loud noise, robot and unstructured 
time in a laboratory environment (Goodwin et al., 2006).   
Finally, in accord with the pupillary studies presented above, examination of cardiac and 
electrodermal responses in individuals with ASD to stimuli with social relevance has also 
yielded atypical responses.  Persons with ASD have been found to have a higher mean HR 
during social interactions (Kootz et al., 1982; Kootz & Cohen, 1981).  In addition, decreased 
RSA to an unfamiliar person was found in children with ASD, with increased RSA being related 
to improved social skills (Van Hecke et al., 2009); decreased RSA to unfamiliar persons has 
been shown to be related to increases in anxiety in typically developing children (Heilman et al., 
30 
2008), thus in this paradigm decreased RSA may indicate a maladaptive response in ASD.  
Children with ASD have also been found to lack the decline in RSA, found in control groups, 
during separation from their mothers (Sigman, Dissanayake, Corona, & Espinosa, 2003) and 
after a display of emotional distress by an experimenter (Corona, Dissanayake, Arbelle, 
Wellington, & Sigman, 1998), which has been interpreted as a lack of orienting to a psychosocial 
stressor.  Finally, electrodermal responses in persons with ASD have included a lack of skin 
conductance increase to the presentation of familiar human eyes (Hirstein et al., 2001), and a 
smaller amplitude during a task requiring emotional judgment of human faces (Hubert, Wicker, 
Monfardini, & Deruelle, 2009).  Thus, these atypical autonomic responses further support the 
view of impaired stimulus processing in ASD, with the bulk of the findings implicating atypical 
processing of stimuli that are socially relevant.  
 Summary and conclusion.  In general, phasic pupillary responses have been taken to 
indicate the amount of cognitive resources or attention that is allocated to a particular task (e.g., 
Andreassi, 2000; Beatty & Lucero-Wagoner, 2000).  When interpreted in this manner, the 
decreased phasic pupillary response to human faces (Anderson et al., 2006) along with a larger 
pupil response to inverted than upright human faces in ASD (Falck-Ytter, 2008), can be taken to 
indicate that children with the disorder allocate less cognitive resources or attention to upright 
human faces than controls.  The examination of non-pupillary autonomic responses provides 
further support that autonomic reactions during stimulus processing may be altered in individuals 
with ASD.  While the direction and interpretation of these non-pupillary autonomic responses 
vary by the task employed, the results generally agree with the pupillary examinations in 
implicating maladaptive stimulus processing in ASD, predominantly to stimuli with social 
relevance. 
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Conclusion 
The results of the pupillary and non-pupillary autonomic investigations presented above 
indicate that persons with ASD may have an altered ratio of excitatory and inhibitory activity 
within the sympathetic and parasympathetic divisions of the ANS; this appears to be skewed 
during both tonic conditions and during phasic activation to salient stimuli such as those that are 
socially relevant.  Of particular importance to the current investigation are the pupillary 
examinations indicating that individuals with ASD have larger resting and altered reflex 
responses, suggestive of higher levels of tonic arousal, and consistent with tonic investigations of 
non-pupillary autonomic responses in ASD.  The phasic pupillary investigations reveal smaller 
phasic pupillary responses to upright human faces in ASD, signifying decreased attentional or 
cognitive resource allocation to human faces; which is consistent with non-pupillary autonomic 
investigations in finding atypical phasic responding to stimuli with social relevance in persons 
with the disorder.   
The NE and hypothalamic systems are involved in both sympathetic activation and 
parasympathetic inhibition of the ANS, and are central to the production of both pupillary and 
non-pupillary tonic and phasic autonomic reactions; in addition these systems play a major role 
in the regulation of arousal.  Thus, it seems reasonable to examine whether the NE and/or 
hypothalamic systems play a role in producing atypical pupillary responses in ASD.  For 
example, the pupillary findings in ASD are consistent with elevated levels of tonic LC-NE 
activity, which result in increased tonic pupil size along with decreases in phasic pupil responses 
to salient stimuli along with decreased phasic LC-NE activation (Aston-Jones & Cohen, 2005; 
Rajkowski et al., 1993, 1998).  Therefore, it is possible that aberrant activation of the LC-NE 
system plays a role in the atypical pupillary responses found in ASD.  In addition, because the 
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hypothalamic system directly inhibits the EW nucleus within the pupillary system and enhances 
the activity of LC-NE and A1/A5 noradrenergic neurons, which respectively provide indirect and 
direct feedback to the hypothalamic system, it is also possible that the hypothalamic and A1/A5 
nuclei may play a role in producing the atypical pupillary responses in ASD.     
Potential Neural Mechanisms of Atypical Pupillary Responses in Autism Spectrum 
Disorder 
Both the NE (A1/A5 and LC) and hypothalamic systems play major roles in balancing 
the ratio of inhibitory and excitatory activity within the sympathetic and parasympathetic 
divisions of the pupillary system.  Furthermore, atypical functioning and/or impairment in either 
of these systems could affect this balance and result in atypical tonic and phasic pupillary 
responses.  Therefore, the following section will examine functional, structural, and 
neurochemical evidence of dysfunction in the NE (A1/A5 and LC) and hypothalamic systems in 
ASD to determine their potential role in producing atypical pupillary responses in this disorder.  
Sleep-Wake Cycle Deficits 
The NE (A1/A5 and LC) and hypothalamic systems (PH and LH) are part of the reticular 
formation that is responsible for the regulation of the sleep-wake cycle (Jones, 2005; Moruzzi & 
Magoun, 1949).  Therefore, if impairment were present in either of these systems, sleep-wake 
cycle deficits would be expected, and in fact, have been reported to be highly prevalent (44% to 
86%) in those with ASD (e.g., Liu, Hubbard, Fabes, & Adam, 2006; Richdale & Prior, 1995).  
Both parent-report and actigraphic data indicate sleep onset delays (Allik, Larsson, & Smedje, 
2006a, 2006b; Giannotti et al., 2008; Honomichl et al., 2002; Krakowiak, Goodlin-Jones, Hertz-
Picciotto, Croen, & Hansen, 2008; Oyane & Bjorvatn, 2005; Williams, Sears, & Allard, 2004), 
night waking (Giannotti et al., 2008; Honomichl et al., 2002; Krakowiak et al., 2008; Williams et 
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al., 2004), and decreased sleep time in those with ASD (Goodlin-Jones, Tang, Liu, & Anders, 
2008; Giannotti et al., 2008; Oyane & Bjorvatn, 2005; Schreck, Mulick, & Smith, 2004).  
Polysomnographic data provide additional support of sleep-wake cycle disturbances in those 
with the disorder (e.g., Daoust, Limoges, Boldue, Mottron, & Godbout, 2004; Limoges, Mottron, 
Bolduc, Berthiaume, & Godbout, 2005).  In addition, hours of sleep per night have been shown 
to be negatively correlated with severity of ASD symptomology (Schreck et al., 2004), with 
improvements in ASD symptomology being related to improvements in sleep disturbances 
(Segawa, Katoh, Katoh, & Normura, 1992).   
Norepinephrine System 
Structural impairments.  As stated earlier, both the pons and medulla have been 
investigated using postmortem and neuroimaging technology (see sections on Pontine theory and 
Inferior olive theory).  In postmortem examinations, six out of the 18 brains of persons with ASD 
that were examined for pontine abnormalities have revealed impairment within this structure.  
Rodier et al. (1996) found a shortening of the pons in the brain of a 21-year-old female with 
ASD compared to an 80-year-old male.  Bailey et al. (1998) found an atypical tract within the 
pontine tegmentum in a 4-year-old male with ASD, a widely dispersed LC region in a 24-year-
old male with ASD, and loosely grouped LC neurons in a second 24-year-old male with ASD.  
Weidenheim et al. (2001) found the dorsal raphe, LC, interpeduncular nucleus, and nucleus of 
the lateral lemniscus of the pons to contain swollen axon terminals in the brain of an 11-year-old 
female and 20-year-old male with ASD.  However, Martchek et al. (2006) examined the LC 
region in the brains of five adults with ASD, 19 to 54 years of age, and found no differences in 
total cell count or volume.  In MRI examinations, six studies have found the pontine structure to 
be significantly smaller in persons with ASD compared to controls (Ciesielski et al., 1997; Craig 
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et al., 2007; Gaffney et al., 1988; Hashimoto et al., 1991, 1993, 1995), while eight of the studies 
found no volumetric differences within this region (Elia et al., 2000; Garber & Ritvo, 1992; 
Hardan et al., 2001; Hashimoto et al., 1992, Hashimoto, Tayama, Miyazaki, Murakawa, 
Shimakawa et al., 1993; Hsu et al., 1991; Kleiman et al., 1992; Piven et al., 1992).   
   Within the medulla, postmortem examinations have revealed impairment in 11 of the 14 
cases with ASD.  Bauman and Kemper (1985, 1994) found inferior olive neurons to be small and 
pale in three adults with ASD (ages 22, 28, and 29) and significantly enlarged in three children 
with ASD (ages 9, 10, and 12); in addition, in all ASD brains olivary neurons were found to be 
abnormally distributed along the periphery of this structure.  Rodier et al. (1996) found an 
absence of the superior olive and facial nucleus, and a shortening of the area between the 
trapezoid body of the medulla and the inferior olive in the ASD brain (21-year-old female).  
Bailey et al. (1998) found the shape of the inferior olive to be atypical in three males with ASD 
(ages 4, 20, and 27), and found an enlarged medulla in the 4-year-old, and a slightly flattened 
medulla with demarcated pyramids in the 20-year-old.  Finally, Weidenheim et al. (2001) found 
swollen axon terminals within the inferior olive and other portions of the medulla in an 11-year 
old female and 20-year old male with ASD.  MRI examinations have also revealed abnormalities 
within the medulla in persons with ASD.  Specifically, four studies have found the medulla to be 
significantly smaller in persons with ASD (Hashimoto et al., 1992, 1995; Hashimoto, Tayama, 
Miyazaki, Murakawa, & Kuroda, 1993; Hashimoto, Tayama, Miyazaki, Murakawa, Shimakawa 
et al., 1993), while two others have found no differences (Gaffney et al., 1988; Hardan et al., 
2001). 
 Summary and conclusion.  The most consistent results found from the structural 
examinations of the medulla and pons in ASD is impairment within the inferior olive of the 
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medulla.  The inferior olive is located within the ventral portion of the medulla, and the ventral 
lateral (A1) portion of the medulla is part of the NE system that regulates pupil size; thus, 
impairment within this structure could contribute to altered pupillary responses in ASD.  
Impairment within the pontine structure is less conclusive.  However, it has been suggested that 
because the pontine structure has an early development (Bayer et al., 1993) and shows a decline 
in LC cell number with age (e.g., Baker et al., 1989; Chan-Palay & Asan, 1989; Manaye et al., 
1995), that structural abnormalities may only be evident at earlier stages of development and/or 
in the functional capacity of the NE system (Martchek et al., 2006).  Therefore, it is important to 
conduct further investigations of the pons in young children with ASD to determine its 
involvement in the disorder.  In addition, neurochemical examinations of NE will facilitate 
further understanding of the function of the NE system in ASD. 
Norepinephrine.  As stated earlier, the LC contains the largest group of NE containing 
neurons in the CNS (Dahlstrom & Fuxe, 1964) and sends NE innervations throughout the spinal 
cord, cerebellum, forebrain, cerebral cortex, and hippocampus (see Aston-Jones et al., 1984; 
Foote et al., 1983 for reviews).  The A1/A5 nuclei of the ventral medulla and pons, respectively, 
also supply a portion of NE innervations, which are sent to the brainstem and hypothalamus 
(e.g., Kuhar, Couceyro, & Lambert, 1999).  Both the LC and A1/A5 nuclei send direct excitatory 
NE innervations to sympathetic structures controlling pupil size.  In addition, both structures are 
involved in providing inhibitory connections to the EW nucleus of the parasympathetic system; 
however, while the LC provides direct NE innervations to the EW nucleus, the A1/A5 nuclei 
provide an indirect influence through the hypothalamic system (Szabadi & Bradshaw, 1996).  
Therefore, if any of the structures involved in the NE system were impaired in ASD and 
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involved in the atypical pupillary responses, then alterations in NE levels would also be 
expected.   
Levels of NE in persons with ASD have been examined through blood, urine, and 
cerebral spinal fluid (CSF).  Measurement of plasma levels of NE have yielded the most 
consistent results, with six studies finding elevated levels of plasma NE in persons with ASD (3- 
to 23-years-of-age) compared to controls (Cook et al., 1990; Israngkun, Newman, Patel, Duruibe, 
& Abou-Issa, 1986; Lake, Ziegler, & Murphy, 1977; Launay et al., 1987; Leboyer, Bouvard, & 
Launay, 1992; Leventhal, Cook, Morford, Ravitz, & Freedman, 1990), and two studies finding 
no differences (Herault et al., 1994; Martineau et al., 1994).  Plasma NE has a short half-life and 
reflects phasic sympathetic arousal (Minderaa, Anderson, Volkmar, Akkerhuis, & Cohen, 1994).  
Therefore, the results of these studies suggest that persons with ASD may have atypically 
heightened sympathetic arousal responses to blood draw (e.g., Cook, 1990; Minderaa et al., 
1994).  To our knowledge, however, only one study conducted in the last 15 years, has failed to 
observe differences in the NE system in ASD.  This study found no differences between high-
functioning adults with ASD and controls in their blood NE responses to a psychosocial stressor 
(public speaking) (Jansen et al., 2006).  Further investigations into task-specific NE responses to 
a variety of salient stimuli in ASD seem a promising avenue to understand the phasic responding 
of this system. 
In contrast to plasma NE studies, urine and cerebral spinal fluid (CSF) measures of NE 
reflect time-averaged measures of NE release and are thought to reflect tonic sympathetic 
arousal.  The results of these investigations in ASD have yielded mixed results.  Studies 
examining urine levels of NE and the NE metabolite 3-methoxy-4-hydroxyphenylglycol 
(MHPG) have found increased (Barthelemy et al., 1988; Martineau et al., 1994) and decreased 
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levels in children (1- to 16-years-of-age) with ASD (Barthelemy et al., 1988; Young, Cohen, 
Brown, & Caparulo, 1978; Young, Cohen, Caparulo, Brown, & Maas, 1979), while others have 
shown no differences (Croonenberghs et al., 2000; Launay et al., 1987; Minderaa et al., 1994).  
Plasma and CSF measures of MHPG have not revealed any differences between persons with 
ASD (1- to 29-years-of-age) and controls (Gillberg & Svennerholm, 1987; Minderaa et al., 1994; 
Young et al., 1981).  However, because alterations in levels of NE are often not observed until 
tissue levels are below 90% due to compensatory effects (Abercrombie & Zigmond, 1989), 
alterations in tonic levels of NE in ASD may only be evident in postsynaptic receptor number 
and altered levels of second messengers.  In fact, all of the studies that have examined the NE 
second messenger, cyclic AMP (cAMP) have found increases in the plasma (5- to 19-years-of-
age) (Goldberg, Hattab, Meir, Ebstein, & Belmaker, 1984; Hoshino et al., 1979, 1980) and CSF 
levels (Winsberg, Sverd, Castells, Hurwie, & Perel, 1980) in ASD.   
Summary and conclusion.  The relatively consistent finding of heightened levels of 
plasma NE in response to blood draw suggest that persons with ASD do have atypical phasic 
sympathetic responses.  However, the results of these investigations are limited to phasic 
responses to only one event, blood draw.  Therefore, the NE phasic responses should be further 
examined in ASD to a variety of salient stimuli and conditions to gain a better understanding of 
the nature of the NE phasic response impairment in ASD.  In addition, future studies should 
utilize less invasive techniques for examining NE phasic responses, such as saliva measures, to 
ensure that the responses of the NE system are due to the selected stimulus and not the collection 
technique.  Because the phasic NE investigations in ASD are consistent but limited in number, 
are limited to responses to blood draw, and are outdated, phasic NE responses in ASD must be 
reexamined.   
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While the tonic levels of NE are less conclusive, the consistent finding of elevated levels 
of cAMP is promising and suggests that impairment to the NE system may only be apparent in 
compensatory mechanisms.  Therefore, tonic NE levels in ASD must also be further examined 
through measurement of cAMP.  In addition, because there have been no studies published to 
date that have examined NE synthesis through the use of positron emission technology (PET), 
studies using this technique to examine the regional synthesis of NE levels in ASD is warranted.  
PET examinations of NE would provide detailed information about the regional differences in 
NE utilization in ASD and may help to clarify the mixed results of the urine and CSF levels of 
NE in this disorder.    
Hypothalamic System  
Structural impairment.  Within the PH and LH, a few postmortem examinations have 
revealed impairment in persons with ASD.  Bauman and Kemper (1994) found the brains of six 
persons with ASD (9, 10, 12, 22, 28, and 29 years of age) to have reduced neuronal cell size and 
increased cell number within the mammillary bodies, located on the floor of the PH.  
Weidenheim et al (2001), found axonal spheroids (swellings of axons) within the mammillary 
bodies and PH of a 20-year-old male with ASD, and within the LH of both the 20-year-old male 
and 11-year-old female with ASD.  Thus, the most consistent structural impairment within the 
hypothalamus in persons with ASD is impairment of the mammillary bodies.  However, unlike 
most other hypothalamic nuclei, the mammillary bodies do not relay information to other parts of 
the hypothalamus and thus are not involved in the regulation of pupil size.  Instead, the 
mammillary bodies act as part of the limbic system relaying impulses from the amygdala and 
hippocampus to the thalamus.  Therefore, these mammillary impairments are more consistent 
with the limbic system impairments repeatedly found in persons with ASD (see Bauman & 
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Kemper, 2005; Palmen et al., 2004 for reviews) than impairments within the hypothalamic 
systems (LH and PH) that help to regulate pupil size.      
 Histamine and orexin.  The PH and LH systems that contribute to pupil size and arousal 
can be investigated by examining levels of histamine and orexin.  The tuberomamillary nuclei of 
the PH are the only source for neuronal histamine in the CNS, and histamine-containing neurons 
that derive from this nucleus help to maintain arousal and pupil size by enhancing LC-NE 
neuronal firing and LH activity (Hou et al., 2006).  Thus, if atypical functioning of the PH 
contributes to altered pupillary responses in ASD, atypical levels of histamine would also be 
expected.  However, to my knowledge, only one study has reported an investigation of histamine 
levels in ASD and no differences between ASD and control groups were found (Launay et al., 
1988).   Therefore, further investigation into histamine in ASD is necessary to determine if the 
PH may contribute to atypical pupillary responses in the disorder.   
Orexin is a recently discovered neuropeptide, synthesized within the LH (de Lecea et al., 
1998; Sakurai et al., 1998), that enhances LC-NE and PH activity (Bayer et al., 2001; van den 
Pol et al., 2002) to help maintain arousal and pupil size.  In addition, orexin-A has been found to 
modulate activity of the hypothalamic-pituitary-adrenal axis (HPA) by enhancing the release of 
corticotropin-releasing hormone (CRH) from the paraventricular nucleus (PVN) of the 
hypothalamus (Russell et al., 2001).  The PVN then stimulates the anterior pituitary to release 
adrenocorticotropic hormone (ACTH) into the general circulation resulting in stimulation of the 
adrenal cortex to release cortisol.  Thus, orexin-A indirectly stimulates the release of cortisol 
through activation of the PVN causing an increase in both ACTH and cortisol (Al-Barazanji, 
Wilson, Baker, Jessop, & Harbuz, 2001; Ida et al., 2000; Kuru et al., 2000; Mazzocchi, 
Malendowicz, Gottardo, Aragona, & Nussdorfer, 2001; Spinazzi, Rucinski, Neri, Malendowicz, 
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& Nussdorfer, 2005).  While no studies were found that have examined orexin in persons with 
ASD, several studies have examined ACTH and cortisol.  These studies have yielded mixed 
results with some finding lower baseline levels of plasma and serum cortisol (Curin et al., 2003; 
Herman, Arthur-Smith, Hammock, & Josephs, 1988; Hill, Wagner, Shedlarski, & Sears, 1977), 
and higher baseline levels of urinary cortisol (Richdale & Prior, 1992) and plasma ACTH in 
ASD (Curin et al., 2003; Tani et al., 2005; Tordjman et al., 1997), while others have found no 
differences (Brambilla, Viani, & Rossotti, 1969; Goodwin, Cowen, & Goodwin, 1971; Maher, 
Harper, Macleay, & King, 1975; Sandman, Barron, Chicz-DeMet, & DeMet, 1991; Tordjaman et 
al., 1997).  In addition, studies have revealed abnormal patterns of plasma (Hill et al., 1977; 
Yamazaki, Saito, Okada, Fujidea, & Yamashita, 1976) and salivary cortisol secretion rhythms in 
individuals with ASD (Corbett, Mendoza, Abdullah, Wegelin, & Levine, 2006; Corbett, 
Mendoza, Wegelin, Carmean, & Levine, 2008; Corbett, Schupp, Levine, & Mendoza, 2009; 
Hoshino et al., 1989).  In response to stressors, persons with ASD have been found to have 
heightened salivary cortisol responses following exposure to a non-social stressor (MRI) 
compared to controls (Corbett et al., 2006), along with slower salivary cortisol elevation 
following ACTH stimulation (Marinovic-Curin et al., 2008); while other studies have found no 
difference in cortisol responses to non-social (mock-MRI) (Corbett et al., 2008, 2009), physical 
(exercise) or psychosocial (public speaking) stress in persons with ASD (Jansen, Wied, van der 
Gaag, van Engeland, 2003; Jansen et al., 2006).   
Summary and conclusion. There is a dearth of structural and neurochemical 
examinations of the hypothalamic components of the pupillary system (LH and PH) in ASD.  
Postmortem examinations of the hypothalamus have yielded impairments within the mammillary 
bodies that are more consistent with limbic system impairments, and which do not indicate LH or 
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PH impairment in ASD.  However, more targeted postmortem and neuroimaging examinations 
are necessary to determine if the LH and PH are structurally unaltered in ASD.  The 
investigation of histamine and orexin in ASD has been very limited, with one study examining 
histamine while none have directly examined orexin; therefore, studies directly measuring levels 
of histamine and orexin in ASD are necessary to determine their involvement in the disorder.  
However, because orexin-A has been found to modulate the activity of ACTH and cortisol, 
implications about the responses of the orexin system in ASD can be inferred through 
examination of cortisol and ACTH levels in ASD.  While these examinations have yielded mixed 
results, it has been suggested that the source of these inconsistencies may be the measurement 
method.  The use of blood draw may lead to altered arousal in persons with ASD, therefore, the 
results of ACTH and cortisol levels measured through plasma and serum may be indicative of 
phasic responses to venipuncture (e.g., Jansen et al., 2006; Lam, Aman, & Arnold, 2005).  
Cortisol measurement through non-invasive techniques, such as saliva, has yielded more 
consistent tonic results suggestive of impaired secretion rhythms, while phasic salivary cortisol 
responses to physical and psychological stressors have been less conclusive.  Therefore, further 
investigation into the salivary cortisol levels in ASD is necessary to determine its involvement in 
the phasic and tonic responses of the hypothalamic system.  
Aim and Predictions of the Current Study 
It is the goal of the current study to replicate and extend the findings from previous 
investigations (Anderson et al., 2006; Anderson & Colombo, 2009) by examining tonic pupillary 
responses to a one-minute baseline, and phasic pupillary and scanning responses to social and 
non-social dynamic and multimodal scenes in young children with ASD.  The current study was 
designed to address some of the methodological concerns of the previous investigation by 
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including a more homogeneous MA-matched group (e.g., children with Down’s syndrome), and 
by presenting the children with dynamic and multimodal stimuli that possess more ecological 
validity than static photos.  Finally, we sought to extend previous findings by conducting an 
examination of the NE and hypothalamic systems through measurement of the salivary correlates 
of these systems, alpha-amylase (AA) and cortisol, respectively, in response to the social and 
non-social dynamic and multimodal scenes.  The measurement of salivary cortisol and AA in the 
current study extends previous findings (Anderson et al., 2006; Anderson & Colombo, 2009) by 
determining the relationship between these salivary measures and phasic and tonic pupillary 
responses in children with ASD.  In addition, the use of these non-invasive salivary measures 
allowed for the opportunity to determine if the atypical NE and cortisol levels previously found 
in those with ASD were the result of heightened stress associated with blood draw, given that a 
measurement of saliva presumably invokes less anxiety.   
Scanning Measures 
 The use of static stimuli in eye-tracking investigations has yielded mixed results.  Some 
studies have shown no difference between ASD and control groups scanning of whole upright 
human faces (Anderson et al., 2006; Speer, Cook, McMahon, & Clark, 2007; Freeth, Chapman, 
Ropar, & Mitchell, 2009; van der Geest, Kemner, Verbaten, & van Engeland, 2002) or cartoon 
figures of humans (van der Geest, Kemner, Camfferman, Verbaten, & van Engeland, 2002).  
Other studies, however, have found persons with ASD to show decreased scanning of whole 
upright human faces (Riby & Hancock, 2009a; Sasson, Turner-Brown, Holtzclaw, Lam, & 
Bodfish, 2008), particularly within the eye (Boraston, Corden, Miles, Skuse, & Blakemore, 
2008; Dalton et al., 2005; Hernandez et al., 2009; Nacewicz et al., 2006; Neumann, Spezio, 
Piven, & Adolphs, 2006; Pelphrey et al., 2002; Sterling et al., 2008), nose (Hernandez et al., 
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2009; Pelphrey et al., 2002), and mouth (Sterling et al., 2008) region of the faces.  In contrast, 
studies using video clips containing human characters have been consistent in finding scanning 
differences between ASD and control groups; these studies have found significant decreases in 
looking time to the eye region (Jones et al., 2008; Klin et al., 2002; Norbury et al., 2009; Riby & 
Hancock, 2009b; Speer et al., 2007) along with corresponding looking time increases to the 
mouth (Jones et al., 2008; Klin et al., 2002) and body region of the human characters (Riby & 
Hancock, 2009b; Speer et al., 2007) in persons with ASD.  Thus, it has been suggested that 
scanning deficits in ASD may be dependent upon the ecological validity of the stimulus (Speer et 
al., 2007), which has been approximated in these previous studies through the use of social 
stimuli that is dynamic and multimodal; suggesting that scanning of dynamic social stimuli may 
be more sensitive to ASD classification than scanning measures to static human faces.   
Hypotheses and predictions.  For the current study, it was predicted that if scanning 
deficits were present in persons with ASD and sensitive to increased ecological validity, that the 
ASD group would spend a significantly smaller proportion of time looking at the dynamic social 
stimulus than either the DS or TD control groups.  Specifically, we expected the ASD group to 
spend a significantly smaller proportion of time looking within the internal feature region than 
either control group.  None of the studies examining scanning of dynamic social stimuli in ASD 
(Jones et al., 2008; Klin et al., 2002; Norbury et al., 2009; Riby & Hancock, 2008b; Speer et al., 
2007) included a non-social dynamic control stimulus.  Therefore, the atypical scanning found in 
individuals with ASD may have been due to the dynamic nature of the stimulus and not the 
social content per se.  In the current study, a non-social dynamic stimulus has been built into the 
design, which allowed for the determination that differences in scanning were due to the social 
nature of the stimulus.  However, based on the results of a previous investigation (Anderson et 
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al., 2006), we did not expect any between-group differences in the proportion of time spent 
looking at the non-social stimulus.   
Pupillary Measures 
The results of previous investigations (Anderson et al., 2006; Anderson & Colombo, 
2009) also suggest that children with ASD have a larger tonic (baseline) pupil size, and a smaller 
phasic pupillary response to human faces than control groups.  Studies of tonic pupil size from 
other laboratories have shown that pupil size varies with sleep-wake cycle changes, with pupil 
size being largest during states of high arousal or alertness (e.g., Lowenstein & Lowenfeld, 1961, 
1964; Willhelm et al., 2001).  Therefore, the larger tonic pupil size in children with ASD may be 
indicative of atypically higher levels of sympathetic arousal (alertness) along with a 
corresponding decrease in parasympathetic input.  This is consistent with tonic pupil (Fan et al., 
2009; Rubin, 1961) and non-pupillary autonomic studies (e.g., Bal et al., 2009; Hirstein et al., 
2001; Ming et al., 2005; Van Hecke et al., 2009) finding heightened tonic sympathetic responses 
along with decreased parasympathetic input in ASD, and with studies demonstrating sleep-wake 
cycle impairments in those with the disorder (e.g., Allik et al., 2006a, 2006b; Giannotti et al., 
2008; Honomichl, et al., 2002; Oyane & Bjorvatn, 2005; Williams et al., 2004).   
Phasic pupillary responses have been shown to be related to the amount of attention or 
cognitive resources that are allocated to the processing of information, with the size of the pupil 
becoming larger as processing demands increase (e.g., Bradshaw, 1968; Steinhauer et al., 2000, 
2004) and with increases in social relevance (Conway et al., 2008; Fitzgerald, 1968).  Thus, the 
previous finding of a decreased phasic pupil size to human faces in children with ASD 
(Anderson et al., 2006) can be taken to indicate less attention or cognitive resource allocation to 
the processing of stimuli with social relevance in ASD.  This finding is further supported by 
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studies showing atypical phasic pupil (Falck-Ytter, 2008) and non-pupillary autonomic responses 
(e.g., Corona et al., 1998; Hirstein et al., 2001; Hubert et al., 2009; Kootz et al., 1982; Kootz & 
Cohen, 1981; Sigman et al., 2003) to stimuli with social relevance in ASD. 
Hypotheses and predictions.  Based on previous pupil and non-pupillary autonomic 
investigations, it was predicted that the ASD group would have a larger tonic pupil size during 
the one-minute baseline, consistent with heightened tonic sympathetic activity, than either of the 
control groups, who were not expected to differ from each other.  In addition, if persons with 
ASD allocate less attention or cognitive resources to stimuli with social relevance, then the 
results of the current study should be similar to previous pupil and non-pupillary autonomic 
studies in finding altered phasic pupillary responses to the social stimulus in the ASD group.  
More specifically, based on previous phasic pupillary studies finding smaller phasic responses to 
upright human faces (Anderson et al., 2006; Falck-Ytter, 2008), the ASD group was expected to 
have a smaller phasic pupil response to the social stimulus compared to control groups.  Phasic 
pupillary responses to the non-social stimulus allowed me to determine if these responses were 
specific to the social stimulus, or if altered phasic pupil size represents a general deficit in 
attention or cognitive resource allocation.  Based on previous investigations (Anderson et al., 
2006; van Engeland et al., 1991) no between-group differences in phasic pupillary responses 
were expected to emerge for the non-social stimulus.  No differences in phasic pupillary 
responses were expected to emerge among the control groups for either stimulus.         
Salivary Measures 
 Alpha-amylase.  The salivary enzyme AA is regulated through NE activation of α- and 
ß-adrenergic receptors, leading to secretion of AA from the parotid salivary gland (Turner & 
Sugiya, 2002), and thus, salivary AA has been found to vary with changes in plasma levels of 
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NE (Chatterton, Vogelsong, Lu, Ellman, & Hudgens, 1996; Rohleder, Nater, Wolf, Ehlert, & 
Kirschbaum, 2004; Wetherell et al., 2006), along with cardiac (Bosch, de Geus, Veerman, 
Hoogstraten, & Amerongen, 2003; Chatterton et al., 1996; Nater et al., 2006) and electrodermal 
measures of autonomic activity (El-Sheikh, Erath, Buckhalt, Granger, & Mize, 2008).  In 
addition, like plasma levels of NE, salivary AA decreases in response to ß-adrenergic blockers 
(Speirs, Herring, Cooper, Hardy, & Hind, 1974; van Stegeren, Rohleder, Everaerd, & Wolf, 
2006), and increases in response to α2-adrenergic antagonists (Ehlert, Erni, Hebisch, & Nater, 
2006).  Finally, several studies have found AA to increase in response to psychological stress 
(Bosch et al., 1996, 1998, 2003; Gordis, Granger, Susman, & Trickett, 2006; Kivlighan & 
Granger, 2006; Nater et al., 2005, 2006; Rohleder et al., 2004; Rohleder, Wolf, Maldonado, & 
Kirschbaum, 2006; Skosnik, Chatterton, Swisher, & Park, 2000).  Therefore, plasma levels of 
NE, associated with phasic responses of the NE system, can be estimated through the non-
invasive measurement of salivary AA; and to my knowledge salivary AA has not been 
previously examined in persons with ASD.   
Hypotheses and predictions.  The results of previous investigations showing atypical 
tonic (Anderson & Colombo, 2009; Fan et al., 2009; Rubin, 1961) and phasic (Anderson et al., 
2006; Falck-Ytter, 2008) pupillary responses in persons with ASD, indicate that the functioning 
of the neurological systems involved in controlling pupil size may be altered in those with the 
disorder.  The findings of structural and neurochemical alterations within the NE system in 
persons with ASD implicates that the NE system may be a potential source of these altered 
responses.  The atypical resting and reflex tonic pupillary responses along with decreased phasic 
pupil responses are consistent with elevated levels of tonic NE activity, which result in reduced 
NE phasic activation, a larger resting pupil size, and reduced phasic pupillary responses to salient 
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stimuli (e.g., Aston-Jones & Cohen, 2005).  The A1/A5 nuclei and LC are part of the pupillary 
system and their activation results in increased NE sympathetic activity and parasympathetic 
inhibition of the EW nucleus.  Therefore, if the atypical pupillary responses previously found in 
ASD involve atypical activation of the NE system then, it was predicted that the ASD group 
would have atypical levels of salivary AA that mirrored their pupillary responses.  More 
specifically, baseline concentrations of salivary AA were expected to be greater for the ASD 
group compared to controls.  In addition, we expected for the ASD groups’ salivary AA 
concentrations to significantly decrease following the presentation of the social stimulus, while 
control groups levels were expected to either remain stable or slightly increase.  In addition, if 
the NE system is involved in the atypical pupillary responses in those with ASD, the salivary AA 
concentrations during both baseline and phasic conditions should be correlated with the 
corresponding tonic and phasic pupillary responses for the ASD group.  No between-group 
differences in salivary AA responses to the non-social stimulus were predicted.  
Cortisol.  In the current study, salivary cortisol measures were examined as a correlate 
measure of the hypothalamic system (the HPA system, modulated by the release of orexin-A 
from the LH).  Because both salivary cortisol levels are uncorrelated with salivary AA levels 
(Chatterton et al., 1996; Granger et al., 2006; Nater et al., 2005, 2006; Nater, Rohleder, Schlotz, 
Ehlert, & Kirschbaum, 2007) these are not redundant measures.  Instead, cortisol and AA are 
correlates of two independent neurological systems, both of which are responsive to 
psychological stimuli and are involved in the control of arousal and pupillary responses.   
Hypotheses and predictions.  The hypothalamic system is involved in controlling pupil 
size and acts in conjunction with the NE system to maintain optimal levels of arousal through 
sympathetic activation and parasympathetic inhibition.  Therefore, if the hypothalamic system is 
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involved in producing the atypical tonic and phasic pupillary responses previously found in those 
with ASD, then salivary concentrations of cortisol was also expected to be altered in the ASD 
group.  More specifically, the ASD group was expected to have atypical concentrations of 
salivary cortisol during both baseline conditions and following the presentation of the social 
stimulus compared to controls, who were not expected to differ.  In addition, if the hypothalamic 
system is involved in the atypical pupillary responses in those with ASD, then salivary cortisol 
concentrations during both baseline and phasic conditions were predicted to correlate with the 
corresponding tonic and phasic pupillary responses for the ASD group.  No between-group 
differences in salivary cortisol responses to the non-social stimulus were expected.  Finally, 
because cortisol responses are uncorrelated with AA responses (Chatterton et al., 1996; Granger 
et al., 2006; Nater et al., 2005, 2006, 2007), only one of these measures were expected to emerge 
as a correlate to the tonic and phasic pupillary responses for the ASD group, and no correlations 
between tonic or phasic concentrations of salivary AA and cortisol levels were anticipated. 
Method 
Participants 
 Inclusion criteria.  Children between the ages of 20 to 72 months of age were recruited 
for the current study if they had a diagnosis of Autistic Disorder (AD), Pervasive Developmental 
Disorder-Not Otherwise Specified (PDD-NOS), Down Syndrome (DS) without a comorbid AD 
or PDD-NOS diagnosis, or if they were typically-developing (TD).  Children were recruited 
through mail from a variety of developmental disability organizations in metropolitan and 
suburban areas of Kansas City, KS and MO, and through a pre-established commercial list of 
families in Johnson, Wyandotte, and Douglas county Kansas.  Using these criteria 37 children 
were recruited for participation and seen at the laboratory for testing sessions.   
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 Exclusion criteria.  Out of these 37 children, data for 32 of the participants were used in 
the final analysis (see sections below on attrition and group assignment).  Children were 
excluded from participation if they had comorbid impairments in vision and/or hearing that could 
significantly impede their ability to see or hear the stimulus (i.e., severe hearing or vision loss), 
and if they had motor impairments that would interfere with their ability to sit upright without 
assistance in a car seat.  However, children who had vision, hearing, and/or motor impairments 
that were corrected and did not interfere with data acquisition were included in the final analysis; 
these conditions included mild amblyopia or “lazy eye” (n = 5), corrective lenses for myopia (n = 
4), ear tubes with no reported hearing loss (n = 4), and low muscle tone (n = 1).  In addition, with 
the exception of the AD, PDD-NOS, or DS diagnoses, none of the children included in the final 
analysis had a history of chronic illness or medication use; the only exception to this was 
seasonal allergies and occasional anti-histamine use (n = 8).  All children who participated in the 
current study were healthy (i.e., did not have any symptoms of acute illness such as cold, flu, 
allergies, etc.) and medication-free at least 48 hours prior to the testing sessions.       
 Attrition.  The data from three children were unusable due to inaccurate or insufficient 
calibration during both testing sessions, and so their data were excluded from the final analysis; 
one child with DS had poor calibration on only one testing session, which was not included in 
the final analysis (see section on visual testing session for further explanation of attrition due to 
calibration).  Additionally, two children were excluded because of the group-matching strategy 
(see sections below on group assignment).  Out of the 32 children used in the final analysis, five 
children had data for only one testing session because of attrition due to participant drop-out.  
Thus, 26 children had data included in the final analysis for both testing sessions, while six 
children had data from only one session.     
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 Group assignment.  Thirty-two participants were assigned to either the Autism 
Spectrum Disorder (ASD), Down Syndrome (DS), or typically-developing (TD) groups.  The 
ASD group consisted of children who had been previously diagnosed with either AD (n = 8) or 
PDD-NOS (n = 4).  The DS group consisted of children with a diagnosis of DS, without a 
comorbid ASD diagnosis (n = 9).  The TD group was comprised of children who had scores on 
all subscales of the Mullen Scales of Early Learning (Mullen, 1995) not less than one standard 
deviation below the test mean, and who did not have a diagnosed developmental disability (n = 
11).  The presence or absence of an ASD diagnosis was confirmed through administration of the 
Autism Diagnostic Observation Schedule-Generic (ADOS-G; Lord, Rutter, & DiLavore, 1997).        
 The age and gender composition of the ASD group dictated the recruitment and 
formation of the control groups (DS and TD).  The control groups were matched with the ASD 
group on mean age and frequency of each gender.  Age was considered a match if between-
group differences in mean age were non-significant, and gender was considered a match if 
between-group gender frequencies were equal.  Using these criteria, the DS group was matched 
with the ASD group on chronological age (CA), t (19) = .243, p = .811, mental age (MA; based 
on their Early Learning Composite scores on the Mullen), t (19) = .359, p = .723, and was 
approximately matched on gender.  In addition, subscale age equivalents on the Mullen (Visual 
Reception, Fine Motor, Receptive Language, and Expressive Language) for the DS group did not 
vary significantly from those of the ASD group (all ps > .25).  The TD group was matched with 
the ASD group on CA, t (21) = -.289, p = .776, and gender, but not on MA, t (21) = -5.095, p < 
.025, or Mullen subscale age equivalents (all ps < .025).  There were no differences among the 
three groups in any of the demographic measures (all ps > .05).  Table 1 presents age, gender, 
diagnostic, and demographic information for each group.   
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Table 1 
Age, Gender, Diagnostic, and Demographic Information for All Groups 
 Group 
 ASD  DS  TD 
Gender distribution 11 male, 1 female  7 male, 2 female  10 male, 1 female 
n 12  9  11 
 M Range  M Range  M Range 
CAa 50.25 30 – 69  48.67 20 – 73  51.73 34 – 69 
 Mullen 
Visual Receptionab 36.17 16 – 54  32.22 13 – 54  56.91 33 – 69 
Fine Motorab 34.42 16 – 53  29.67 17 – 49  52.55 33 – 68 
Receptive Languageab 31.70 14 – 49  34.63 17 – 55  59.67 33 – 69 
Expressive Languageab 31.90 10 – 46  31.50 17 – 70  61.89 39 – 70 
Composite (MA) ab 33.33 14 – 47  31.44 16 – 57  57.43 35 – 68 
 ADOS-G 
Social 10 6 – 15  0.75 0 – 2  0  
Communication  10.10 3 – 18  3.63 0 – 11  0  
Behavior 2.5 0 - 5  0.13 0 – 1  0  
 Demographic measures 
Parent education levelc 13.45 8 – 18  14.44 9 – 18  15.78 12 – 18 
Mother’s aged 34.25 30 – 38  33.57 25 – 41  38.88 33 – 47 
Father’s aged 36.75 33 – 41  35.71 27 – 45  40.75 35 – 49 
Number of siblingse 1.64 1 – 3  1.89 0 – 6  2.11 1 – 6 
Hours in daycaref 7.50 0 – 42  8.22 0 – 35  4.44 0 - 15 
Note.  ASD = Autism Spectrum Disorder; DS = Down syndrome; TD = typically developing; 
CA = Chronological age.  Mullen = Mullen Scales of Early Learning (Mullen, 1995); Composite 
= Early Learning Composite; MA = Mental age; ADOG-G = Autism Diagnostic Observation 
Schedule-Generic (Lord, Rutter, & DiLavore, 1997); Social = Qualitative impairments in 
reciprocal social interaction; Behavior = Stereotyped behaviors and restricted interests. 
a Presented in months. b Age equivalent score. c Number of years beyond high school for both 
parents. c Presented in years. e Includes siblings living at home full- and part-time. f Number of 
hours per week in center and home-based daycare and preschool.     
 
Standardized Tests 
 Two standardized tests were used for the current study, the ADOS-G (Lord et al., 1997) 
and the Mullen Scales of Early Learning (Mullen; Mullen, 1995).   
 Autism Diagnostic Observation Schedule-Generic (ADOS-G).  The ADOS-G is a 
semi-structured play observation, with administered activities designed to provide an opportunity 
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to observe the presence or absence of the core deficits of AD and PDD-NOS (Lord et al., 1989).  
The administration of this test is concise and it yields three separate scores that reflect core ASD 
impairments (Communication, Qualitative Impairments in Reciprocal Social Interaction, and 
Stereotyped Behaviors and Restricted Interests) along with an overall score; each of the scores 
are used to assist in diagnosing those whose scores fall within the PDD-NOS/AD range.  For the 
current study, this test was administered to all children that were seen for testing appointments, 
to confirm the diagnosis of AD or PDD-NOS in the ASD group, and to ensure that the children 
in the DS and TD were appropriately assigned.  Thus, the ADOS-G was used to quantify the 
level of impairment (if any) and confirm group assignment. 
 Mullen Scales of Early Learning (Mullen).  The Mullen is a standardized cognitive 
assessment that allows for flexibility of administration, which has advantages for children with 
disabilities.  This assessment was administered to all children in the current study for the 
purposes of group MA matching and description of the populations.  The Mullen is a 
standardized test of general cognitive function/developmental status and is comprised of five 
subscales:  Gross Motor, Visual Reception, Fine Motor, Receptive Language, and Expressive 
Language.  Each subscale yields a T-score, percentile rank, and an age equivalent.  All subscales, 
with the exception of the Gross Motor scale, are summarized into an Early Learning Composite 
score.  Therefore, to assist in brevity of administration, participants were administered all 
subscales except Gross Motor, for the current study. 
Visual Task 
 Stimuli.  For the visual task, all children were presented with one social and one non-
social stimulus that consisted of dynamic and multimodal color video clips.  The social stimulus 
(see Appendix A, for an example) consisted of digitized video clips taken from “The Wiggles” 
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video series (Wiggles Touring Pty Limited, 1999, 2000, 2001a, 2001b, 2001c, 2002).  These 
images were chosen because they display brief clips of social interactions among the characters, 
and clips of the characters speaking to the viewing audience.  The video clips provided an 
opportunity for the child to observe a naturalistic social interplay among characters, and to 
observe characters attempting to socially engage the child by asking questions or revealing 
information about himself or the scene context; therefore, these scenes mirror social situations 
that the children may encounter in everyday settings.  Clips were chosen from this video series if 
they had human characters speaking with each other and/or speaking to the viewing audience, 
and were excluded if the characters were singing, or included non-human characters (i.e., 
animals, humans dressed as animals, or talking inanimate objects).  The video clips that were 
chosen varied in length from 16 to 166 s, and were edited together to form a 10-minute clip that 
was cohesive in both content (i.e., speaking was not “cut-off” mid sentence or context) and form 
(i.e., there were no pauses between clips). 
 The non-social stimulus (see Appendix B, for an example) consisted of digitized video 
clips taken from the “Baby Einstein” video series (The Baby Einstein Company, LLC, 1998, 
2002a, 2002b, 2002c).  These images were chosen because they displayed toys and objects 
moving to non-voice sounds and instrumental music, and therefore contained movement, sound, 
and color, but did not include human or animal pictures/noises (i.e., voices or animal sounds).  
The clips that were chosen varied in length from 6 to 131 s and were edited together to form a 
cohesive 10-minute video clip (music appeared continuous and there were no pauses between the 
clips). 
 Both stimuli were presented on a 40.6 cm computer monitor, which subtended a 21.6º 
visual angle at the viewing distance.  Each stimulus lasted for 10 minutes and was presented 
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twice for a total of 20 minutes.  Average luminance (M = 3.0 lx, range: 2.1 – 3.8 lx) and sound 
level (M = 60 dB, range: 50-63 dB; conversational speech is around 60 dB) were held constant.  
Immediately prior to the presentation of each stimulus, a blank grey slide, matched for luminance 
(3.0 lx) with the stimulus clips, was presented for three minutes to obtain baseline measures.  
Each stimulus was presented on a separate day to avoid interference or overlap among the 
salivary and pupil response measures. 
 Eye-tracking apparatus.  Scanning paths and pupillary responses were recorded using 
an Applied Science Laboratory (ASL) E6 eye-tracking system, Model 504 (Applied Science 
Laboratory, 2001).  The pan/tilt module, which is a component of the ASL E6 eye-tracking 
system, uses infrared technology to illuminate the eye and telephoto an image of the eye on an 
eye camera.  The E6 control unit then extracts the pupil and reflection of the light source on the 
cornea and computes both pupil diameter and line of gaze at a sampling rate of 60 Hz.   
 Use of this system requires calibration to account for individual differences in the 
distance between the pupil center and corneal reflection, used to calculate line of gaze.  A five-
point calibration was administered prior to the presentation of baseline and experimental stimuli.  
Calibration consisted of dynamic and multimodal cartoons that appeared at five calibration 
points (Appendix C).  During calibration and throughout the visual task, a remote control was 
used to manually move the pan/tilt module to keep the child’s eye centered in the eye monitor.  
Calibration was considered successful if corneal reflection and pupil thresholds were consistently 
tracked, and if crosshairs appeared stable and consistent on the eye monitor while the child was 
looking at each of the five calibration points. 
 Visual testing room setup.  The E6 eye-tracking system (ASL, 2001) with the 
GazeTracker (GT) interface program (Eye-Gaze Response Interface Computer Aid [ERICA], 
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2001) was set up in a partitioned interior room, divided into experimenter and participant areas.  
The ASL pan/tilt module was elevated 7.6 cm below the stimulus monitor within the participant 
area.  In addition, a Panasonic video camera was located on top of the stimulus monitor and 
connected to a RCA television monitor for the purposes of monitoring the child.         
 Each child was secured in a child-sized car seat using a five-point restraint, to ensure the 
child’s safety and to minimize movement.  The car seat was securely fastened onto a hydraulic 
chair, which enable adjustment of the child’s eye height to be approximately centered with the 
mid-point of the stimulus monitor, which was 124.5 cm from the ground and at a visual angle of 
21.57º from the stimulus monitor.  The pan/tilt module was repositioned by aiming the remote 
control through a 232.3 cm2 opening, located in the middle partition behind the child’s head.  A 
schematic of the testing room setup is presented in Figure 3.           
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Figure 3.  Visual testing room setup. 
Salivary Sample Collection  
 Baseline measures of salivary cortisol and AA were taken 1 minute after the start of the 
baseline slide.  Stimulus response measures of salivary AA were taken at 10 and 20 minutes 
post-stimulus onset, and salivary cortisol measures were taken at 20 minutes post-stimulus onset.  
The post-stimulus time of sample collection was based on previous salivary AA and cortisol 
studies in preschool-aged children suggesting a peak change from baseline levels in AA between 
10 and 20 minutes post-stimulus onset, and in salivary cortisol at 20 minutes post-stimulus onset 
(e.g., Davis & Granger, 2009; Fortunato, Dribin, Granger, & Buss, 2008).  Salivary samples 
were collected at each time point using three Sorbettes, small absorbent sponges provided by 
Salimetrics LLC, which were simultaneously placed under the child’s tongue for approximately 
2 minutes to ensure an adequate amount of saliva collection for assay purposes (based on 
recommendations by Salimetrics LLC).  The three Sorbettes for each time point (baseline, 10 
minute post-stimulus, and 20 minute post-stimulus), were then placed into one 2 mL cryovial, 
and immediately frozen at -20º C.  All samples were sent to Salimetrics LLC to be assayed. 
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 The diurnal rhythms of AA show a rapid decrease during morning hours and a gradual 
increase throughout the afternoon (e.g., Jenzano, Brown, & Mauriello, 1987; Nater, Rohleder, 
Scholtz, Ehlert, Kirschbaum, 2007; Rantonen & Meurman, 2000; Rohleder et al., 2004), and 
cortisol is highest upon waking with a sharp decrease in the morning, followed by a gradual 
decline throughout the rest of the day (Davis, Bruce, & Gunnar, 2002; Nater et al., 2007; 
Watamura, Donzella, Kertes, & Gunnar, 2004).  Therefore, all testing was conducted in the 
afternoon (between 12:00 p.m. and 5:00 p.m.), as salivary levels of AA and cortisol are more 
stable during this period and less influenced by diurnal variations.  In addition, both tests were 
conducted at the same afternoon time on different days (baseline collection time difference, M = 
11.35 minutes) to ensure that differences in salivary responses to each stimulus type were not 
due to diurnal variations.   
 Finally, stressful and physical events, medication use, caffeine consumption equal to or 
greater than 200 mg, and food consumption can interfere and contaminate salivary measures of 
both AA and cortisol (see Granger, Kivlighan, el-Sheikh, Gordia, & Stroud, 2007; Hanrahan, 
McCarthy, Kleiber, Lutendorf, & Tsalikian, 2006, for reviews).  Based on the recommendations 
from AA and cortisol study reviews (Granger et al., 2007; Hanrahan et al., 2006), parents were 
asked to ensure that their child did not consume any caffeinated products two hours prior, no 
food or milk (or other protein-enhanced beverage) at least one hour prior, and no liquids at least 
10 minutes prior to the testing sessions.  The amount of the caffeine consumption reported in the 
children who ingested caffeine within 2 to 12 hours prior to the testing session (28 % of the 
sessions, 8 subjects) was estimated between 3 and 15 mg.  Testing appointments were scheduled 
on typical days that were free of stressful or atypical events (e.g., first day of school, birthday 
party, loss of a favorite toy, car wreck etc.), and parents were asked to reschedule their 
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appointments if any unusual or stressful event occurred.  Parents were also asked keep their child 
inactive and to ensure that their child did not engage in any exhaustive physical activity (e.g., 
running, biking, swimming, etc.) at least one hour prior to the testing sessions; participants were 
reported to last engage in physical activity between 1.5 and 48 hours prior to the testing sessions 
(M = 12.63 hours).  As stated earlier, none of the participants had taken any medications 
(prescription or over-the-counter) within 48 hours of their scheduled testing appointments.  
Confirmation of compliance with these restrictions was confirmed prior to the start of each 
session.   
Procedure 
Recruitment 
 Children were recruited for the current study from October 2007 to July 2009.  Families 
were solicited through a variety of developmental disability organizations (Appendix D) that 
agreed to assist in the recruitment of prospective participants.  The organizations were solicited 
through phone or e-mail by the researcher or student assistants if they had contact with families 
who met the study inclusion criteria.  Once contacted they were informed about the study 
purpose and were asked to assist in recruitment by either posting the study information in a 
newsletter or website, or by delivering the recruitment letter (Appendix E) to families of 
potential participants via postal mail, e-mail, or in person.  In addition, family names were also 
derived from a purchased commercial list, and families from this list were sent the recruitment 
letter via postal mail, if they had children who could meet the study inclusion criteria.       
 Once parents received the recruitment letter and determined interest in participation, they 
contacted our laboratory via telephone or e-mail and were screened for information about the 
age, diagnosis, comorbid disorders (such as hearing, vision and/or motor impairments), and 
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current health and medication use for the potential participant.  If the child met the study 
inclusion criteria, then two study appointments were scheduled for the family to come to our 
Lawrence laboratory.  The study appointments were initially scheduled to be approximately one 
week apart, however, due to rescheduling issues resulting from illness, the occurrence of 
stressful or unusual events, and other family issues, the actual appointment dates varied between 
four and 52 days apart (M = 14.04 days).  Both testing appointments were scheduled to be at the 
same afternoon time.  Parents were informed about food, medication, and physical and stressful 
event constraints when scheduling their appointments and were reminded of this criterion both 
verbally and in a written letter (sent via postal or e-mail) during appointment confirmation. 
Data Collection    
 As stated earlier, participants were seen at our Lawrence laboratory for two testing 
sessions that were scheduled at the same afternoon time of day.  Only one stimulus was 
presented at each testing session (either social or non-social), and the order of the stimulus 
presentation (either session one or two) was counterbalanced.   
 Upon arrival at the laboratory, participating families were escorted into the standardized 
testing room where informed consent (Appendix F) was obtained.  The parent was then asked to 
complete the questionnaires in Appendices G and H.  The questionnaire in Appendix G was 
completed during the first testing session and asks about the child’s previous and current health, 
ASD or DS diagnosis, parent demographic information, medications, food and caffeine 
consumption, physical activity, and unusual or traumatic events that may have occurred that day.  
The questionnaire in Appendix H was completed during the second testing session and asks 
about current health, medications, food and caffeine consumption, physical activity, and unusual 
or traumatic events that may have occurred that day.   
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 While the parent was completing the questionnaires, a “practice” saliva sample was taken 
from the child in the standardized testing room to familiarize them with the collection procedure.  
First, the child was shown the Sorbette, used for sample collection, and was given the 
opportunity to touch and hold the Sorbette.  Next, the collection procedure was described to the 
child; they were told that they were going to go into another room and watch some videos and 
that while they were watching these videos the Sorbette was going to be placed under their 
tongue.  Next, the child was asked to open their mouths and the Sorbette was placed under their 
tongue for approximately 2 minutes; this sample was not tested for either cortisol or AA.  Once 
this procedure and all paperwork were completed, the visual testing procedure began. 
 Visual testing procedure.  Parents were invited to accompany their child into the visual 
testing room during set-up and testing, but siblings were not allowed.  A cartoon was playing on 
the stimulus monitor when the participant entered the visual testing room to help obtain their 
interest and cooperation with the testing procedure.  Once the participant entered the visual 
testing room, they were shown the apparatus and asked if they would like to sit in the car seat 
and watch the video.  Once assent was received, the child was assisted into the car seat and 
secured using the five-point restraint to ensure the child’s safety and to minimize movement.  
Parent(s) who remained in the testing room with the child were asked to either stay in the 
experimenter area or were allowed to stand behind the child in the participant area.  To help 
ensure that responses were due to the nature of the stimulus and not the ambient environment, 
neither the parents nor the experimenter interacted with the child or each other during baseline or 
stimulus conditions.  
 To begin the visual test, the lights were turned out in the testing room.  Then, while the 
child was watching the cartoon, the child’s left eye1 was found in the eye camera, and pupil and 
61 
corneal reflection thresholds were obtained using the ASL system.  A 4 mm model pupil, which 
is a black aluminum bar with a 4 mm white circle in the center, was then placed over the child’s 
left eye1 and the pupil diameter value given by the ASL system was recorded.  The recorded 
value was used to convert the child’s pupil size (obtained in pixels) to mm during data extraction 
and reduction.  Calibration was then completed, and success of calibration was determined by 
examining pupil and corneal reflection cross hairs at each of the five calibration points.  This 
procedure was repeated up to five times to achieve successful calibration.  Once calibration was 
achieved, either the social or non-social stimulus was presented on the stimulus monitor using 
the GT program.  The child’s behavior was observed via television monitor to ensure safety and 
compliance during calibration and stimulus presentation.   
 Each stimulus presentation began with a baseline slide, presented for 3 minutes.  At 1 
minute after the start of the baseline slide, salivary samples were taken to obtain baseline levels 
by simultaneously placing three Sorbettes under the child’s tongue for 2 minutes.  After the 3 
minute baseline slide was presented the experimenter left the participant area and stimulus 
presentation automatically began.  The stimulus was presented using the GT program for 10 
minutes.  During this time, pupil and scanning data were obtained using the ASL system and 
eye-tracking was observed on the eye-monitor and ASL system to ensure that the eye remained 
centered and that pupil and corneal reflection levels were steady and consistent throughout data 
collection.  At 10 minutes post-stimulus onset, a second salivary sample was taken by again 
placing three Sorbettes under the child’s tongue for two minutes to obtain post-stimulus AA 
levels.  This sample collection coincided with the completion of the 10 minute stimulus 
presentation, and while samples were collected the scanning and pupil data was saved.  The 10 
minute stimulus presentation was then repeated using Windows Media Player 9.0 (Microsoft 
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Corporation, 2004); therefore scanning and pupil responses were not recorded during this time.  
At 20 minutes post-stimulus onset (recorded from the start of the first 10-minute stimulus 
presentation), the final salivary sample was taken to obtain post-stimulus levels of AA and 
cortisol.  During salivary sample collection, the experimenter stood beside the car seat in the 
participant area to obtain samples and did not block the child’s view of the stimulus monitor.  
Immediately following the collection of each salivary sample (baseline, 10-minute, and 20-
minute), the three Sorbettes were placed into one 2 mL cryovial.  The cryovials were then 
labeled with the subject number, sample collection time and date, and stimulus type.  Samples 
were placed into the freezer at the end of the visual testing session.  Once the 20-minute saliva 
sample was taken, the stimulus was turned off and the child was removed from the car seat.   
 Standardized testing procedure.  Once the visual task was complete the child was taken 
back into the standardized testing room to complete either the ADOS-G or the Mullen.  The 
Visual Reception and Fine Motor subscales of the Mullen were completed during the first testing 
session.  During the second testing session, any portion of the Visual Reception or Fine Motor 
subscales of the Mullen that were not finished during the first session were completed along with 
the Receptive Language and Expressive Language subscales, concluding Mullen administration.  
The administration of the ADOS-G followed completion of the Mullen during the second 
session.  Administration of both assessments followed standardization procedures specified in 
the manuals.  After completion of the both tests, scores were sent to the parents in a report letter 
(Appendix I). 
Data Extraction and Reduction 
 Look zones.  The GT interface program, which was used to present stimulus and baseline 
slides, extracts line of gaze and pupil size from the ASL E6 eye-tracking system.  This program 
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allows for analysis of scanning and pupil size based on specific areas of interest, and using this 
program “look zones” were created for each stimulus type.  For the non-social stimulus, only one 
look zone was created for the non-social objects (excluding any blank areas around the objects).  
See Appendix J for a non-social stimulus example with defined look zones.  For the social 
stimulus, four look zones were created: (a) internal features, which includes the eyes, nose and 
mouth, (b) external features, which includes the head and neck area and excludes internal 
features, (c), hands, which includes hands and wrists, (d) body, which includes the torso, arms 
and legs, and excludes previous zones.  See Appendix K for a social stimulus example with 
defined look zones.  The distance of the perimeter of the zone from the actual objects was 
determined using GT’s recommendations for a five-point calibration, which was 1º visual angle. 
 Scanning data.  For the analysis of scanning to each stimulus type, the duration of 
looking time was examined for the first 10 minutes of stimulus presentation.  Proportion of time 
tracked was examined for both the social and non-social stimulus, this variable was calculated as 
the amount of time tracked across all look zones/ total time tracked on screen.  Within the social 
stimulus, proportion of time tracked for each look zone (internal features, external features, 
hands, and body) was also examined; this was calculated to be the amount of time tracked within 
each look zone/ total time tracked on screen.   
 Pupillary response data.  Pupil diameter is recorded by the ASL and GT systems at a 60 
Hz sampling rate (16.7 ms inter-sampling time).  The GT system organizes this data into a time-
ordered data file that provides gaze coordinates, pupil diameter in pixels, time of look (from 
beginning of the video clip), and look zone name in which the gaze occurred.  Pupil diameters 
were converted to mm by dividing the model eye pupil size (4 mm) by the recorded pixel size of 
the model eye for each child to gain a scale factor; this scale factor was then multiplied by the 
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recorded pixel value to obtain pupil size in mm at each data point.  These data files were then 
examined and traces of pupil data that occurred on the screen for baseline and stimulus slides 
were inspected and corrected for artifacts (blinks, loss of tracking, partial eyelid closures, head 
movements, and accommodation responses) using linear interpolation.  Artifacts were identified 
as (a) a time difference between data points that is greater than 20 ms, (b) a discontinuity in pupil 
data, or (c) a difference in pupil size that is greater than 0.20 mm.  Each pupil trace included in 
the final analysis was at least 500 ms in length, with artifacts no longer than 500 ms.  In addition, 
if artifacts were present within the trace, the summed duration of these artifacts could be no more 
than 20% of the duration of the pupil trace.  
 Once adequate pupil traces were found and corrected for artifacts, an average pupil size 
was computed for the first minute of the baseline slide.  Next, because phasic pupillary responses 
(but not tonic pupil size) has been found to decrease in amplitude over time on the task (e.g., 
Beatty, 1982), average pupil size to the first 10 minutes of each stimulus slide was broken into 1-
minute epochs.  The average pupil size during each time epoch was then subtracted from the 
average pupil size of the baseline for each stimulus type and within each look zone.  These 
artifact removal and difference score computation methods are similar to those used in several 
previous studies (e.g., Granholm, Asarnow, Sarkin, & Dykes, 1996; Libbey et al., 1973; 
Matthews, Middleton, Gilmartin, & Bullimore, 1991; Steinhauer et al., 2004; Verney, Granholm, 
& Dionisio, 2001).   
 Salivary data.  Every three months, salivary samples were mailed on dry ice, via FedEx 
overnight, to Salimetrics, LLC to be assayed for both cortisol and AA.  Once received and tested, 
Salimetrics, LLC returned the assay results via e-mail in a data file providing cortisol (µg/dL) 
and AA concentrations (U/mL) for baseline and post-stimulus time points.  Because salivary AA 
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distributions are typically highly variable and positively skewed, salivary concentrations of AA 
(U/mL) were subjected to square-root transformations based on recommendations from previous 
studies (e.g., Gordis et al., 2006; Granger et al., 2007).  As in previous cortisol studies (e.g., 
Fortunato et al., 2008) to adjust for positive skew of the cortisol concentrations (ug/dL), a 
logarithm transformation was completed.  Post-stimulus values of cortisol and AA were then 
subtracted from baseline values to determine the amount of change in cortisol 20 minutes post-
stimulus onset and AA at 10 and 20 minutes post-stimulus onset for both social and non-social 
conditions.  Salimetrics, LLC disposed of all samples after assays were completed.                                    
Results 
Scanning Measures 
 We first sought to determine if scanning deficits were present in the ASD group, and if 
scanning differences were sensitive to the increased ecological validity of the dynamic video 
clips.  To do this, we examined between-group differences in proportion of time tracked for 
responses within the specified look zones of the social and non-social stimulus for the entire 10-
minute presentation period.  In addition, to ensure that the results of the scanning analyses were 
not a function of between-group changes in scanning profiles over the 10-minute presentation 
period, responses to each stimulus type were split into two time epochs (a) T1 = the amount of 
time tracked within each look zone during minutes 1 to 5 minutes of stimulus presentation/ total 
time tracked during minutes 1 to 5 on screen, and (b) T2 = the amount of time tracked within 
each look zone during minutes 6 to 10 of stimulus presentation/ total time tracked during minutes 
6 to 10 on screen.  Due to the small sample size, the scanning data were evaluated in two 5-
minute epochs (instead of 10 one-minute epochs) to maintain power and ensure that 
homogeneity-of-variance assumptions were not violated.   
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 Responses to the social stimulus.  Repeated measures ANOVA tests were conducted to 
evaluate between- and within-group differences in proportion of time tracked to the social 
stimulus look zones (internal features, external features, hands, and body) for the entire 
presentation period and for each time epoch (T1 and T2).  One outlier within the DS group was 
identified and removed2; calibration for this subject was difficult and out-of-range scanning 
values may have been due to the inaccuracy of eye-tracking for this subject.    
 Proportion of time tracked for the total presentation period.  The Look Zone (4) × 
Diagnosis (3) repeated measures ANOVA3 for proportion of time tracked, revealed a significant 
main effect of Look Zone, F(1.586, 36.479)4 = 11.917, p < .001, η2 = .341.  Other terms from the 
analysis – the main effect for Diagnosis, F(2, 23) = 1.396, p = .268, η2 = .108, and the Look Zone 
× Diagnosis interaction, F(3.172, 36.479)4 = 1.051, p = .384, η2 = .084 – did not attain 
significance.  Follow-up pairwise comparisons5 of the Look Zone main effect revealed that all 
subjects spent a significantly larger proportion of time within the internal features look zone than 
the external features and hands (all ps < .001), but spent similar proportions within the body look 
zone (p = .188).  In addition, a significantly larger proportion of time was spent examining the 
body look zone than the hands (p < .001).  The external features and body look zone did not vary 
significantly (p = .159), but the external look zone was tracked significantly more than hands (p 
= .011).  Group and total means and standard deviations for proportion of time tracked within 
each social look zone are presented in Table 2.  Thus, while expected within-group differences in 
scanning were found, no between-group differences emerged.  These results are consistent with 
our previous investigation (Anderson et al., 2006) in finding children with ASD to have scanning 
profiles that are similar to control groups.   
Table 2 
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Proportion of Time Tracked to the Social Stimulus for each Look Zone 
 
   Group 
Look Zone All groups 
N = 26 
 ASD 
n = 10 
DS 
n = 7 
 TD 
n = 9 
Internal .24 (.08)  .26 (.10) .21 (.09)  .24 (.08) 
External .16 (.05)  .16 (.06) .19 (.06)  .14 (.04) 
Hands .12 (.04)  .12 (.04) .10 (.02)  .14 (.03) 
Body .20 (.08)  .17 (.06) .21 (.12)  .22 (.07) 
Note.  Data are presented in means.  Standard deviations are in parentheses.  All means and 
standard deviations represent the total 10-minute presentation period.  ASD = Autism Spectrum 
Disorder; DS = Down Syndrome; TD = Typically developing, Internal = Internal features; 
External = External features. 
 
 Proportion of time tracked by time epoch.  A Time (2) × Diagnosis (3) repeated 
measures ANOVA3 for proportion of time tracked was conducted for each of the four social look 
zones.  Table 3 shows that the Time main effect was significant for all look zones (all ps < .001), 
with the exception of the “hands” look zone, which approached significance.  Thus, the 
proportion of time tracked within the internal and external features look zones decreased 
significantly from T1 to T2, while the proportion of time tracked within the body look zone 
increased significantly.  No significant main effect of Diagnosis was found for any of the look 
zones (all ps > .05).    
 To further examine the effect of time on the scanning measures, separate Look Zone (4)  
× Diagnosis (3) repeated measure ANOVAs3 were conducted separately for T1 and T2.  The 
results of these analyses were similar to the findings for the total presentation period, yielding a 
significant main effect of Look Zone, T1: F(1.795, 41.287)4 = 28.844, p < .001, η2 = .556 and 
T2: F(1.415, 32.540)4 = 6.890, p = .007, η2 = .231, with a non-significant Diagnosis main effect, 
T1:  F(2, 23) = 2.029, p = .154, η2 = .150 and T2: F(2, 23) = 1.557, p = .232, η2 = .119, and 
nonsignificant Look Zone × Diagnosis interaction, T1: F(3.590, 41.287)4 = 1.170, p = .337, η2 = 
.092, T2: F(2.830, 32.540)4 = .837, p = .478, η2 = .068.  Significant follow-up comparisons5 
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remained significant (all ps < .025) with the exception of the external features and hands during 
T2, which approached significance (external features > hands, p = .068).  In addition, the 
comparison between internal features and body look zones was significant during T1 (internal 
features > body, p < .001), but not during time 2 (p = .438), and not across the total presentation 
period (p = .188).  Finally, the comparison between external features and body look zones was 
significant during T2 (external features < body, p = .030), but not during T1 (p = .349) and not 
across the total presentation period (p = .159).  Therefore, while there were some within-group 
changes in scanning profiles over time, the between-group results remained consistent with the 
analysis to the entire presentation period in finding no differences.  The scanning profiles for the 
ASD, DS and TD groups were similar for the entire presentation period and across time epochs.    
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 Responses to the non-social stimulus.  A univariate ANOVA6 was conducted to 
evaluate between-group differences in proportion of time tracked to the non-social stimulus for 
the total presentation period.  One outlier within the TD group was identified and removed7.  
Homogeneity of variance was found to be significant (p < .001); therefore, the Welch’s variance-
weighted ANOVA was used.  Although the DS group appeared to spend a smaller proportion of 
time (M = .89, SD = .10, n = 8) tracking the non-social stimulus than either the ASD (M = .96, 
SD = .03, n = 12) or TD groups (M = .97, SD = .02, n = 10), no significant between-group 
differences were found [Welch’s F(2, 13.856) = 2.821, p = .094, η2 = .288].       
 Proportion of time tracked by time epoch.  For the time analysis, one outlier within the 
TD group was identified and removed2; this outlier was identical to the outlier in the above 
analysis of non-social scanning responses for the total presentation period.  A Time (2) × 
Diagnosis (3) repeated measures ANOVA3 for proportion of time tracked revealed non-
significant main effects for Time, F(1, 27) = 2.777, p = .107, η2 = .093, and Diagnosis, F(2, 27) 
= .736, p = .488, η2 = .052.  The Time × Diagnosis interaction also failed to attain significance, 
F(2, 27) = 1.053, p = .363, η2 = .072.   Thus, all subjects (N = 30) spent similar proportions of 
time scanning the non-social stimulus during both T1 (M = .53, SD = .10) and T2 (M = .47, SD = 
.10).  These results indicate that within-group scanning profiles to the non-social stimulus were 
similar across time, and as expected no significant between-group differences emerged.   
Pupillary Measures  
 Tonic pupil size.  To determine if the previous finding of a larger tonic pupil size in 
children with ASD was replicable, between-group differences in the average pupil size (in mm) 
during the first minute of each baseline slide was examined.  Three outliers were identified and 
eliminated (ASD, n = 1; TD, n = 2)7. 
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 Because the measurement of tonic pupil size was recorded across two testing days, 
within-group differences in the tonic pupil size measurements during day 1 (tonic pupil size 
obtained during appointment day 1) and day 2 (tonic pupil size obtained during appointment day 
2) were first examined to determine if an effect of measurement order was present.  The results 
of the paired-samples t test indicated no significant differences between tonic pupil size recorded 
during day 1 (M = 5.11, SD = 1.03) and day 2 (M = 5.21, SD = .91), t(22) = -.699, p = .492.  
Therefore, tonic pupil size measurements from both testing days were averaged together to form 
one variable.   A univariate ANOVA6 revealed significant between-group differences in tonic 
pupil size, F(2, 28) = 6.620, p = .005, η2 = .337.  As can be seen in Figure 4, the ASD group had 
a significantly larger tonic pupil size (M = 5.60, SD = 1.02) than either the DS (M = 4.19, SD = 
.93, p = .002) or TD groups (M = 4.53, SD = .71, p = .015), who did not differ significantly from 
each other (p = .439)5.  This finding provides replication of increased tonic pupil size previously 
reported by Anderson and Colombo (2009) in a different sample. 
 
 
 
 
 
 
 
 
 
Figure 4.  Average tonic pupil size from both testing days for the Autism Spectrum Disorder 
(ASD), Down Syndrome (DS) and Typically developing (TD) groups. 
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 Phasic pupillary responses.  To determine if the ASD group had altered phasic pupillary 
responses that were specific to the social stimulus, between-group differences in the change in 
average pupil size (from the baseline values for each stimulus type) to specified look zones 
within the social and non-social stimulus were examined.  Because between-group differences in 
tonic pupil size were found, baseline pupil size was entered as a covariate to ensure that phasic 
responses were independent and not mediated by altered baseline values.  In addition, because 
phasic pupil responses have been shown to decrease in amplitude over time, change in average 
pupil size was evaluated in time epochs.  
 Responses to the social stimulus.  Repeated measure ANCOVAs3, 8 were conducted to 
evaluate between- and within-group differences in change in average pupil size to the four social 
look zones (internal features, external features, hands, and body) for the entire 10-minute 
presentation period and across time epochs within the social stimulus.  Tonic pupil size, 
measured during the first minute of the social stimulus baseline slide, was entered as a covariate.  
Two multivariate outliers2 were identified and removed (ASD, n = 1; TD, n = 1).   
 Phasic pupil responses for the total presentation period.  The Look Zone (4) × Diagnosis 
(3) repeated measures ANCOVA yielded a nonsignificant main effect for Look Zone, F(1.927, 
40.466)4 = .097, p = .902, η2 = .005, but the main effect for Diagnosis, F(2, 21) = 6.942, p = 
.005, η2 = .398, and the Look Zone × Diagnosis interaction, F(3.854, 40.466)4 = 3.854, p = .043, 
η2 = .208, attained significance.  As can be seen in Figure 5, follow-up analyses5 of the Diagnosis 
main effect was attributable to the ASD group increasing their adjusted mean pupil response to 
the social stimulus (M = .581).  This varied significantly from the TD group, whose adjusted 
mean decreased (M = -.409, p = .001).  Differences between the ASD and DS groups approached 
significance (p = .054), with the DS groups’ adjusted mean pupil response (M = .018) increasing 
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less than those of the ASD group; no significant differences emerged between the DS and TD 
groups (p = .134).   
 Follow-up analysis of the significant Look Zone × Diagnosis interaction were conducted 
by evaluating three repeated measure ANCOVAs3, 8 for each diagnostic group.  The Look Zone 
main effect was insignificant for both the ASD, F(2.302, 16.116)4 = 2.996, p = .072, η2 = .300,  
and DS groups, F(1.119, 7.195)4 = 1.631, p = .248, η2 = .214.  However, the main effect was 
significant for the TD group, F(2.138, 12.826)4 = 5.056, p = .023, η2 = .457, whose phasic pupil 
response to the internal features look zone was significantly larger than those to the external 
features (p = .009) and body look zones (p = .002); all other comparisons were insignificant (all 
ps >.05)5.  Observed group and total means and standard deviations for change in average pupil 
size from baseline values within each social look zone are presented in Table 4.   
 As with our previous investigation (Anderson et al., 2006), significant between-group 
differences in phasic pupil responses to the social stimulus emerged, however the direction of 
these differences were divergent.  The current findings suggest that the ASD group had a 
significant increase in their phasic pupil response to all look zones within the social stimulus, 
while the DS group had a slightly increased response, and the TD groups’ response decreased 
and presented a distinct profile across the social look zones.        
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Table 4 
Mean Change in Average Pupil Size from Baseline Values to the Social Stimulus for each Look 
Zone 
   Group 
Look Zone All groups 
N = 25 
 ASD 
n = 9 
DS 
n = 8 
 TD 
n = 8 
Internal .09 (.68)  .47 (.76) .10 (.45)  -.37 (.54) 
External .08 (.70)  .49 (.76) .13 (.46)  -.42 (.55) 
Hands .08 (.70)  .45 (.73) .16 (.52)  -.41 (.57) 
Body .08 (.70)  .48 (.75) .15 (.49)  -.43 (.55) 
Note.  Data are presented in means.  Standard deviations are in parentheses.  All observed means 
and standard deviations represent the total 10-minute presentation period.  ASD = Autism 
Spectrum Disorder; DS = Down Syndrome; TD = Typically developing; Internal = Internal 
features; External = External features. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.  Observed mean change in pupil size from baseline values, to each look zone within 
the social stimulus, for the entire 10-minute presentation period, by diagnostic group.  ASD = 
Autism Spectrum Disorder; DS = Down Syndrome; TD = Typically developing; Internal = 
internal features; External = external features.  
** p < .025  
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 Phasic pupil responses by time epoch.  A Time (4) × Diagnosis (3) repeated measures 
ANCOVA was initially planned to evaluate the change in average pupil size across time epochs 
for each of the four social look zones.  However, because a significant main effect of look zone 
was not found in the previous analysis, change in average pupil size from baseline values to each 
of the four social look zones were averaged together during each 1-minute epoch to form one 
social pupil size change variable for 5 time epochs: (a) T1; social pupil size change during 
minutes 1 and 2, (b) T2; social pupil size change during minutes 3 and 4, (c) T3; social pupil size 
change during minutes 5 and 6, (d) T4; social pupil size change during minutes 7 and 8, and (e) 
T5; social pupil size change during minutes 9 and 10.  Due to the small sample size, the social 
pupil size change variable was evaluated in five 2-minute epochs, instead of ten 1-minute 
epochs, to maintain power and ensure homogeneity.       
 The Time (5) × Diagnosis (3) repeated measures ANCOVA3, 8 yielded a non-significant 
main effect of Time, F(2.489, 52.264)4 = 1.599, p = .207, η2 = .071, a nonsignificant Time × 
Diagnosis interaction, F(4.977, 52.264)4 = .192, p = .068, η2 = .174.  Similar to the results for the 
total presentation period, the main effect of Diagnosis was significant, F(6, 38) = 6.951, p = .005, 
η2 = .398, with the ASD group having a significantly larger adjusted mean (M = .583) than both 
the DS (M = .008, p = .049) and TD groups (M = -.404, p = .001), who did not differ from each 
other (p = .147)5.  See Figure 6 for group observed means and standard errors for social pupil 
size change across the 5 time epochs (T1 – T5).  Although phasic pupil responses have been 
shown to decrease over time (e.g., Beatty, 1982), no time-related differences were found in the 
current study.  In addition, between-group differences remained, and attained significance for 
comparisons between the ASD and DS groups.        
 
76 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.  Observed means and standard deviations of change in average pupil size to the social 
stimulus from baseline values, for the five time epochs by diagnostic group.  ASD = Autism 
Spectrum Disorder, n = 9; DS = Down Syndrome, n = 8; TD = typically developing, n = 8; T1 = 
social pupil size change during minutes 1 and 2; T2 = social pupil size change during minutes 3 
and 4; T3 = social pupil size change during minutes 5 and 6; T4 = social pupil size change during 
minutes 7 and 8; T5 = social pupil size change during minutes 9 and 10. 
 
 Responses to the non-social stimulus.  A univariate ANCOVA6, 7, 8 was conducted to 
examine between-group differences in phasic pupil response to the non-social stimulus for the 
total presentation period.  Significant between-group differences in change in average pupil size 
to the non-social stimulus were found, F(2, 27) = 1.390, p = .008, η2 = .302, with the TD group 
having a decreased adjusted mean pupil response to the non-social stimulus (M = -.42) that 
varied significantly from the adjusted mean responses of both the ASD (M = .27,  p = .002) and 
DS groups (M = .07, p = .044), whose phasic pupil responses increased and did not vary 
significantly from each other (p = .423)5.  
 Phasic pupil responses by time epoch.  To be consistent with the evaluation of phasic 
pupil responses to the social stimulus, time analyses to the non-social stimulus were conducted 
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across five 2-minute epochs to evaluate non-social pupil size change:  (a) T1; minutes 1 and 2, 
(b) T2; minutes 3 and 4, (c) T3; minutes 5 and 6, (d) T4; minutes 7 and 8, and (e) T5; minutes 9 
and 10.  Although no outliers were identified2, 5 subjects were not included in this time-series 
analysis because of a lack of adequate data during all 5 time epochs (ASD, n = 1; DS, n = 3; TD, 
n = 1).   
 The Time (5) × Diagnosis (3) repeated measure ANCOVA3, 8 yielded a non-significant 
main effect of Time, F(2.715, 51.592)4 = 1.946, p = .139, η2 = .093.  The Diagnosis main effect, 
F(2, 19) = 6.454, p = .007, η2 = .405, and Time × Diagnosis interactions, F(5.431, 51.592)4 = 
2.816, p = .022, η2 = .229, attained significance.  Similar to the findings for the entire 
presentation period, pairwise comparisions5 of the Diagnosis main effect revealed the TD group 
to have a decreased adjusted mean phasic pupil response to the non-social stimulus (M = -.744), 
which varied significantly from the adjusted mean response of both the ASD (M = .481, p = 
.004) and DS groups (M = .373, p = .018), who did not differ from each other (p = .807). 
 The significant Time by Diagnosis interaction was evaluated through three within-
subjects repeated measure ANCOVA’s3, 8 for each diagnostic group.  The Time main effect was 
insignificant for both the ASD, F(1.595, 11.163)4 = .296, p = .701, η2 = .041, and DS groups, 
F(2.311, 6.934)4 = .566, p = .615, η2 = .159, but was found to be significant for the TD group, 
F(2.476, 17.335)4 = 4.515, p = .021, η2 = .392.  For the TD group, phasic responses during T5 
were found to be significantly smaller than the phasic responses during T2, T3 and T4 (all ps 
<.05); all other comparisons were insignificant (all ps > .05)5.  See Table 5 for observed group 
and total means and standard deviations for change in average pupil size from baseline values to 
the non-social stimulus, for each time epoch and for the entire presentation period.   
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 As with phasic responses to the social stimulus, between-group differences in phasic 
pupillary responses to the non-social stimulus emerged, but were unique in distinguishing the TD 
from both clinical groups (ASD and DS); the TD group again showed a decreased response to 
the stimulus, and ASD and DS groups showed an increased response that did not differ.  These 
between-group differences remained once these phasic responses were evaluated in time-epochs, 
but increased significantly during T5 for the TD group only. 
Table 5 
Mean Change in Average Pupil Size from Baseline Values to the Non-Social Stimulus 
Time Epoch  Group 
  ASD DS  TD 
  n = 9 n = 5  n = 9 
T1  .47 (1.03) .07 (.80)  -.75 (.63) 
T2  .65 (.99) .25 (.63)  -.90 (.60) 
T3  .81 (1.10) .96 (.65)  -.75 (.93) 
T4  -.002 (1.15) .54 (.84)  -.79 (.86) 
T5  .04 (1.50) .43 (.70)  -.31 (.92) 
      
  n = 10 n = 8  n = 10 
All Epochs  .20 (.53) .22 (.33)  -.37 (.33) 
Note.  Data are presented in observed means.  Standard deviations are in parentheses.  ASD = 
Autism Spectrum Disorder; DS = Down Syndrome; TD = Typically developing; T1 = non-social 
pupil size change during minutes 1 and 2; T2 = non-social pupil size change during minutes 3 
and 4; T3 = non-social pupil size change during minutes 5 and 6; T4 = non-social pupil size 
change during minutes 7 and 8; T5 = non-social pupil size change during minutes 9 and 10; All 
Epochs = non-social pupil size change during the entire 10-minute presentation period. 
 
Salivary Measures  
 Tonic levels.  To determine if the ASD group had atypical baseline levels of AA and/or 
cortisol, between-group differences in the baseline salivary measures were examined.  One ASD 
subjects’ AA level and another ASD subjects’ (n = 1) cortisol level (for one baseline day) were 
identified as outliers and removed7.  In addition, to determine if tonic measures of AA and/or 
cortisol were related to tonic pupil size, correlation coefficients were also computed. 
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 Because the tonic measures of AA and cortisol were recorded across two testing days, 
within-group differences in baseline salivary measurements during day 1 (baseline values of AA 
or cortisol during appointment day 1) and day 2 (baseline values of AA or cortisol during 
appointment day 2) were first examined to determine if an effect of measurement order was 
present.  The results of the paired-samples t-test indicated no significant differences between 
tonic AA measures recorded during day 1 (M = 7.66, SD = 2.96) and day 2 (M = 7.95, SD = 
2.66), t(24) = -.845, p = .406, nor between tonic cortisol measures recorded during days 1 (M = -
2.47, SD = .53) and 2 (M = -2.65, SD = .49), t(23) = 1.650, p = .113.  Thus, tonic salivary 
measures from both testing days were averaged together to form one variable for tonic AA and 
one variable for tonic cortisol.   See Figure 7 for group means of salivary AA (U/mL) and 
cortisol (µg/dL) concentrations9.       
 Alpha-amylase.  A univariate ANOVA6 for tonic AA revealed significant between-group 
differences, F(2, 32) = 3.516, p = .043, η2 = .195.   The ASD group had a significantly lower 
baseline level of AA (M = 6.44, SD = 3.22, n = 12) than either the DS (M = 8.75, SD = 1.61, n = 
9, p = .050) or TD groups (M = 9.03, SD = 2.34, n = 11, p = .022), who did not differ (p = .806)5.  
In addition, a significant negative correlation was found between tonic measures of AA and pupil 
size, r(26) = -.462, p = .013.  This relationship became non-significant once diagnosis was 
partialed out, rab.c(25) = -.205, p = .296, indicating a mediating effect of diagnosis.  These 
between-group differences in tonic AA levels and significant correlation with tonic pupil size are 
consistent with predictions of NE system involvement in atypical tonic responses in ASD.
 Cortisol.  A univariate ANOVA6 for tonic cortisol also revealed significant between-
group differences, F(2, 32) = 4.645, p = .018, η2 = .243.  The DS group had a significantly 
higher baseline level of cortisol (M = -2.20, SD = .35, n = 9) than either the ASD (M = -2.71, SD 
80 
= .72, n = 12, p = .034) or TD groups (M = -2.89, SD = .34, n = 11, p = .006), who did not differ 
(p = .406)5.  The correlation between tonic measures of cortisol and pupil size was non-
significant, r(24) = -.102, p = .619, and remained non-significant once diagnosis was partialed 
rab.c(23) = -.219, p = .293.  These between-group differences in tonic cortisol levels, along with 
the non-significant relationship with tonic pupil size, are inconsistent with predictions of 
hypothalamic system involvement in ASD.  Instead, these between-group differences indicate 
unique heighted levels of tonic cortisol for the DS group.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.  Mean salivary concentrations of alpha-amylase (AA) and cortisol for the Autism 
Spectrum Disorder (ASD), Down Syndrome (DS), and Typically-developing (TD) groups. 
** p < .025; * p < .05    
 
 Phasic responses.  To determine if the ASD group had altered phasic salivary responses, 
between-group differences in the change in AA and cortisol levels (from baseline values for each 
stimulus type) to the social and non-social stimulus were examined.  Because between-group 
differences in tonic values of both AA and cortisol were found, tonic salivary levels for each 
stimulus type were entered as covariates in the respective analyses to ensure that phasic salivary 
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responses were independent and not mediated by baseline values.  Correlation coefficients were 
also computed to determine if phasic AA and/or cortisol responses to each stimulus type were 
related to the respective phasic pupillary responses.   
 Alpha-amylase.  Repeated measure ANCOVAs3,8 were conducted to evaluate between 
and within-group differences in phasic salivary AA responses to the social and non-social 
stimulus at 10- and 20-minutes post-stimulus onset.  Table 6 shows adjusted and observed group 
means and standard deviations of AA responses to the social and non-social stimulus.      
 Responses to the social stimulus.  One multivariate outlier2 from the ASD group was 
identified and removed.  The Time (2) × Diagnosis (3) repeated measure ANCOVA for phasic 
AA responses to the social stimulus yielded no significant terms: main effect for Time, F(1, 22)4 
= 1.476, p = .237, η2 = .063, main effect for Diagnosis, F(2, 22) = .007, p = .993, η2 = .001 and 
the Time × Diagnosis interaction, F(2, 22)4 = .473, p = .629, η2 = .041.  
 Correlation coefficients were computed among salivary AA responses to the social 
stimulus at 10- and 20-minutes post-stimulus onset, and the phasic pupil responses within each 
of the four social look zones.  As can be seen in Table 7, none of the zero-order correlations were 
significant; in addition, these relationships remained non-significant once diagnosis was partialed 
out (all ps > .05).  Thus, unlike the tonic AA responses, phasic AA responses to the social 
stimulus are unable to differentiate the ASD group from controls and are unrelated to phasic 
pupil responses to the social stimulus, which are unique for the ASD group; these findings are 
incompatable with the prediction of NE system involvement in atypical phasic pupil responding 
to social stimuli in ASD.    
 Responses to the non-social stimulus.  Two multivariate outliers2 were identified and 
removed (ASD, n = 1; TD, n = 1).  The Time by Diagnosis (2 X 3) repeated measure ANCOVA 
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for phasic AA responses to the non-social stimulus was non-significant for the main effects of 
Time, F(1, 25)4 = .423, p = .521, η2 = .017, and Diagnosis, F(2, 25) = 1.634, p = .215, η2 = .116, 
and Time by Diagnosis interaction, F(2, 25)4 = .514, p = .604, η2 = .040.   
 Correlation coefficients were computed among phasic salivary AA responses at 10- and 
20-minutes post-stimulus onset and phasic pupil responses to the non-social stimulus.  The 
relationship between phasic AA at 10-minutes post-stimulus onset and phasic pupillary 
responses to the non-social stimulus was significant, r(24) = .394, p = .047; once diagnosis was 
partialed from the equation this relationship became non-significant, rab.c(23) = .260, p = .209, 
indicating a mediation effect of diagnosis.  The relationship between phasic AA at 20-minutes 
post-stimulus onset and phasic pupillary responses to the non-social stimulus was non-
significant, r(24) = .140, p = .495, and remained non-significant once diagnosis was partialed 
out, rab.c(23) = .002, p = .992.  While no between-group differences in non-social phasic AA 
responses were found, the relationship between 10-minute AA levels and non-social phasic pupil 
responses, which were distinct for the TD group, do appear to be mediated by diagnosis.   
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Table 6 
Adjusted and Observed Group Means and Standard Deviations for Salivary Alpha-Amylase 
Responses  
 Group 
 ASD 
 
 DS  TD 
AA  Madj M SD  Madj M SD  Madj M SD 
 Social 
 n = 9  n = 8  n = 9 
10-minute -.33 -.55 1.08  -.41 -.34 2.83  -.86 -.70 2.22 
20-minute -.85 -.82 1.90  -.79 -.80 3.49  -.54 -.56 1.74 
 Non-Social 
 n = 11  n = 8  n = 10 
10-minute -.60 -.35 1.26  -.35 -.51 .89  -1.88 -2.04 2.59 
20-minute -1.04 -.66 1.89  -.66 -.90 1.48  -1.57 -1.81 2.18 
Note.  AA = Alpha-amylase; ASD = Autism Spectrum Disorder; DS = Down Syndrome; TD = 
Typically developing; Madj = group mean adjusted for baseline AA levels; M = observed group 
mean; SD = standard deviation.   
 
Table 7 
Relationship between Phasic Pupil Responses, and Salivary Alpha-Amylase Responses to the 
Social Stimulus 
AA Look Zone 
 Internal  External  Hands  Body 
 r rab.c  r rab.c  r rab.c  r rab.c 
10-minute a .275 .329  .294 .358  .285 .341  .277 .337 
20-minute a .305 .378  .296 .376  .308 .381  .295 .372 
Note.  Both zero-order and partial correlations, holding diagnosis constant, among phasic 
pupillary responses to each look zone and alpha-amylase (AA) responses to the social stimulus 
are presented.  None of the correlations were significant (p < .05). Internal = internal features; 
External = external features.     
a For zero-order correlations, df = 22; for partial correlations, df = 21. 
 
 Cortisol.  Univariate ANCOVAs6,8 were conducted to evaluate between-group 
differences in phasic salivary cortisol responses to the social and non-social stimulus at 20-
minutes post-stimulus onset.  Tonic salivary cortisol level, measured during the respective social 
or non-social baseline, was entered as a covariate.   
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 Responses to the social stimulus.  One outlier7 from the DS group was identified and 
removed.  The results of the univariate ANCOVA for cortisol responses to the social stimulus 
was significant, F(2, 21) = 7.440, p = .004, η2 = .415.  Follow-up tests5 indicated that the 
adjusted mean cortisol response of the TD group, which decreased to the social stimulus (M = -
.384, SD = .40, n = 9), was significantly different from the adjusted mean response of the ASD 
(M = .325, SD = .32, n = 9, p = .001) and DS groups (M = .105, SD = .47, n = 7, p = .024), 
whose cortisol response increased and did not differ (p = .259).  See Figure 9 for observed group 
mean cortisol responses to the social stimulus.     
 Correlation coefficients were computed among salivary cortisol responses to the social 
stimulus and the phasic pupil responses within each of the four social look zones.  As can be 
seen in Table 8, none of the zero-order correlations were significant.  Once diagnosis was held 
constant, the correlations remained non-significant (all ps > .05), but the coefficients were 
notably decreased from zero-order coefficient values, indicating that diagnosis may have a 
mediation effect on these relationships.  Although no differences emerged between the DS and 
ASD groups, the significant between-group finding and change in correlation coefficients once 
diagnosis was held constant, suggests the possibility that altered cortisol responses may be 
involved in social phasic pupil responding for the clinical groups (ASD and DS). 
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Table 8 
Relationship between Phasic Pupil Responses and Salivary Cortisol Responses to the Social 
Stimulus 
 Look Zone 
 Internal  External  Hands  Body 
 r rab.c  r rab.c  r rab.c  r rab.c 
Cortisola .308 .064  .332 .078  .302 .054  .310 .049 
Note.  Both zero-order and partial correlations, holding diagnosis constant, among phasic 
pupillary responses to each look zone and cortisol responses to the social stimulus are presented.  
None of the correlations were significant (p’s > .05). Internal = internal features; External = 
external features.     
a For zero-order correlations, df = 22; for partial correlations, df = 21. 
 
 Responses to the non-social stimulus.  Two outliers7 were identified and removed (ASD, 
n = 1; TD, n = 1).  The univariate ANCOVA revealed non-significant between-group differences 
in the adjusted mean cortisol responses to the non-social stimulus, F(2, 23) = 1.316, p = .292, η2 
= .122, for the ASD (M = .10, SD = .46, n = 8), DS (M = -.03, SD = .37, n = 7) or TD groups (M 
= -.22, SD = .27, n = 8).  See Figure 9 for observed group mean cortisol responses to the non-
social stimulus.  Correlation coefficients were computed among phasic salivary cortisol and 
pupil responses to the non-social stimulus.  This correlation was non-significant, r(24) = -.179, p 
= .381, but became significant once diagnosis was held constant, rab.c(23) = -.458, p = .021.  
Unlike the social phasic cortisol responses, no between-group differences in non-social phasic 
cortisol responding emerged.  However, the significant change in correlation values once 
diagnosis was partialed from the equation indicates a possible relationship among non-social 
phasic cortisol and pupil responses that is independent of clinical diagnosis.     
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Figure 8.  Observed group mean change in salivary cortisol responses, from baseline values, to 
the social and non-social stimulus.  ASD = Autism Spectrum Disorder; DS = Down Syndrome; 
TD = Typically developing.    
 
 Relationship among tonic and phasic salivary measures.  Correlation coefficients 
were computed among tonic salivary measures of AA and cortisol, and phasic salivary AA and 
cortisol responses to each stimulus type to determine if these salivary responses were indeed 
providing independent measures, as expected.  As can be seen in Table 9, none of the correlation 
coefficients were found to be significant, and thus tonic and phasic salivary AA and cortisol 
responses are not redundant measures.      
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Table 9 
Relationship between Tonic and Phasic Salivary Measures of Alpha-Amylase and Cortisol  
 
Note.  Zero-order correlation coefficients are presented in cells, df are presented in parentheses.  
None of the correlations were significant (p’s >.05).  AA = Alpha-amylase.   
 
Classification of Group Membership 
 The above group-based analyses indicate that tonic pupil size, tonic AA levels, and 
phasic pupil responses to the social stimulus significantly differentiated the ASD group from 
both the DS and TD groups.  Therefore, a discriminant analysis was conducted to determine 
whether tonic pupil size and tonic AA levels, measured during both the social and non-social 
baselines, and change in average pupil size, from baseline values, to the social stimulus (across 
all look zones and sampling times) could successfully identify the diagnostic groups.   
 The overall Wilks’s lambda was significant, Λ = .319, χ2 (6, N = 22) = 20.573, p = .002, 
with a non-significant residual Wilks’s lambda, Λ = .883, χ2 (2, N = 22) = 2.233, p = .327; thus 
only the first discriminant function will be interpreted.  Table 10 presents the within-group 
correlations between the predictors and the first discriminant function as well as the standardized 
weights.   
 The discriminant analysis successfully predicted diagnostic group classification for 
77.3% of the participants (kappa coefficient = .658).  Additionally, the classification was cross-
validated using the “leave-one-out” technique and correctly classified 54.5% of the cases.  Thus, 
classification for the overall sample, based on these three predictor variables, was good.  
 Social AA Non-Social AA Tonic 
Cortisol 10-minute 20-minute 10-minute 20-minute 
 
AA 
Social  .158 (24) .201 (24) -- -- -- 
Non-social -- -- .280 (28) .155 (28) -- 
Tonic -- -- -- -- -.176 (28) 
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Specifically, classification of diagnostic group yielded 100% correct classification (71.4% cross-
validated) for the ASD group, 75% (37.5% cross-validated) for the DS group, and 57.1% (57.1% 
cross-validated) for the TD group. 
Table 10 
Correlations and Standardized Coefficients of Predictor Variables with the First Discriminant 
Function 
 
Predictor Correlation coefficient Standardized coefficientsa 
   
Tonic AA -.533 -.651 
Tonic pupil size .487 .590 
Phasic social pupil response .448 .817 
Note.  Tonic AA = baseline measures of alpha-amylase (AA) taken across two testing days; 
Tonic pupil size = baseline measures of pupil size, recorded across two testing days; Phasic 
social pupil response = average change in pupil size, from baseline values, to the all social look 
zones for the entire presentation period. 
a Standardized canonical discriminant function coefficients.        
 
Discussion 
 The goal of the current study was to replicate and extend the results of previous 
investigations, which found altered tonic (Anderson & Colombo, 2009) and phasic pupillary 
responses to human faces in children with ASD, with no group-based differences in visual 
scanning (Anderson et al., 2006).  The NE (A1/A5 and LC) and hypothalamic (LH and PH) 
systems play a major role in balancing the ratio of inhibitory and excitatory activity within the 
pupillary system, and thus an altered balance of this ratio could result in the atypical tonic and 
phasic pupil size that was previously found in ASD.  Therefore, to extend the results of previous 
pupillary studies, and determine if central neural components of the pupillary system are 
potentially dysfunctional in ASD, salivary measures of AA and cortisol were also examined.  As 
stated earlier, salivary levels of AA have been shown to vary with changes in plasma levels of 
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NE (e.g., Chatterton et al., 1996; Rohleder et al., 2003; Wetherell et al., 2006), and thus were 
examined in the current study as a correlate of NE-system activity.  In addition, orexin-A is 
released from the LH and has been found to modulate activity of the HPA by indirectly 
stimulating the release of cortisol through activation of the PVN (e.g., Al-Barazanji et al., 2001; 
Spinazzi et al., 2005).  Thus, while cortisol does not provide a direct measure of LH or PH 
activity, alterations in cortisol activity, along with significant relationships with pupil size, may 
indicate possible dysfunction within the hypothalamic component of the pupillary system, and 
provide an indication of HPA activity and stress-based responses in ASD.  In addition, 
methodological concerns about the ecological validity of static stimuli, presented during the 
previous investigation, were addressed by presenting dynamic and multimodal video clips 
depicting human interactions (“social stimulus”) and toys moving to music (“non-social 
stimulus”).  The current study was also distinct in the inclusion of a clinical MA-match control 
group (DS), along with a CA-match group (TD), which allowed us to determine if altered 
responses were specific to the ASD group, or a function of mental- and/or chronological-age.   
 In the current study, the ASD group was significantly distinguished from both clinical 
(DS) and TD age-matched controls through (a) a larger tonic pupil size, (b) lower tonic levels of 
AA, which were significantly related to tonic pupil size and (c) increased phasic pupil responses 
to the social stimulus.  These results provide replication of our previous investigations (Anderson 
et al., 2006; Anderson & Colombo, 2009) in finding group-based differences among the 
pupillary measures; in addition the lower AA levels in the ASD group provide a unique result 
that implicates the possible involvement of the NE-system.  Furthermore, the visual scanning 
results of the current study were similar to our previous investigation (Anderson et al., 2006) in 
finding no group-based differences, indicating that visual scanning deficits may not be a function 
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of ecological validity but instead may be due to other methodological differences such as age.  
However, the use of dynamic and multimodal stimuli in the current study did result in a unique 
direction of the phasic pupillary responses and could provide information that implicates deficits 
in the processing of motion-based stimuli.   
 The current study was also successful in utilizing pupillary measures of both tonic size 
and phasic responding to social stimuli and tonic salivary levels of AA to correctly classify 
100% (71.4% cross-validated) of the ASD group.  Therefore, results of the current study, along 
with previous findings, may provide clues about underlying NE-system pathology in ASD, and 
the potential of non-invasive measures of pupil size and salivary AA in the early identification 
and screening of the disorder.  The following sections delineate these results by measure (visual 
scanning, tonic pupil and saliva, and phasic pupil and saliva), and the implications and 
limitations of each finding are discussed.   
Scanning Responses 
 Consistent with our previous investigation (Anderson et al., 2006), no between-group 
differences in scanning profiles to the social or non-social stimulus emerged for the current 
study, and scanning profiles across social look zones were similar for the ASD, DS, and TD 
groups.  The results of previous research on visual scanning in ASD have been mixed, but it has 
been suggested that this ambiguity is the result of the type of social stimulus utilized (Speer et 
al., 2007).  Specifically, studies employing socially-relevant stimuli (human-based) that are 
dynamic have been consistent in finding atypical scanning profiles in persons with ASD (Jones et 
al., 2008; Klin et al., 2002; Norbury et al., 2009; Riby & Hancock, 2009b, Speer et al., 2007), 
while paradigms utilizing static social stimuli (human faces), including our previous 
investigation, have resulted in mixed findings (e.g., Anderson et al., 2006; Boraston et al., 2008; 
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Neumann et al., 2006; Sasson et al., 2008; Speer et al., 2007; Freeth et al., 2009).  Therefore, for 
the current study, we chose to present stimuli that were dynamic and multimodal in nature.  We 
hypothesized a priori that, as with previous studies using this type of stimulus, between-group 
differences in scanning profiles to the social stimulus would emerge for the ASD group, and vary 
in degree between the four social look zones (internal features, external features, hands, and 
body).  The non-social stimulus was presented as a “control” stimulus to evaluate if scanning 
differences were due to the social or dynamic and multimodal nature of the stimulus and no 
between-group differences were expected to emerge.   
 While the results of the current study were not consistent with previous investigations 
using dynamic social stimuli in ASD, this finding is coherent with our previous investigation 
(Anderson et al., 2006) and others studies that have examined visual scanning to static human 
faces in children with ASD (Speer et al., 2007; Freeth et al., 2009; van der Geest et al., 2002).  
Thus, the discrepancy in results between static and dynamic visual scanning investigations may 
not be due to the ecological validity of the stimulus used, but instead may be a function of other 
methodological differences such as age.  In previous studies (both dynamic and static) where 
between-group differences emerged, the chronological-age of the participants was slightly older; 
the majority of these studies included participants that ranged in age from 14 to 35 years of age 
(Boraston et al., 2008; Dalton et al., 2005; Hernandez et al., 2006; Klin et al., 2002; Nacewicz et 
al., 2006; Neumann et al., 2006; Norbury et al., 2009; Speer et al., 2007; Sterling et al., 2008), or 
included a wide age-range of older children and adult participants, 8 to 28 years of age (Riby & 
Hancock, 2009a, 2009b; Sasson et al., 2008).  The exception is Jones et al. (2008), who found 
between-group differences among 2-year-old children.  In contrast, previous studies with null 
results have recruited a narrower and younger age-range of children, e.g., 2 to 5 year of age 
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(Anderson et al., 2006), 9 to 18 years of age (Speer et al., 2007), 11 to 16 years of age (Freeth et 
al., 2009), and 10 to 12 years of age (van der Geest, Kemner, Verbaten et al., 2002; van der 
Geest, Kemner, Camfferman et al., 2002).  This suggests that visual scanning deficits to socially-
relevant stimuli in ASD may have a developmental course, with the emergence of more robust 
and obvious deficits occurring during late childhood or early adolescence, based on the age-
range of previous studies finding significant between-group differences.  Furthermore, the 
finding of atypical pupillary responses to social stimuli in the current and previous studies 
(Anderson et al., 2006; Falck-Ytter, 2008), suggests that the information processing of these 
stimuli may be altered in young children with ASD.  Thus, it is possible that some more 
fundamental deficit in response or reaction to socially-relevant stimuli in young children with 
ASD may lead to less adaptive behavioral responses (e.g., decreased visual scanning) later in 
life.    
 A second possibility is that scanning differences to socially-relevant stimuli do exist in 
young children with ASD, but are strongly affected by some non-obvious aspect or property of 
the stimulus.  Thus, previous studies examining orienting to human faces and voices in a 
naturalistic environment, found decreased overt attentional orienting (i.e., looking) in young 
children, 6 to 64 months-of-age, with ASD (e.g., Maestro et al., 2002; Osterling & Dawson, 
1994; Sweetenham et al., 1998; Zwaigenbaum et al., 2005).  It might be argued that the social 
stimulus employed in the current study may not have adequately approximated the naturalistic 
environment enough to generate differentiation of the ASD group.  Future studies examining 
visual scanning responses to stimuli varying in their approximation of naturalistic “social” 
situations, across cross-sectional and/or longitudinal age-groups, will help to illuminate the role 
of age and ecological validity in differentiating those with ASD.    
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Tonic Pupil and Salivary Responses   
 As predicted, significant between-group differences in tonic pupil size were found, 
replicating our previous investigation; the ASD group had a significantly larger tonic pupil size 
than either the DS or TD groups, who were not appreciably different from each other.  In 
addition, only tonic levels of AA were significantly related to tonic pupil size and distinguished 
the ASD group from both control groups, suggesting aberrant tonic responding of the NE system 
in ASD.  Unexpectedly, increased salivary cortisol levels distinguished the DS group from the 
ASD and TD groups, but were unrelated to tonic pupil size; this finding is discussed in terms of 
stress and risk for chronic illness in DS.   
 Tonic responses in ASD.  Previous investigations of autonomic function have found 
altered pupillary (Fan et al., 2009; Rubin, 1961) and non-pupillary autonomic responses during 
tonic/resting conditions in persons with ASD (e.g., Bal et al., 2009; Cohen & Johnson, 1977; 
Hirstein et al., 2001; Kootz & Cohen, 1981; Ming et al., 2005; Van Hecke et al., 2009; Zahn et 
al., 1987).  These atypical responses are indicative of an altered ratio of ANS activity that 
appears to result from tonic increases in sympathetic activation, along with corresponding 
decreases in parasympathetic activation in ASD.  Consistent with these findings, we recently 
found children with ASD to have a larger tonic pupil size than age-matched controls (Anderson 
& Colombo, 2009); thus, the current study replicates the results of our previous investigation.  
This significant finding was extended in the current study through an examination of baseline 
measures of salivary AA and cortisol.  As predicted, based on previous studies demonstrating the 
independence of these salivary measures (Chatterton et al., 1996; Granger et al., 2006; Nater et 
al., 2005, 2006, 2007), no relationship was found among tonic measures of AA and cortisol.  
Only tonic levels of AA were significantly related to tonic pupil size and this measure 
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significantly distinguished the ASD group from both control groups, suggesting aberrant tonic 
responding of the NE system in ASD. 
 Alpha-amylase and pupil size.  Because salivary levels of AA have been shown to vary 
with changes in plasma levels of NE (Chatterton et al., 1996; Rohleder et al., 2004; Wetherell et 
al., 2006), the lower levels of salivary AA in the ASD group would appear to indicate decreased 
tonic levels of NE.  However, the larger tonic pupil size found in the current and previous study, 
along with previous findings consistent with elevated sympathetic activation such as increased 
non-pupillary ANS responses (e.g., Bal et al., 2009; Ming et al., 2005; Zahn et al., 1987), and 
increased plasma levels of NE (Cook et al., 1990; Israngkun et al., 1986; Lake et al., 1977; 
Launay et al., 1987; Leboyer et al., 1992; Leventhal et al., 1990) and time-averaged urine 
measures of MHPG (Barthelemy et al., 1988; Martineau et al., 1994), necessitates further 
exploration of this finding.    
 The apparent discrepancy between these findings may be a function of differences in NE 
receptor density and type within peripheral targets among pupil and salivary systems.  Within the 
salivary system, sympathetic activation results in a higher concentration of AA, along with 
decreased and thickened saliva volume, and is primarily mediated by β-adrenergic receptors, 
particularly the β1 subtype (e.g., Busch, Sterin-Borda, & Borda, 2006; Skov et al., 1988).  In 
contrast, as reported earlier, sympathetic stimulation of α-adrenergic receptors dominate NE-
mediated increases in tonic pupil size (e.g., Heal, Prow, Butler, & Buckett, 1995; Koudas et al., 
2009).  Furthermore, β-adrenergic antagonists, such as propranolol, have been shown to reduce 
salivary levels of AA (Speirs et al., 1974; van Stegeren et al., 2006) and mean HR (Koudas et al., 
2009; van Stegeren et al., 2006), while producing no effects on resting pupil size or blood 
pressure (e.g., Koudas et al., 2009).  This further implicates differential involvement of α- and β-
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adrenergic receptors in tonic ANS responding.  Therefore, the current finding of an inverse 
relationship among tonic measures of salivary AA and pupil size (that was mediated by 
diagnosis) could provide clues about the density and functioning of differential adrenergic 
receptors in ASD.     
 Furthermore, altered tonic levels of salivary AA have been found to be related to problem 
social behaviors and stress in typically-developing children.  For example, increased tonic AA 
levels were found to be associated with more internalizing problems, such as anxiety, depression, 
fear and worry (El-Sheikh et al., 2008) and poor academic performance in 8-year-old children 
(Granger et al., 2007), while lower tonic levels of AA were found to be related to decreased 
approach behavior in children 2 years of age (Fortunato et al., 2008) and increased chronic stress 
in children, 8 to 18 years of age (Wolf, Nicholls, & Chen, 2008).  Thus, while more studies are 
necessary to establish the relationship among social behaviors and basal AA levels, the current 
study finding of lower AA in the ASD group is, at face value, coherent with the previous study 
finding these levels to be associated with decreased social approach.  In addition, the larger tonic 
pupil size, which is indicative of tonic increases in arousal (e.g., Lowenstein & Loewenfeld, 
1961, 1964; Wilhelm et al., 2001), may along with the lower AA levels may also be compatible 
with an increased chronic stress response.      
 Cortisol and pupil size.  Basal measurements of cortisol were unable to distinguish the 
ASD group from the DS and TD groups in the current study.  As reported earlier, basal measures 
of plasma and serum cortisol measurement in ASD has yielded mixed results (e.g., Brambilla et 
al., 1969; Curin et al., 2003; Goodwin et al., 1971; Herman et al., 1988), with these 
inconsistencies suggested to be due to the measurement method as venipuncture may lead to 
increased phasic cortisol levels (Jansen et al., 2006; Lam et al., 2005).  Salivary measures of 
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circadian variations in cortisol have yielded more consistent results and indicate atypical tonic 
responding in ASD (e.g., Corbett et al., 2006, 2008, 2009; Hoshino et al., 1989), but those 
previous studies examined changes in salivary cortisol levels at several collection points 
throughout the day; the current study examined a baseline measure of cortisol collected at only 
one afternoon time.  Thus, it is possible that cortisol alterations in ASD are only present when 
evaluating secretion rhythms, with unaffected overall tonic levels.    
 Summary and conclusion.  The larger tonic pupil size and lower AA levels observed here 
are consistent with dysfunctional tonic ANS activation in ASD, and the relationship among these 
tonic measures suggests NE system involvement in producing atypical tonic responding in those 
with the disorder.  Further replication and extension of these results are necessary to determine 
the veracity of this finding and evaluate both the behavioral and neurological implications of 
these findings in ASD.  Future studies examining pupillary and non-pupillary ANS responses 
along with time-averaged measures of NE release and tonic levels of AA will help to determine 
the involvement of the NE system in ASD.  In addition, evaluation of intracellular signaling 
mechanisms characteristic of each adrenergic receptor variety (e.g., second messengers and G-
proteins) is necessary to further evaluate the involvement of adrenergic-receptor types in ASD.  
Finally, while tonic cortisol levels were not able to distinguish the ASD group from controls, and 
were unrelated to tonic pupil size, future investigations examining circadian variations in 
salivary cortisol, along with neurochemical measurements of the LH and PH (orexin-A and 
histamine, respectively) may be necessary to determine the role of the hypothalamic component 
of the pupillary system in ASD.   
   Tonic cortisol and DS.  Unexpectedly, the DS group was distinguished from both the TD 
and ASD groups by heightened tonic levels of cortisol.  Cortisol has been found to increase in 
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response to stressful stimuli such as venipuncture (McCarthy et al., 2009), challenging cognitive 
tasks (Spinrad et al., 2009), and in response to the laboratory environment (Jones et al., 2006).  
Therefore, it is possible that the increased cortisol levels found in the DS group could be 
attributed to an increased stress-response resulting from exposure to the laboratory environment.  
Alternatively, there may be reason to expect individuals with DS to have higher cortisol levels 
due to conditions comorbid with, or secondary to the DS diagnosis.  For example, cortisol is a 
correlate of growth deficiencies due to suppression of growth hormone (GH) (Charmandari, 
Kino, Souvatzoglou, & Chrousos, 2003; Savage et al., 2002, for reviews), and DS is 
characterized by deficient growth rates (Cronk et al., 1988) that have been found to be 
responsive to GH treatment in young children with the disorder (Anneren et al., 1999).  In 
addition, heightened cortisol inhibits thyroid-stimulating hormone (TSH) and is associated with 
slowed growth, cognitive delays, and impaired cardiac function (see Charmandari et al., 2003, 
for a review); hypothyroidism and congenital heart defects are commonly found in those with DS 
(Cohen, 2006; Vis et al., 2009, for reviews).  Finally, heightened cortisol levels have also been 
linked to suppressed immune and inflammatory responses (e.g., Charmandari et al., 2003) that 
are frequently found in individuals with DS (see Kusters, Verstegen, Gemen, & de Vries, 2009, 
for a review).  As this result was unexpected, we did not collect data on these chronic conditions 
in our DS sample, but the possibility remains that the heightened levels of cortisol seen in the DS 
group merely represent an increased risk for the thyroid, cardiac, immune-deficient, and/or 
autoimmune diseases that are comorbid with DS.  Thus, examination of salivary cortisol in DS 
warrants further investigation to evaluate its usefulness in detecting possible risk for these 
chronic conditions.   
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Phasic Pupil and Salivary Responses 
 As expected, phasic pupil responses to the social stimulus differentiated the ASD group 
from both the DS and TD groups, but the direction of the phasic response was different from our 
previous investigation; the ASD group showed a phasic increase to the social stimulus, while the 
DS group had a slightly increased response and the TD group showed a decreased response.  The 
pattern of these phasic responses were similar for the non-social stimulus, but only differentiated 
the ASD group from TD controls.  The distinct pattern of these phasic pupillary responses may 
be due to the dynamic nature of the stimuli and these findings are discussed below in terms of 
motion-processing deficits in ASD.  No between-group differences in either phasic AA or 
cortisol responses to either stimulus were able to distinguish the ASD group from both control 
groups.    
 Phasic pupil responses.  Previous autonomic investigations have found altered phasic 
pupil and non-pupillary responses to stimuli with social relevance in ASD (Corona et al., 1998; 
Falck-Ytter, 2008; Heilman et al., 2008; Hirstein et al., 2001; Hubert et al., 2009; Kootz et al., 
1982; Kootz & Cohen, 1981; Sigman et al., 2003; Van Hecke et al., 2009), indicative of altered 
processing in those with the disorder.  Consistent with these findings, we recently found children 
with ASD to have a decreased pupillary response to static photos of human faces, particularly to 
the internal features of the face, while age-matched controls showed an increased response and 
did not differ (Anderson et al., 2006).  In our previous investigation, no between-group 
differences were found for phasic pupillary responses to any of the non-face stimuli.  Therefore, 
we concluded that the decreased phasic pupil response of the ASD group was indicative of 
decreased attention to human faces.  However, the results of the current study which reveal 
significant between-group differences in phasic pupil responses between the ASD and TD groups 
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to the non-social stimulus, along with significant differences between the ASD and both control 
groups to the social stimulus.  Contrary to previous work, this suggests that phasic pupillary 
responses may represent a more general processing deficit in ASD accentuated by social content.  
In fact, a post-hoc paired-samples t test revealed no significant differences between phasic pupil 
responses to the social and non-social stimulus for all groups, t(22) = -.584, p = .565, or when 
examined by diagnostic group, ASD [t(7) = -1.161, p = .284], DS [t(6) = .234, p = .823] and TD 
group [t(7) = -.074, p = .943]; indicating that similar phasic pupil responses and consequently 
cognitive resources and/or attention were allocated to each stimulus type.   
 The difference between the phasic pupil direction of the current and previous study may 
be due to methodological differences in stimulus parameters and complexity.  Thus, studies have 
found individuals with ASD to have performance deficits (reaction times, reporting accuracy, 
and higher coherence thresholds) on tasks utilizing both socially-relevant (human figure) (Freitag 
et al., 2008; Koldewyn, Whitney, & Rivera, 2010) and non-social (random dot arrays) stimuli 
that contain movement (Freitag et al., 2008; Koldewyn et al., 2010; Spencer et al., 2000), but 
have found intact performance when presented with static stimuli compared to controls 
(Koldewyn et al., 2010; Spencer et al., 2000).  Furthermore, task performance on motion tasks 
has been found to be related to language and cognitive ability (Koldewyn et al., 2010; Takarae, 
Luna, Minshew, & Sweeney, 2008), but performance deficits on tasks involving biological 
motion (human-based) appear to be more robust to ASD classification as between-group 
differences persist even when cognitive ability is controlled (Koldewyn et al., 2010).  Thus, it is 
possible that deficits in motion processing could have resulted in the ASD groups increased pupil 
size, as pupil size tends to increase with task difficulty (e.g., Andreassi, 2000; Beatty & Lucero-
Wagoner, 2000); intact processing of static stimuli in ASD would have required less cognitive 
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effort and resulted in a smaller pupil size.  The similar responses to the non-social stimulus 
provide further support for this position, as ASD-related deficits in motion processing would also 
be expected to result in an increase in cognitive resources and consequently pupil size to any 
dynamic stimulus.  In addition, the initial findings that motion processing deficits are a 
consequence of cognitive and language ability, explains why the DS group, who were matched 
with the ASD group on MA and CA, would also have an increased phasic response to the 
stimuli.  Thus, the visual dynamics of the stimuli used in the current study create more noise in 
detection of between-group differences to the social stimulus.  Finally, the discrepant findings 
between the TD groups’ responses to static (increased phasic pupil response) and dynamic 
(decreased phasic pupil response) stimuli may also be a function of the dynamic nature of the 
stimuli.  Movement has been shown to elicit pupillary constriction (e.g., Sahraie & Barbur, 
1997), thus the responses of the TD group in the current study are consistent with this 
observation.   
 Delays in the development of the dorsal pathway within the visual system (dorsal 
occipital and parietal lobes), which has been found to result in altered motion processing in 
several neurodevelopmental disorders (e.g., Gunn et al., 2002; Klaver et al., 2008; Taylor, 
Jakobson, Maurer, & Lewis, 2009), may help to explain the direction of the phasic pupil 
responses.  Additionally, the finding that persons with ASD have slowed disengagement to 
peripheral targets (e.g., Landry & Bryson, 2004; van der Geest, Kemner, Camfferman, Verbaten, 
& van Engeland, 2001) may further support the involvement of dorsal pathway delays in ASD;  
however, as presented earlier, the timing of disengagement deficits in ASD (slowed responses to 
targets that occur at 500 msec or less, and preserved responses when targets occur after 700 
msec) may be more consistent with the commonly found cerebellum impairment in those with 
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the disorder (e.g., Casey et al., 1993; Harris et al., 1999; Townsend et al., 1996, 1999; Townsend 
& Courchesne, 1994).  Thus, while neural delays with the dorsal stream may help to explain the 
direction of the phasic pupil responses, they do not provide an adequate explanation for the 
ability of performance-based responses to biological motion (e.g., Freitag et al., 2008; Koldewyn 
et al., 2010) and phasic pupil responses to both static (Anderson et al., 2006) and dynamic 
(current study) social stimuli to distinguish individuals with ASD from MA- and CA-matched 
controls.     
 Phasic alpha-amylase.  Salivary levels of AA have been shown to vary with changes in 
plasma levels of NE (Chatterton et al., 1996; Rohleder et al., 2004; Wetherell et al., 2006), 
indicative of phasic NE system activation (Minderaa et al., 1994).  Therefore, because 
heightened plasma levels of NE have been found in ASD (e.g., Cook et al., 1990; Israngkun et 
al., 1986; Lake et al., 1977; Launay et al., 1987; Leboyer et al., 1992; Leventhal et al., 1990), 
phasic AA responses were expected to differentiate the ASD group from controls in current 
study.  In addition, because the NE system plays a central role in balancing the ratio of inhibitory 
and excitatory activity within the pupillary system, a significant relationship was also anticipated 
between phasic AA and pupillary responses.  AA responses to both the social and non-social 
stimulus decreased from baseline values for all groups.  However in contrast to plasma NE 
studies in ASD, no between-group differences emerged for the current study.  In addition, 
correlations among phasic AA levels and phasic pupil responses were all insignificant, with the 
exception of the correlation between 10-minute AA responses and phasic pupil responses to the 
non-social stimulus.  As presented above, non-social phasic pupil responses distinguished the TD 
group from both clinical groups (ASD and DS) and thus were attributed to developmental delay.  
Similarly, the correlation between these phasic non-social measures were found to be mediated 
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by diagnostic group, thus, it is possible that the relationship between phasic non-social responses 
may also be a function of differences between the mental age of the TD and clinical groups.      
 Phasic cortisol.  As reported earlier, previous investigations of phasic cortisol responses 
to physical, social, and non-social stressors in ASD have yielded mixed results (e.g., Corbett et 
al., 2006, 2008, 2009; Jansen et al., 2003, 2006; Marinovic-Curin et al., 2008).  These 
inconsistent findings coupled with the lack of structural abnormalities within the LH or PH in 
ASD have led to some uncertainty about hypothalamic (LH and PH) and/or cortisol involvement 
in ASD.  Between-group differences did emerge for the current study; phasic cortisol decreased 
to the social stimulus for the TD group, but was significantly increased for both clinical groups 
(ASD and DS) who did not differ from one another.  Cortisol responses to the non-social 
stimulus decreased for the TD group, marginally decreased for the DS group, and increased for 
the ASD group, but these between-group differences did not attain conventional levels of 
statistical significance.  In addition, none of the correlations among phasic pupil and cortisol 
responses to either stimulus were significant, but coefficients did change once diagnosis was held 
constant.  Thus, coefficients for responses to the social stimulus were notably decreased once 
diagnosis was partialed out but remained insignificant, while the partial correlation coefficient 
for responses to the non-social stimulus attained significance.  Since the ASD and DS groups did 
not differ, these results are consistent with the possibility that phasic cortisol responses to the 
social stimulus (and possibly their relation to phasic pupil responses) are due to differences in 
MA.  It is possible that increased cortisol responses could reflect a heightened level of stress 
resulting from the presentation of the social stimulus.  While this would provide additional 
clarification of the increased phasic pupil response, this interpretation is only speculative as no 
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relationship emerged among these phasic measures and does not provide an adequate explanation 
for increased phasic pupil size that also occurred in the clinical groups to the non-social stimulus. 
 Summary and conclusion.  Increased phasic pupillary responses to the social stimulus 
were able to differentiate the ASD group from both control groups and are indicative of 
increased attention or cognitive resource allocation that may result from general deficits in 
motion-processing that are most robust to ASD classification when stimuli with biological 
motion (human-based) are utilized.  Thus, the increased pupil size for both clinical groups to the 
non-social stimulus further supports the indication of a general motion-processing deficit in 
developmental disorders and emphasizes the importance of including a non-social “control” 
stimulus in future studies examining human-based processing in ASD.  While the discrepant 
direction of the phasic pupillary responses, between the current and previous investigation, seem 
to be logically explained by the dynamic nature of the stimuli, future studies of phasic pupil 
responding in ASD that integrate both static and dynamic human-based and control stimuli are 
warranted. 
 None of the phasic salivary correlates distinguished the ASD group from both control 
groups.  However, the altered cortisol response to the social stimulus for both clinical groups 
indicates a possible developmental effect that may be a function of a stress-based response or 
delayed development of neural system that underlie and mediate cortisol release.  Thus, future 
neurochemical investigations, measuring NE, cortisol, and LH and PH activation through a 
variety of mediums (e.g., saliva, plasma, urine, etc.), and phasic pupillary responses in ASD to 
social and non-social stimuli with differing parameters and complexity are necessary to exclude 
involvement of these systems in ASD phasic pupil responding.    
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Conclusions and Limitations 
 The current study demonstrated that tonic pupil size, tonic AA responses, and phasic 
pupil responses to the social stimulus were able to significantly differentiate the ASD group from 
both the DS and TD age-matched controls; and a discriminant analysis indicated that these 
measures correctly classified 100% (71.4% cross-validated) of the ASD group.  The results of 
the current study are consistent with our previous investigations in finding that both tonic pupil 
size and phasic pupil responses to a socially-relevant stimulus can distinguish those with ASD 
from age-matched controls.  In addition, the current results extend our previous pupillary 
findings by indicating that alterations in the NE system may underlie the atypical tonic pupil 
responses in ASD, and that the direction of the phasic pupil response may be altered by 
movement.   
 Pupil size has been shown to change in response to socially-relevant stimuli as early as 
one month of age (Fitzgerald, 1968).  Therefore because both tonic and phasic pupil measures 
can be obtained during infancy and have been found to significantly distinguish young children 
with ASD in the current and previous studies, the candidacy of these responses as early 
indicators of ASD are warranted.  The time course for the emergence of salivary AA is more 
protracted than pupil measures; AA is not present in the saliva until approximately 1 year of age 
(e.g., Granger et al., 2007).  However, the current finding of lower levels of salivary AA that can 
distinguish young children with ASD from controls merits the investigation of this salivary 
measure as a potential biological marker of ASD.  In addition, because the NE system (A1/A5 
and LC) begins neurogenesis very early during the prenatal period (Bayer et al., 1993) and 
makes vast NE innervations that help to regulate CNS development (e.g., Coyle, 1977; Schlumpf 
et al., 1980; Sievers et al., 1981), a neurochemical or structural indication of disruption in this 
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system is likely present during infancy and possibly prenatally.  Therefore, because salivary AA 
was related to tonic pupil size, it could be argued that if tonic pupil size is able to differentiate 
ASD during infancy, that other correlates of the NE system (neurochemical and structural 
measures) may also be present during this period and have the ability to identify those with the 
disorder.  In addition, if the NE system is indeed impaired in ASD, measurements of this system 
during the infancy may lead to a greater understanding of how the pathology and functional 
impairment of the NE system is involved in producing ASD symptomology.    
 However, there are several limitations that should be addressed in future investigations.  
In the current study, the groups were mean-matched on both MA and CA to ensure that group 
differences were not a function of variations in developmental level.  Because we only examined 
pupil and salivary responses in young children with ASD, future investigations with older 
children and adults are necessary to determine if the significant findings in the current and 
previous studies vary across development.  Second, some autonomic responses such as blood 
pressure, respiration rate, and HR have been found to be correlated with body mass index (BMI) 
(e.g., Gelber, Pfeifer, Dawson, & Shumer, 1997; Nagai & Moritani, 2004; Pitzalis et al., 2000).  
However, no such responses have been found with pupillary responses (e.g., Filipe, Falcao-Reis, 
Castro-Correia, & Barros, 2003; Phia, Rommemaa, & Koskenvuo, 1994) and thus BMI was not 
examined in the current study.  However, BMI has been found to be associated with salivary 
cortisol responses (e.g., Charmandari et al., 2003), and the BMI of both children with DS (Cronk 
et al., 1988) and ASD (e.g., Mraz, Green, Dumont-Matbieu, Makin, & Fein, 2007; Torrey, 
Dhavale, Lawlor, & Yolken, 2004) have been found to be increased.   Thus, it is possible that the 
increased tonic cortisol responses in the DS group, and heightened phasic cortisol reactions to 
social stimuli in both clinical groups may have been the result of altered BMI; therefore, BMI 
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should be examined in future pupil and salivary studies.  Finally, in the current study, only 
indirect peripheral measurements (salivary AA and cortisol) were obtained; therefore, any 
inferences to the functioning of the neurological components of the pupillary system should be 
interpreted with caution and were included in the current study to determine if further 
investigation of these pupillary systems in ASD were warranted.  Thus, future structural and 
neurochemical studies are necessary to determine the involvement of the NE system, HPA, and 
LH and PH in ASD, in addition to examining the candidacy of these responses as early 
identifiers of the disorder.  
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Footnotes 
1. The exception to this was the participants who had amblyopia of the left eye (n = 5) 
whose right eye was tracked. 
2. Multivariate outliers were identified by evaluating Mahalanobis distance at p < .005.   
3. Homogeneity of the variance-covariance matrices was evaluated at the p < .001 level 
using Box’s M estimate for multivariate tests, and Levene’s estimate at the p < .05 level 
for univariate tests; these assumptions were met unless noted.   
4. Due to small sample sizes, the results of the within-subject univariate tests are presented 
using the Greenhouse Geisser estimate, which does not assume sphericity, and corrects 
the degrees of freedom of the F statistic as a function of sphericity violations.   
5. Follow-up tests were evaluated using the LSD adjustment for multiple comparisons. 
6. Homogeneity of the variance-covariance matrices was evaluated at the p < .05 level using 
Levene’s estimate; this assumption was not violated unless noted. 
7. Univariate outliers were identified as values that were greater than 2 SD from the group 
mean. 
8. Homogeneity-of-regression was evaluated at the p < .001 level and was not violated. 
9. Salivary concentrations of AA (U/mL) were subjected to square-root transformations and 
cortisol concentrations (µg/dL) to logarithmic transformations.   The transformed values 
were utilized in all statistical analyses, but the actual concentrations are presented in 
figures for descriptive purposes.  
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Appendix D 
 
Developmental Disability Organizations that Assisted in Participant Recruitment 
 
ABC’nD Enterprises LLC 
Autism Alliance of Kansas City 
Autism and Behavior Consulting, INC 
Autism Society of America, Johnson County 
Autism Society of Johnson County 
Autism Speaks 
Capper Foundation 
Center for Child Health and Development at the University of Kansas Medical Center 
Children’s Mercy Hospital 
Children’s TLC 
Down Syndrome Guild of Greater Kansas City 
Early Childhood Autism Program (ECAP) 
Individualized Behavior Solutions 
Infant and Toddler Services of Johnson County 
Infant and Toddler Services of Leavenworth County 
Infant and Toddler Services of Topeka KS 
Infant and Toddler Services of Wyandotte County 
Families Together Inc. Kansas City 
Families Together Inc. Topeka 
Kansas City Autism Training Center 
Lawrence Autism Society 
Olathe School District 
Successful Sounds 
Sunflower Early Education Center 
Tiny K Early Intervention 
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Appendix E 
Recruitment Letter 
 
 
RESEARCH AT THE UNIVERSITY OF KANSAS 
Children with Autism, children with Down syndrome, and typically developing children are 
needed to participate in an autism research project at the University of Kansas.   
 
Dear Parents:   
 
Autism is a neurological disorder that is marked by impaired development in social interaction and 
communication and a restricted repertoire of activities and interests.  Although we know that 
autism is a neurological disorder, the root of the neurological dysfunction is unknown.  Therefore, 
research efforts have been focused at trying to identify what brain areas may primarily contribute 
to the disorder.  In addition, because children with Down syndrome share some of the language 
delays with children with autism, we are interested in determining whether or not children with this 
diagnosis share similar neurological dysfunctions with children with autism.   Hopefully, through 
various research efforts, we will obtain a clearer idea about the causes of autism and Down 
Syndrome.  The research project that we will be conducting will study the function one two brain 
regions to determine if either of these areas may be a key to identifying and diagnosing children 
with autism and /or children with Down syndrome.   
 
What is the purpose of this research project? 
The purpose of the research project is to determine if locus coeruleus and/or hypothalamic activity 
is dysfunctional in children with autism and/or children with Down syndrome.  The locus coeruleus 
and hypothalamic systems are involved in controlling pupil size and are involved in the control of 
attentional arousal.  Therefore, this project will use activities that elicit this attentional responses 
and will examine salivary measures of these systems.   
 
Who may participate in this project? 
We are looking for children who are between the ages of 2 and 6 years of age and who have either 
(a) a diagnosis of autism or PDD-NOS, (b) diagnosed Down syndrome without an autism spectrum 
disorder diagnosis, and (c) typically developing children.  The children must not have neurological 
disorders (beyond autism or Down syndrome), should be free of hearing or vision difficulties 
(corrected vision and hearing with glasses and/or hearing aids is okay) or other serious health 
problems such as heart disease.  In addition, the children should not be taking any medications 
(vitamins are okay). 
 
What type of activities will my child participate in? 
Each child will be seen at our Lawrence laboratory for two separate sessions.  During each session, 
your child will complete a visual stimuli task, in which your child will sit in a car seat and will be 
shown a movie clip.  While they are looking at the pictures, their eye movements and pupil diameters 
will be recorded.  In addition, salivary samples will be taken from your child at various specific time  
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points during and after the movie clip.  Finally, a standardized intelligence assessment, and a 
standardized assessment of autism will be completed (they will be completed at separate sessions).  
The standardized intelligence assessment will consist of a variety of activities that your child will 
be asked to complete.  The standardized assessment of autism will be completed while your child 
participates in free play with toys.   
 
How long will these activities take? 
Participation would require 2 sessions, and each session should take approximately 2 hours to 
complete.  In addition, you will be asked to take salivary measures from your child on two additional 
days in your home-environment, and these samples will be picked up by a research assistant when 
completed.   
 
Will we be reimbursed for our time and travel? 
YES!  You will be give $100 for participation in this study, $50 for each of the two sessions.    
 
How do I sign up for participation? 
If you are interested in participating in this research project or if you have any further questions, 
please contact us directly at our Lawrence office at (785) 312-5345 (please ask to speak with 
Christa Anderson, or leave a message if no one is available) or e-mail Christa at cjanders@ku.edu.   
 
 
We hope that you will consider participation. 
 
Sincerely, 
 
Christa J. Anderson, M.A. and John Colombo Ph.D.   
Doctoral Student 
University of Kansas 
Schiefelbusch Life Span Institute 
KU Infant Cognition Lab 
 
165 
Appendix F 
 
Consent Form 
 
The University of Kansas 
Infant Cognition Research Program 
Wakarusa Research Facility 
1315 Wakarusa Drive, Suite 121 
Lawrence, KS 66049 
(785) 312-5345 
 
INFORMED CONSENT STATEMENT 
Autism Research Project 
 
 
INTRODUCTION 
 
The Scheifelbusch Institute for Life Span Studies at the University of Kansas supports the practice of protection for 
human subjects participating in research.  The following information is provided for you to decide whether you and 
your child wish to participate in the present study.  You may refuse to sign this form and not participate in this study.  
You should be aware that even if you agree to participate, you and your child are free to withdraw at any time.  If 
you and your child do withdraw from this study, it will not affect your or your child’s relationship with this unit, the 
services it may provide to you or your child, or the University of Kansas. 
 
PURPOSE OF THE STUDY 
The purpose of our research is to record certain types of eye movements and ocular responses in infants who have a 
sibling with a diagnosed Autism Spectrum Disorder.   
 
PROCEDURES 
To do this, we will need to conduct three different assessments: 
 
1.  We will need to determine the mental ability for all of the children in this study, and so we will be administering 
a standardized assessment of intelligence.  This should take approximately forty-five minutes.   
 
2.  We will need assess autism symptomology by administering a standard assessment of autism.  This should also 
take approximately fifteen minutes to one half hour.  In addition, while your child is completing this assessment 
he/she will be videotaped for blind coding purposes.   
 
3.  Finally, we will be administering a visual stimuli task.  During this task your child will sit alone in a car/booster 
seat facing a computer screen.  Eight static photographs of human faces, animal faces, toys, and landscapes will be 
presented to your baby for 15 to 30 seconds each.   While your child is looking at the pictures, we will measure your 
child's pupil diameter, and measure the part of the picture at which they are looking.  The eye movement 
measurement system uses an infrared light source that tracks your child's pupil, and a head tracking sensor that will 
be attached to a head band worn by your child.  In addition, while your child is completing this task, he/she will be 
videotaped in order to monitor their behavior.  This will be done at our laboratory facility, and should take 
approximately 1 hour to complete. 
 
At the end of the session, we will be able give you a brief description of your child's performance, and ask that you 
fill out a questionnaire that pertains to your child’s health, background, and environment.  You will also be asked to 
take 8 salivary measures from your child in their home environment on two additional days to determine how their 
levels of alpha-amylase and cortisol vary throughout the day and fill out a questionnaire asking about salivary 
collection times, food intake, physical activity, and abnormal events that may have happened that day. In addition, 
you will be asked to complete the Children’s Sleep Habits Questionnaire at home and return to us when completed. 
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RISKS    
Please be assured that none of our procedures will present any risk to you or your child.  The use of infrared light 
will be used to measure eye movement and pupil diameter.  However, the level of the infrared light used (0.8 
mW/cm2) is well below the standards for risk from infrared light sources prescribed by OSHA (10.0 mW/cm2).   
 
BENEFITS 
Upon completion of the entire project, we will send you a general report of our results.  In addition, if we suspect 
that your child is showing symptomology indicative of autism, you will be referred to a diagnostic clinic for further 
assessment.  You and your child’s participation will make an important contribution toward our understanding of 
autism.    
 
PAYMENT TO PARTICIPANTS  
Participants will be paid $50 per session for their time and travel.  You do not have to consent to the study to be 
reimbursed; if after reading this consent you choose not to participate, you will still be given $50 for time and travel.  
However, parents must provide all information on the payment receipt (parent name, address, and parent social 
security number) to be given payment, as this is information that the University of Kansas is required to provide to 
the IRS.  This is taxable income and you are required to report this to the IRS.  Receipts will be given to the 
LifeSpan Institute accounting department and our lab will keep copies of these receipts in a locked file cabinet in a 
locked room; this will only be accessible by member of our lab.  
 
INFORMATION TO BE COLLECTED    
To perform this study, researchers will collect information about you and your child from the questionnaire that you 
will be asked to complete.  In addition, to receive reimbursement for time and travel parents will be asked to 
complete a receipt which requires the parent to provide their social security number.  Also, information will be 
collected from the study activities that are listed in the Procedures section of this consent form.   
 
It is our policy to protect the confidentiality of all of our participants.  You and your child’s name will be coded by a 
confidential number and will not appear in any analyses or publications involved with this study.  We would also 
like to assure you that you and your child’s participation is voluntary and that you and your child may withdraw 
from the study at any time, even after you have signed this consent form. Also, you and/or your child’s decision to 
participate or withdraw from the study will not affect or influence any relationship that you or your child might have 
with our department in the future.  
 
The information collected about you and your child will be used by: Christa Anderson, M. A,  John Colombo, Ph.D., 
and other research members of the Infant Cognition Lab, KUCR, and officials at KU that oversee research, 
including committees and offices that review and monitor research studies.  In addition, Christa Anderson or Dr. 
John Colombo may share the information gathered in this study with investigators at the University of Kansas 
involved in the Center for Behavioral Neuroscience in Communicative Disorders. 
The researchers will not share information about you or your child with anyone not specified above unless required 
by law or unless you give written permission.    
Permission granted on this date to use and disclose you and your child’s information remains in effect indefinitely.  
By signing this form you give permission for the use of you and your child’s information for the purposes of this 
study or any future analysis that uses the information collected during this study at any time in the future. 
 
REFUSAL TO SIGN CONSENT AND AUTHORIZATION 
 
You are not required to sign this Consent and Authorization form and you may refuse to do so without affecting 
your right to any services you are receiving or may receive from the University of Kansas or to participate in any 
programs or events of the University of Kansas.  However, if you refuse to sign, you cannot participate in this study. 
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CANCELLING THIS CONSENT AND AUTHORIZATION 
 
You may withdraw your consent to participate in this study at any time.  You also have the right to cancel your 
permission to use and disclose information collected about you and your child, in writing, at any time, by sending 
your written request to:  Christa Anderson or Dr. John Colombo at 1315 Wakarusa, Lawrence, KS 66049.  If you 
cancel permission to use you and your child’s information, the researchers will stop collecting additional 
information about you and your child.  However, the research team may use information that was gathered before 
they received your cancellation, as described above.  
 
PARTICIPANT CERTIFICATION: 
 
I have read this Consent and Authorization form. I have had the opportunity to ask, and I have received answers to, 
any questions I had regarding the study and the use and disclosure of information about me for the study.  I 
understand that if I have any additional questions about my or my child’s rights as a research participant, I may 
call (785) 864-7429 or write the Human Subjects Committee Lawrence Campus (HSCL), University of Kansas, 2385 
Irving Hill Road, Lawrence, Kansas   66045-7563, email dhann@ku.edu. 
 
I agree to allow my child to take part in this study as a research participant.  I further agree to the uses and 
disclosures of my and my child’s information as described above.  By my signature I affirm that I am at least 18 
years old and that I have received a copy of this Consent and Authorization form.  
 
We are very grateful for your participation.  
 
Date ___/___/___    
 
Child’s Name________________________   
 
Research Staff Signature  ______________________________________ 
 
Parent's Signature ______________________________________ 
 
Parent's Address ___________________________________________________________ 
 
[If signed by a personal representative, a description of such representative’s authority to act for the individual must 
also be provided, e.g. parent/guardian.] 
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Health and Background Questionnaire 
 
University of Kansas 
Autism Research Program 
 
Health and Background Questionnaire 
 
Child’s Date of Birth: ____/____/____ 
 
Child’s Current Health (Mark any that apply) 
 _____ Has a cold 
 _____ Running a temperature 
 _____ Has and ear infection 
 _____ Is currently taking medication (prescription or over the counter).   
Please specify:  ______________________________________ 
 _____ Has taken medications (prescription or over the counter) within the last 48 hours. 
 _____ Has had shots within one week of appointment 
  If yes, what shots:____________________________________ 
  Date of shots:_______________________________________ 
_____ Has been rehospitalized since birth 
             If so, for what condition?   _____________________________________________ 
              For how long?             _____________________________________________ 
 _____ Has chronic condition  Please specify:  _______________________________ 
 _____ Other (please indicate if there are any conditions not listed here that your child has) 
  Please specify: _____________________________________________________ 
 
 Child has had _____ ear infections since birth. 
 
 
Time your child last had anything to eat (including gum or candy): _____________________________ 
Time your child last had anything to drink: ________________________________________________ 
Time your child last consumed caffeine (this includes chocolate, soda, tea, or other caffeinated products):  
___________________________________________________________________________________  
Time your child last engaged in exhaustive physical activity (running, swimming, biking, etc): _______ 
___________________________________________________________________________________ 
 
Today’s food intake: 
 Please list all foods that your child has eaten today: 
____________________________________________________________________________________ 
____________________________________________________________________________________ 
____________________________________________________________________________________ 
____________________________________________________________________________________ 
____________________________________________________________________________________ 
 
Traumatic events: 
 Please list any events that happened today that may have been stressful or unusual to the child  
(i.e., loss of a pet, car accident, loss of a favorite toy, birthday party etc.) 
____________________________________________________________________________________ 
____________________________________________________________________________________ 
____________________________________________________________________________________ 
____________________________________________________________________________________ 
Lab Use Only 
 
Child’s Code:  ___________ 
Today’s Date:  ___/___/____ 
Appointment Time:  _____:_____ 
 
HQ filled out by       Mom  Dad  Rel  Care  Other 
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Autism/Down’s syndrome Diagnosis: 
 Does your child have the diagnosis of autism? _________ 
  If yes, when did your child receive this diagnosis?_____________ 
  At what age did you first notice autism-like symptoms in your child?___________ 
  Is your child currently receiving services?____________ 
  If yes, what type of services is your child receiving 
  (e.g., behavioral intervention, speech therapy, etc.)? 
—Please list all that apply.  
______________________________________________________________________ 
______________________________________________________________________ 
______________________________________________________________________ 
  How many hours per week is your child receiving each service?___________________ 
______________________________________________________________________ 
  ______________________________________________________________________ 
______________________________________________________________________ 
 
 Does your child have a Down’s syndrome diagnosis?___________ 
  Is your child currently receiving services?____________ 
  If yes, what type of services is your child receiving  
(e.g., behavioral intervention, speech therapy, etc.)? 
—Please list all that apply.  
_______________________________________________________________________ 
_______________________________________________________________________ 
_______________________________________________________________________ 
  How many hours per week is your child receiving each service?____________________ 
_______________________________________________________________________ 
  _______________________________________________________________________ 
_______________________________________________________________________ 
 
 
Caregiving Arrangements (these caregiving arrangements should not include treatment services for autism  
or a developmental disability). 
 Child is in daycare for _____ hours per week.  (If not in daycare, enter zero) 
  If in daycare, what type: 
  _____ Daycare center 
  _____ Home-based care 
   _____ Your home (i.e., you run a daycare for other children 
   _____ A relative’s home (e.g., grandparent, aunt, etc.) 
   _____ Someone else’s home 
  _____ Private caretaker/nanny/au pair in your home 
 
Home Environment 
 How many siblings living at home full-time? _____ (include half-siblings) 
 Ages of these siblings _____________________________________________________________ 
 
 How many siblings visit or live at home part-time? _____ 
 Ages of these siblings _____________________________________________________________ 
 Approximate frequency and length of visit/stay:  ________________________________________ 
 
 _____ Individuals other than the baby’s mother, father, siblings living at home full-time 
  _____grandmother _____grandfather 
  _____aunt  _____uncle 
  _____friend  _____other (_______________________) 
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Please indicate highest level of education completed. 
High 
School
Jr. 
Coll.
College or 
University
Grad Degree 
(MA, PhD, MD, JD, etc.)
1 2 3 4 1 2 1 2 3 4
1 2 3 4 1 2 1 2 3 4
Age 
Mother
Father
Occupation 
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Current Health Questionnaire 
 
University of Kansas 
Autism Research Program 
 
Current Health Questionnaire 
 
Child’s Current Health (Mark any that apply) 
 _____ Has a cold 
 _____ Running a temperature 
 _____ Has an ear infection 
 _____ Is currently taking medication (prescription or over the counter).   
Please specify:  ______________________________________ 
 _____ Has taken medications (prescription or over the counter) within the last 48 hours. 
 _____ Has had shots within one week of appointment 
  If yes, what shots:____________________________________ 
  Date of shots:_______________________________________ 
 _____ Has chronic condition  Please specify:  _______________________________ 
 _____ Other (please indicate if there are any conditions not listed here that your child has) 
  Please specify: _____________________________________________________ 
 
 
Time your child last had anything to eat (including gum or candy): _____________________________ 
Time your child last had anything to drink: ________________________________________________ 
Time your child last consumed caffeine (this includes chocolate, soda, tea, or other caffeinated products):  
___________________________________________________________________________________  
Time your child last engaged in exhaustive physical activity (running, swimming, biking, etc): _______ 
___________________________________________________________________________________ 
 
Today’s food intake: 
 Please list all foods that your child has eaten today: 
____________________________________________________________________________________ 
____________________________________________________________________________________ 
____________________________________________________________________________________ 
____________________________________________________________________________________ 
____________________________________________________________________________________ 
 
Traumatic events: 
 Please list any events that happened today that may have been stressful to the child 
(i.e., loss of a pet, car accident, loss of a favorite toy, birthday party etc.) 
____________________________________________________________________________________ 
____________________________________________________________________________________ 
____________________________________________________________________________________ 
____________________________________________________________________________________ 
____________________________________________________________________________________ 
 
 
 
 
Lab Use Only 
 
Child’s Code:  ___________ 
Today’s Date:  ___/___/____ 
Appointment Time:  _____:_____ 
 
HQ filled out by       Mom  Dad  Rel  Care  Other 
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Report Letter 
 
Dear Parent: 
We thank you for your participation and support of the University of Kansas Autism Research 
Project.  As part of the tests administered for the Autism Research Project, we gave (child’s 
name) two tests.  One was the Mullen, which measures various mental abilities.  The other was 
the Autism Diagnostic Observation Schedule Module 1 or 2, which measures the degree to 
which autism-like symptoms are exhibited.  The purpose of this letter is to give you some 
feedback on your child’s performance on these measures.  Similar letters are provided to all of 
the families in the project. 
 
Before providing this information, we think that it is important for us to emphasize that the 
outcome of these tests should be interpreted very cautiously.  There are three reasons for this:  
 
1. These two tests were given by our research assistants for the purposes of our research project. 
Our staff are not trained clinicians, and so the test results cannot be used to diagnose 
developmental delays or autism, or to identify children with high ability. 
 
2. Measures of children’s ability during the toddler or preschool ages is far from an "exact 
science."  Scores at these ages are greatly influenced by many factors that can artificially 
lower a child's score (the child's mood, sleepiness, and/or hunger at the time of testing) or 
raise a child's score.   
 
3. These tests measure only a limited number of abilities, and do not measure many other skills 
or strengths that your child may have in other areas. 
 
Mullen 
For the Mullen, we obtain "percentile ranks" for the Early Learning Composite (an overall 
score), and for four subtests (tests of specific abilities, Visual Reception, Fine Motor, Receptive 
Language, and Expressive Language).   The percentiles range from 99 to 0, with higher numbers 
reflecting more optimal scores.  In addition, a descriptive category is presented next to each 
score.  This description explains where your child’s scores lie, relative to the typically 
developing children that were tested in the making of the test.  
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Your child’s percentile scores on the Mullen are as follows:  
Subscale Percentile Descriptive 
Category 
Age 
Equivalent 
Visual Reception 
Fine Motor 
Receptive Language 
Expressive Language 
Early Learning Composite (overall 
score) 
 
Autism Diagnostic Observation Schedule (ADOS) 
 The ADOS yields two category scores (Communication and Qualitative Impairments in 
Reciprocal Social Interaction) which are added together to generate one total score.  The scores 
for this test indicate the degree to which autism-like symptoms were present.  The cut-off score 
for falling within the autism range is 12; this means that any scores below 12 do not qualify as 
being in the range of autism.  Again, these scores are not meant to diagnose or not diagnose your 
child.  This test was completed for research purposes only, and only a qualified clinician who 
would complete several assessments on your child is able to give a diagnosis.     
 
Your child’s score on the ADOS was:  
 
The phrase 'no score' may appear in one or more of the boxes above.  If that occurs, it means that 
we were unable to obtain what we would consider to be a valid score for your child on that test 
or subtest. 
If you have any questions or concerns, please feel free to call the laboratory at (785) 312-5345.  
Again we would like to thank you for your participation in our project. 
Sincerely, 
 
Christa J. Anderson, M.A. and John Colombo Ph.D. 
Doctoral Student 
University of Kansas 
Schiefelbusch Life Span Institute 
KU Infant Cognition Lab 
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Non-Social Stimulus Example with Defined Look Zones (White Lines) 
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Social Stimulus Example with Defined Look Zones (White Lines) 
 
Internal features: Represented in the shaded area 
External features:  Area within white lines, excluding shaded area 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hands: Represented in the shaded area 
Body:  Area within white lines, excluding shaded area
